Pengenalan
Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Felix Baker. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.
Purata Keuntungan Perdagangan
Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.
Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.
Kekerapan Kemas Kini: Harian
Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan
Pemfailan SEC menunjukkan Felix Baker telah melaporkan pegangan atau perdagangan dalam syarikat berikut:
Bagaimana Mentafsir Carta
Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Felix Baker. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.
Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.
Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.
Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.
Pembelian Orang Dalam ACAD / ACADIA Pharmaceuticals Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam ACAD / ACADIA Pharmaceuticals Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam CELC / Celcuity Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Maks |
Harga pada Maks |
Maks Keuntungan ($) |
Pulangan Maks (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam CELC / Celcuity Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam HOOK / HOOKIPA Pharma Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam HOOK / HOOKIPA Pharma Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam KALA / KALA BIO, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam KALA / KALA BIO, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam KNSA / Kiniksa Pharmaceuticals, Ltd. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam KNSA / Kiniksa Pharmaceuticals, Ltd. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam KOD / Kodiak Sciences Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam KOD / Kodiak Sciences Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam KYMR / Kymera Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam KYMR / Kymera Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam MDGL / Madrigal Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam MDGL / Madrigal Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam NTLA / Intellia Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam NTLA / Intellia Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam PRLD / Prelude Therapeutics Incorporated - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam PRLD / Prelude Therapeutics Incorporated - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam REPL / Replimune Group, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Maks |
Harga pada Maks |
Maks Keuntungan ($) |
Pulangan Maks (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam REPL / Replimune Group, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam SERA / Sera Prognostics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Maks |
Harga pada Maks |
Maks Keuntungan ($) |
Pulangan Maks (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam SERA / Sera Prognostics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam SYRE / Spyre Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Maks |
Harga pada Maks |
Maks Keuntungan ($) |
Pulangan Maks (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam SYRE / Spyre Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam TCRX / TScan Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam TCRX / TScan Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam TLIS / Talis Biomedical Corporation - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam TLIS / Talis Biomedical Corporation - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam TRDA / Entrada Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam TRDA / Entrada Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam VTVT / vTv Therapeutics Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Maks |
Harga pada Maks |
Maks Keuntungan ($) |
Pulangan Maks (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam VTVT / vTv Therapeutics Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam XOMAO / XOMA Royalty Corporation - Preferred Stock - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam XOMAO / XOMA Royalty Corporation - Preferred Stock - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam ZYME / Zymeworks Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Maks |
Harga pada Maks |
Maks Keuntungan ($) |
Pulangan Maks (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam ZYME / Zymeworks Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ACAD / ACADIA Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Sejarah Dagangan Orang Dalam
Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Felix Baker seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).
Tarikh Fail | Tarikh Tran | Borang | Simbol Saham | Sekuriti | Kod | Saham | Baki Saham | Peratus Ubah |
Saham harga |
Tran Nilai |
Baki Nilai |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46,692 | 135,946 | 52.31 | ||||
2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4,308 | 12,368 | 53.45 | ||||
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,128 | 1,859,091 | 0.55 | 372.16 | 3,769,209 | 691,874,287 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194,625 | 0.48 | 372.16 | 347,223 | 72,431,115 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,494 | 1,848,963 | 0.30 | 371.00 | 2,038,301 | 685,974,518 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193,692 | 0.26 | 371.00 | 187,729 | 71,860,700 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,747 | 1,843,469 | 0.15 | 369.34 | 1,014,563 | 680,857,623 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193,186 | 0.13 | 369.34 | 93,442 | 71,350,351 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,419 | 1,840,722 | 0.08 | 368.84 | 523,384 | 678,931,902 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192,933 | 0.07 | 368.84 | 48,318 | 71,161,408 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,798 | 1,839,303 | 0.26 | 367.77 | 1,764,565 | 676,442,304 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192,802 | 0.23 | 367.77 | 162,555 | 70,906,984 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,289 | 1,834,505 | 0.12 | 366.30 | 838,459 | 671,977,714 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192,360 | 0.11 | 366.30 | 77,289 | 70,461,314 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,772 | 1,832,216 | 0.15 | 363.75 | 1,008,308 | 666,463,806 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192,149 | 0.13 | 363.75 | 92,756 | 69,893,699 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,587 | 1,829,444 | 0.31 | 362.39 | 2,024,662 | 662,968,735 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191,894 | 0.27 | 362.39 | 186,630 | 69,540,102 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,443 | 1,823,857 | 0.30 | 361.37 | 1,966,957 | 659,093,770 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191,379 | 0.26 | 361.37 | 181,410 | 69,159,318 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,514 | 1,818,414 | 0.47 | 359.39 | 3,059,873 | 653,525,445 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190,877 | 0.41 | 359.39 | 281,764 | 68,599,877 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,472 | 1,809,900 | 0.14 | 358.21 | 885,495 | 648,324,279 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190,093 | 0.12 | 358.21 | 81,672 | 68,093,214 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,328 | 1,807,428 | 0.46 | 357.02 | 2,973,289 | 645,293,728 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189,865 | 0.41 | 357.02 | 273,837 | 67,786,210 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1,799,100 | 0.05 | 355.00 | 325,180 | 638,680,500 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189,098 | 0.04 | 355.00 | 29,820 | 67,129,790 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,923 | 1,798,184 | 0.11 | 353.88 | 680,503 | 636,333,262 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189,014 | 0.09 | 353.88 | 62,636 | 66,887,424 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,362 | 1,947,968 | 0.48 | 392.24 | 3,672,178 | 764,076,617 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202,813 | 0.43 | 392.24 | 338,113 | 79,551,959 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,506 | 1,938,606 | 0.13 | 389.89 | 977,059 | 755,838,828 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201,951 | 0.11 | 389.89 | 90,064 | 78,738,231 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1,936,100 | 0.02 | 389.00 | 142,374 | 753,142,900 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201,720 | 0.02 | 389.00 | 13,226 | 78,469,080 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,441 | 1,935,734 | 0.23 | 387.07 | 1,718,969 | 749,260,688 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201,686 | 0.20 | 387.07 | 158,311 | 78,066,197 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,545 | 1,931,293 | 0.71 | 385.06 | 5,215,601 | 743,658,468 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,248 | 201,277 | 0.62 | 385.06 | 480,552 | 77,503,178 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,049 | 1,917,748 | 0.21 | 383.79 | 1,553,954 | 736,007,135 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200,029 | 0.19 | 383.79 | 143,153 | 76,768,570 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,838 | 1,913,699 | 0.15 | 382.82 | 1,086,447 | 732,604,739 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199,656 | 0.13 | 382.82 | 100,299 | 76,432,569 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,136 | 1,910,861 | 0.06 | 382.29 | 434,280 | 730,501,332 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199,394 | 0.05 | 382.29 | 40,140 | 76,226,153 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,477 | 1,909,725 | 0.50 | 381.12 | 3,611,889 | 727,837,448 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199,289 | 0.44 | 381.12 | 332,719 | 75,953,343 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,919 | 1,900,248 | 0.10 | 380.78 | 730,717 | 723,576,433 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198,416 | 0.09 | 380.78 | 67,017 | 75,552,844 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,209 | 1,898,329 | 0.28 | 380.44 | 1,981,694 | 722,193,641 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198,240 | 0.24 | 380.44 | 182,610 | 75,417,732 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,325 | 1,893,120 | 0.39 | 374.43 | 2,742,728 | 708,848,115 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197,760 | 0.34 | 374.43 | 252,743 | 74,048,028 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,704 | 1,885,795 | 1.44 | 372.87 | 9,957,102 | 703,155,062 | |
2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,460 | 197,085 | 1.26 | 372.87 | 917,258 | 73,486,946 | |
2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3,763,362 | 0 | -100.00 | ||||
2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357,048 | 0 | -100.00 | ||||
2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689,944 | ||||||||
2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7,055,748 | ||||||||
2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600,309 | 6,117,295 | 10.88 | 44.00 | 26,413,596 | 269,160,980 | |
2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55,191 | 534,134 | 11.52 | 44.00 | 2,428,404 | 23,501,896 | |
2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326,302 | ||||||||
2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3,405,393 | ||||||||
2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,069 | 17.42 | ||||
2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,065 | 17.42 | ||||
2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28,184,571 | 0.00 | ||||
2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2,813,892 | 0.02 | ||||
2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,762,409 | 0.03 | ||||
2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356,095 | 0.27 | ||||
2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92,349 | 2,144,060 | 4.50 | 29.56 | 2,729,864 | 63,379,057 | |
2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8,589 | 178,596 | 5.05 | 29.56 | 253,893 | 5,279,351 | |
2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646,290 | 2,051,711 | 45.99 | 29.74 | 19,221,699 | 61,021,168 | |
2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60,110 | 170,007 | 54.70 | 29.74 | 1,787,768 | 5,056,280 | |
2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929,241 | ||||||||
2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10,116,095 | ||||||||
2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671,976 | 8,068,411 | -7.69 | 260.00 | -174,713,760 | 2,097,786,860 | |
2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60,851 | 730,642 | -7.69 | 260.00 | -15,821,260 | 189,966,920 | |
2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432,434 | ||||||||
2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5,065,736 | ||||||||
2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 9,999,674 | 0.04 | ||||
2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 918,483 | 0.48 | ||||
2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,761,456 | 0.05 | ||||
2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 355,142 | 0.56 | ||||
2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279,939 | 1,083,398 | 34.84 | 6.44 | 1,802,807 | 6,977,083 | |
2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30,620 | 118,496 | 34.84 | 6.44 | 197,193 | 763,114 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457,631 | 9,995,274 | 4.80 | 15.34 | 7,020,883 | 153,345,495 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42,369 | 914,083 | 4.86 | 15.34 | 650,017 | 14,023,679 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566,814 | 9,537,643 | 6.32 | 13.80 | 7,824,300 | 131,657,624 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52,656 | 871,714 | 6.43 | 13.80 | 726,863 | 12,033,140 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244,587 | 8,970,829 | 2.80 | 13.72 | 3,356,761 | 123,117,451 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22,722 | 819,058 | 2.85 | 13.72 | 311,841 | 11,240,916 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59,995 | 8,726,242 | 0.69 | 13.63 | 817,660 | 118,928,207 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5,573 | 796,336 | 0.70 | 13.63 | 75,953 | 10,853,104 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30,241 | 8,666,247 | 0.35 | 13.50 | 408,190 | 116,976,135 | |
2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2,809 | 790,763 | 0.36 | 13.50 | 37,916 | 10,673,640 | |
2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916,964 | 8,740,387 | -9.49 | 186.50 | -171,013,786 | 1,630,082,176 | |
2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83,036 | 791,493 | -9.49 | 186.50 | -15,486,214 | 147,613,444 | |
2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33,943 | 9,657,351 | -0.35 | 208.01 | -7,060,609 | 2,008,861,314 | |
2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3,074 | 874,529 | -0.35 | 208.01 | -639,434 | 181,914,013 | |
2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28,183,638 | 0.00 | ||||
2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2,812,959 | 0.02 | ||||
2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,759,462 | 0.05 | ||||
2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 353,148 | 0.57 | ||||
2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5,516,986 | 0.00 | 46.41 | 46 | 256,043,320 | |
2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87,876 | ||||||||
2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803,459 | ||||||||
2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2,186,686 | 8,636,006 | 33.91 | ||||
2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196,098 | 787,954 | 33.13 | ||||
2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5,283,206 | 28,182,605 | -15.79 | 60.00 | -316,992,360 | 1,690,956,300 | |
2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175,977 | 2,811,926 | -5.89 | 60.00 | -10,558,620 | 168,715,560 | |
2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109,897 | ||||||||
2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1,405,421 | ||||||||
2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 33,462,981 | 0.04 | 49.01 | 735,150 | 1,640,020,699 | |
2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 2,985,073 | 0.51 | 49.01 | 735,150 | 146,298,428 | |
2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579,856 | ||||||||
2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6,437,320 | ||||||||
2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33,447,981 | 0.00 | ||||
2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2,970,073 | 0.02 | ||||
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89,407 | 3,753,480 | 2.44 | 9.62 | 860,042 | 36,106,226 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,066 | 347,166 | 2.38 | 9.62 | 77,590 | 3,339,529 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,439 | 3,664,073 | 0.23 | 9.27 | 78,207 | 33,956,064 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339,100 | 0.22 | 9.27 | 7,052 | 3,142,541 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,101 | 3,655,634 | 0.47 | 9.22 | 157,683 | 33,707,504 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1,543 | 338,339 | 0.46 | 9.22 | 14,228 | 3,119,722 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247,656 | 3,638,533 | 7.30 | 8.26 | 2,046,159 | 30,061,923 | |
2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22,344 | 336,796 | 7.11 | 8.26 | 184,608 | 2,782,642 | |
2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12,836 | ||||||||
2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142,135 | ||||||||
2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52,881 | 89,254 | -37.20 | ||||
2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4,776 | 8,060 | -37.21 | ||||
2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42,977,301 | 0 | -100.00 | 229.00 | -9,841,801,929 | ||
2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1,731,202 | 0 | -100.00 | 229.00 | -396,445,258 | ||
2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,277 | 0 | -100.00 | 229.00 | -5,330,433 | ||
2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,280 | 0 | -100.00 | 229.00 | -5,331,120 | ||
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214,025 | 3,390,323 | 6.74 | 6.60 | 1,412,565 | 22,376,132 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,066 | 313,898 | 5.75 | 6.60 | 112,636 | 2,071,727 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52,528 | 3,176,298 | 1.68 | 6.37 | 334,399 | 20,220,631 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4,188 | 296,832 | 1.43 | 6.37 | 26,661 | 1,889,662 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3,123,770 | 0.01 | 6.36 | 1,176 | 19,851,558 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292,644 | 0.01 | 6.36 | 95 | 1,859,753 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145,749 | 3,123,585 | 4.89 | 6.50 | 947,602 | 20,308,300 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11,621 | 292,629 | 4.14 | 6.50 | 75,555 | 1,902,557 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71,219 | 2,977,836 | 2.45 | 5.99 | 426,751 | 17,843,491 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5,679 | 281,008 | 2.06 | 5.99 | 34,029 | 1,683,828 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9,649 | 2,906,617 | 0.33 | 5.76 | 55,567 | 16,738,626 | |
2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275,329 | 0.28 | 5.76 | 4,429 | 1,585,565 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,857 | 1,699,129 | 0.23 | 221.24 | 853,330 | 375,918,358 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178,461 | 0.17 | 221.24 | 68,142 | 39,483,033 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,408 | 1,695,272 | 0.26 | 220.65 | 972,645 | 374,069,565 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178,153 | 0.20 | 220.65 | 77,670 | 39,310,279 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,005 | 1,690,864 | 0.90 | 219.24 | 3,289,711 | 370,706,714 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,195 | 177,801 | 0.68 | 219.24 | 261,993 | 38,981,269 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,873 | 1,675,859 | 0.17 | 217.91 | 626,049 | 365,182,748 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176,606 | 0.13 | 217.91 | 49,901 | 38,483,825 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,672,986 | 0.01 | 217.90 | 40,312 | 364,543,649 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,377 | 0.01 | 217.90 | 3,268 | 38,432,548 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,769 | 1,672,801 | 0.11 | 216.67 | 383,286 | 362,442,949 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176,362 | 0.08 | 216.67 | 30,550 | 38,212,055 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1,671,032 | 0.04 | 214.72 | 143,434 | 358,807,834 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176,221 | 0.03 | 214.72 | 11,380 | 37,838,578 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1,670,364 | 0.03 | 213.80 | 110,107 | 357,122,821 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176,168 | 0.02 | 213.80 | 8,766 | 37,664,613 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,669,849 | 0.01 | 213.62 | 39,521 | 356,721,493 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,127 | 0.01 | 213.62 | 3,204 | 37,625,130 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,669,664 | 0.04 | 212.04 | 137,403 | 354,037,892 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,112 | 0.03 | 212.04 | 11,026 | 37,343,035 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,669,016 | 0.01 | 209.76 | 19,508 | 350,101,141 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176,060 | 0.00 | 209.76 | 1,468 | 36,931,226 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1,668,923 | 0.02 | 208.69 | 77,216 | 348,289,710 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176,053 | 0.02 | 208.69 | 6,261 | 36,740,729 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,668,553 | 0.04 | 206.93 | 134,092 | 345,277,176 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,023 | 0.03 | 206.93 | 10,760 | 36,424,809 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1,667,905 | 0.04 | 205.60 | 145,565 | 342,921,268 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175,971 | 0.03 | 205.60 | 11,514 | 36,179,638 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,667,197 | 0.01 | 205.32 | 19,095 | 342,308,888 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175,915 | 0.00 | 205.32 | 1,437 | 36,118,868 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,960 | 1,793,403 | 0.22 | 229.86 | 910,264 | 412,240,043 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185,979 | 0.17 | 229.86 | 72,637 | 42,750,007 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,204 | 1,789,443 | 0.12 | 228.79 | 504,252 | 409,405,411 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185,663 | 0.09 | 228.79 | 40,267 | 42,477,708 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11,602 | 1,787,239 | 0.65 | 227.86 | 2,643,597 | 407,234,917 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185,487 | 0.50 | 227.86 | 210,768 | 42,264,511 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,343 | 1,775,637 | 0.08 | 226.97 | 304,822 | 403,018,106 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184,562 | 0.06 | 226.97 | 24,286 | 41,890,222 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,594 | 1,774,294 | 0.32 | 224.91 | 1,258,156 | 399,059,480 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184,455 | 0.24 | 224.91 | 100,311 | 41,486,088 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1,768,700 | 0.02 | 223.94 | 81,289 | 396,078,079 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184,009 | 0.02 | 223.94 | 6,494 | 41,206,497 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,262 | 1,768,337 | 0.53 | 222.68 | 2,062,425 | 393,766,210 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183,980 | 0.40 | 222.68 | 164,335 | 40,967,930 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,532 | 1,759,075 | 0.26 | 221.78 | 1,005,101 | 390,125,367 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183,242 | 0.20 | 221.78 | 80,062 | 40,639,173 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,518 | 1,754,543 | 0.26 | 219.87 | 993,351 | 385,762,948 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182,881 | 0.20 | 219.87 | 79,151 | 40,209,168 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29,738 | 1,750,025 | 1.73 | 218.46 | 6,496,513 | 382,307,486 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,373 | 182,521 | 1.32 | 218.46 | 518,402 | 39,873,227 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,894 | 1,720,287 | 0.64 | 217.52 | 2,369,611 | 374,188,571 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180,148 | 0.48 | 217.52 | 189,021 | 39,184,928 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,264 | 1,709,393 | 0.60 | 216.70 | 2,224,203 | 370,424,437 | |
2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179,279 | 0.46 | 216.70 | 177,260 | 38,849,652 | |
2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1,941,607 | 2,168,818 | 854.54 | 0.00 | 194 | 217 | |
2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174,742 | 196,654 | 797.47 | 0.00 | 17 | 20 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,917 | 1,667,104 | 0.48 | 190.14 | 1,505,308 | 316,976,653 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175,908 | 0.37 | 190.14 | 124,539 | 33,446,461 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,620 | 1,659,187 | 0.95 | 188.70 | 2,947,539 | 313,093,399 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 175,253 | 0.74 | 188.70 | 243,615 | 33,070,749 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,505 | 1,643,567 | 0.83 | 188.46 | 2,545,218 | 309,754,690 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,117 | 173,962 | 0.65 | 188.46 | 210,515 | 32,785,731 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,011 | 1,630,062 | 0.80 | 188.32 | 2,450,273 | 306,978,492 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,076 | 172,845 | 0.63 | 188.32 | 202,636 | 32,550,724 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,712 | 1,617,051 | 0.29 | 187.27 | 882,420 | 302,826,273 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171,769 | 0.23 | 187.27 | 72,661 | 32,167,301 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,124 | 1,612,339 | 0.13 | 187.24 | 397,706 | 301,900,642 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171,381 | 0.10 | 187.24 | 32,955 | 32,090,047 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,385 | 1,610,215 | 0.09 | 186.59 | 258,431 | 300,454,847 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171,205 | 0.07 | 186.59 | 21,458 | 31,945,655 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1,608,830 | 0.04 | 186.32 | 120,547 | 299,752,540 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171,090 | 0.03 | 186.32 | 9,875 | 31,876,993 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1,608,183 | 0.02 | 183.16 | 67,586 | 294,554,798 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171,037 | 0.02 | 183.16 | 5,678 | 31,327,137 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1,607,814 | 0.01 | 185.94 | 27,148 | 298,963,688 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171,006 | 0.01 | 185.94 | 2,231 | 31,797,574 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,022 | 1,607,668 | 0.19 | 189.70 | 573,267 | 304,971,083 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170,994 | 0.15 | 189.70 | 47,424 | 32,437,186 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,147 | 1,604,646 | 0.07 | 188.84 | 216,595 | 303,014,772 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170,744 | 0.06 | 188.84 | 17,939 | 32,242,597 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,895 | 1,603,499 | 0.31 | 187.34 | 917,054 | 300,407,520 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170,649 | 0.24 | 187.34 | 75,875 | 31,970,237 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,206 | 1,598,604 | 0.08 | 185.86 | 224,153 | 297,124,532 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170,244 | 0.06 | 185.86 | 18,586 | 31,642,401 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,010 | 1,597,398 | 0.44 | 183.40 | 1,285,633 | 292,962,633 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170,144 | 0.34 | 183.40 | 106,189 | 31,204,393 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,847 | 1,590,388 | 0.12 | 181.93 | 336,025 | 289,339,289 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169,565 | 0.09 | 181.93 | 27,835 | 30,848,960 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,715 | 1,588,541 | 0.68 | 175.82 | 1,883,889 | 279,293,943 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169,412 | 0.54 | 175.82 | 158,764 | 29,785,662 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,923 | 1,577,826 | 0.31 | 175.72 | 865,062 | 277,253,218 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168,509 | 0.25 | 175.72 | 72,923 | 29,610,149 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18,125 | 1,572,903 | 1.17 | 174.87 | 3,169,606 | 275,061,098 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,528 | 168,094 | 0.92 | 174.87 | 267,209 | 29,395,405 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1,554,778 | 0.06 | 174.67 | 170,827 | 271,572,762 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166,566 | 0.05 | 174.67 | 14,323 | 29,094,050 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,660 | 1,553,800 | 0.11 | 173.75 | 288,422 | 269,969,798 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166,484 | 0.08 | 173.75 | 24,325 | 28,926,279 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,151 | 1,552,140 | 0.27 | 173.20 | 718,960 | 268,833,131 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166,344 | 0.21 | 173.20 | 60,621 | 28,811,047 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1,547,989 | 0.03 | 171.79 | 79,195 | 265,929,030 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165,994 | 0.02 | 171.79 | 6,700 | 28,516,109 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,107 | 1,547,528 | 0.07 | 168.78 | 186,842 | 261,195,645 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165,955 | 0.06 | 168.78 | 15,697 | 28,010,300 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,546,421 | 0.04 | 167.63 | 108,289 | 259,226,552 | |
2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165,862 | 0.03 | 167.63 | 9,052 | 27,803,447 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,548 | 1,500,227 | 0.91 | 154.78 | 2,096,961 | 232,205,285 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,142 | 161,969 | 0.71 | 154.78 | 176,759 | 25,069,578 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,098 | 1,486,679 | 0.55 | 153.97 | 1,246,878 | 228,909,318 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160,827 | 0.43 | 153.97 | 105,164 | 24,763,112 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,877 | 1,478,581 | 0.19 | 153.25 | 440,907 | 226,595,939 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160,144 | 0.15 | 153.25 | 37,087 | 24,542,436 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,475,704 | 0.04 | 152.21 | 98,330 | 224,621,185 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159,902 | 0.03 | 152.21 | 8,219 | 24,339,147 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,022 | 1,475,058 | 0.41 | 152.48 | 918,235 | 224,916,844 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159,848 | 0.32 | 152.48 | 77,307 | 24,373,623 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,542 | 1,469,036 | 0.24 | 154.60 | 547,582 | 227,108,412 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159,341 | 0.19 | 154.60 | 46,224 | 24,633,625 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,426 | 1,465,494 | 1.84 | 146.21 | 3,863,756 | 214,270,464 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,228 | 159,042 | 1.42 | 146.21 | 325,757 | 23,253,594 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,994 | 1,439,068 | 0.21 | 145.98 | 437,057 | 210,071,549 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156,814 | 0.16 | 145.98 | 36,786 | 22,891,316 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,369 | 1,436,074 | 0.45 | 145.46 | 926,430 | 208,890,175 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156,562 | 0.34 | 145.46 | 78,112 | 22,773,383 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 1,429,705 | 0.09 | 142.86 | 184,429 | 204,244,082 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156,025 | 0.07 | 142.86 | 15,571 | 22,289,341 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,790 | 1,428,414 | 0.76 | 141.44 | 1,526,192 | 202,042,018 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155,916 | 0.59 | 141.44 | 128,715 | 22,053,539 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,072 | 1,417,624 | 0.36 | 140.90 | 714,657 | 199,746,624 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155,006 | 0.28 | 140.90 | 60,165 | 21,840,717 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,631 | 1,412,552 | 0.33 | 137.69 | 637,622 | 194,487,928 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154,579 | 0.25 | 137.69 | 53,697 | 21,283,287 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,693 | 1,407,921 | 0.26 | 136.91 | 505,605 | 192,756,915 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154,189 | 0.20 | 136.91 | 42,579 | 21,109,846 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,144 | 1,404,228 | 0.22 | 136.18 | 428,151 | 191,228,471 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153,878 | 0.17 | 136.18 | 36,088 | 20,955,183 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,018 | 1,545,775 | 0.92 | 161.97 | 2,270,439 | 250,362,994 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,181 | 165,808 | 0.72 | 161.97 | 191,282 | 26,855,259 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31,530 | 1,531,757 | 2.10 | 156.42 | 4,932,061 | 239,604,170 | |
2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,658 | 164,627 | 1.64 | 156.42 | 415,776 | 25,751,680 | |
2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,008,660 | 9,691,294 | -9.43 | 180.50 | -182,063,130 | 1,749,278,567 | |
2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91,340 | 877,603 | -9.43 | 180.50 | -16,486,870 | 158,407,342 | |
2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251,902 | 2,971,128 | -7.82 | 0.40 | -101,391 | 1,195,879 | |
2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22,837 | 286,893 | -7.37 | 0.40 | -9,192 | 115,474 | |
2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535,601 | 1,658,190 | 47.71 | ||||
2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57,049 | 155,874 | 57.73 | ||||
2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33,446,882 | 0.00 | ||||
2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2,968,974 | 0.02 | ||||
2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,968 | 0.02 | ||||
2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274,560 | 0.20 | ||||
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61,134 | 5,612,949 | 1.10 | 0.69 | 42,354 | 3,888,651 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5,041 | 494,133 | 1.03 | 0.69 | 3,492 | 342,335 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93,091 | 5,551,815 | 1.71 | 0.69 | 64,456 | 3,844,077 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7,676 | 489,092 | 1.59 | 0.69 | 5,315 | 338,647 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,434 | 5,458,724 | 0.08 | 0.68 | 3,028 | 3,727,217 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481,416 | 0.08 | 0.68 | 250 | 328,711 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207,676 | 5,454,290 | 3.96 | 0.68 | 141,324 | 3,711,644 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17,124 | 481,050 | 3.69 | 0.68 | 11,653 | 327,355 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,342 | 5,246,614 | 0.08 | 0.66 | 2,887 | 3,488,998 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463,926 | 0.08 | 0.66 | 238 | 308,511 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1,740,581 | 5,242,272 | 49.71 | 0.63 | 1,097,958 | 3,306,825 | |
2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143,519 | 463,568 | 44.84 | 0.63 | 90,532 | 292,419 | |
2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148,821 | ||||||||
2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1,396,292 | ||||||||
2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259,109 | 39,317,673 | 0.66 | 25.65 | 6,646,146 | 1,008,498,312 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,113 | 3,610,443 | 0.67 | 25.65 | 618,498 | 92,607,863 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,878 | 39,058,564 | 0.07 | 25.51 | 736,788 | 996,532,390 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,688 | 3,586,330 | 0.08 | 25.51 | 68,581 | 91,500,906 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,171 | 39,029,686 | 0.56 | 25.27 | 5,513,683 | 986,369,933 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20,304 | 3,583,642 | 0.57 | 25.27 | 513,129 | 90,566,876 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74,582 | 38,811,515 | 0.19 | 25.54 | 1,904,824 | 991,246,093 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,941 | 3,563,338 | 0.20 | 25.54 | 177,273 | 91,007,653 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116,672 | 38,736,933 | 0.30 | 25.33 | 2,955,325 | 981,214,260 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,858 | 3,556,397 | 0.31 | 25.33 | 275,035 | 90,084,247 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40,632 | 38,607,761 | 0.11 | 24.80 | 1,007,674 | 957,472,473 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,781 | 3,533,039 | 0.11 | 24.80 | 93,769 | 87,619,367 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82,148 | 38,567,129 | 0.21 | 24.46 | 2,009,373 | 943,367,402 | |
2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,645 | 3,529,258 | 0.22 | 24.46 | 187,000 | 86,327,062 | |
2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21,912 | ||||||||
2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227,211 | ||||||||
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2,368,357 | 1,729,158 | -57.80 | ||||
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,573 | 97.65 | ||||
2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,569 | 97.66 | ||||
2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10,622,568 | 14,575,984 | 268.69 | ||||
2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1,252,432 | 1,585,054 | 376.53 | ||||
2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26,450 | 4,501,658 | 0.59 | 6.42 | 169,849 | 28,907,397 | |
2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,118 | 364,161 | 0.86 | 6.42 | 20,022 | 2,338,460 | |
2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,815 | 4,475,208 | 0.17 | 6.35 | 49,654 | 28,434,129 | |
2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361,043 | 0.26 | 6.35 | 5,852 | 2,293,959 | |
2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,364 | 4,467,393 | 0.05 | 5.82 | 13,759 | 26,001,121 | |
2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360,122 | 0.08 | 5.82 | 1,624 | 2,095,982 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170,549 | 15,967,504 | 1.08 | 7.78 | 1,327,008 | 124,239,955 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20,108 | 1,342,986 | 1.52 | 7.78 | 156,456 | 10,449,505 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101,315 | 15,796,955 | 0.65 | 7.75 | 785,070 | 122,407,445 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,945 | 1,322,878 | 0.91 | 7.75 | 92,559 | 10,250,717 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78,271 | 15,695,640 | 0.50 | 7.95 | 622,466 | 124,822,716 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,224 | 1,310,933 | 0.71 | 7.95 | 73,356 | 10,425,457 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,155 | 15,617,369 | 0.08 | 7.93 | 104,363 | 123,897,273 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,550 | 1,301,709 | 0.12 | 7.93 | 12,297 | 10,326,848 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138,122 | 15,604,214 | 0.89 | 7.68 | 1,060,680 | 119,829,441 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,278 | 1,300,159 | 1.27 | 7.68 | 125,004 | 9,984,311 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,585 | 15,466,092 | 0.07 | 7.51 | 79,540 | 116,218,402 | |
2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,247 | 1,283,881 | 0.10 | 7.51 | 9,370 | 9,647,595 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88,046 | 15,455,507 | 0.57 | 6.92 | 609,278 | 106,952,108 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,386 | 1,282,634 | 0.82 | 6.92 | 71,871 | 8,875,827 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51,082 | 15,367,461 | 0.33 | 6.78 | 346,367 | 104,200,606 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,026 | 1,272,248 | 0.48 | 6.78 | 40,860 | 8,626,605 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15,316,379 | 0.00 | 6.64 | 2,375 | 101,624,175 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1,266,222 | 0.00 | 6.64 | 279 | 8,401,383 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15,316,021 | 0.01 | 6.76 | 6,647 | 103,459,722 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1,266,180 | 0.01 | 6.76 | 784 | 8,553,046 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53,401 | 15,315,037 | 0.35 | 6.75 | 360,521 | 103,394,878 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,299 | 1,266,064 | 0.50 | 6.75 | 42,526 | 8,547,451 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,090 | 15,261,636 | 0.19 | 6.71 | 195,089 | 102,350,636 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,432 | 1,259,765 | 0.27 | 6.71 | 23,016 | 8,448,488 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,250 | 15,232,546 | 0.28 | 6.60 | 279,002 | 100,589,641 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,984 | 1,256,333 | 0.40 | 6.60 | 32,912 | 8,296,321 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48,222 | 15,190,296 | 0.32 | 6.53 | 315,058 | 99,245,799 | |
2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,688 | 1,251,349 | 0.46 | 6.53 | 37,163 | 8,175,689 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19,789 | 4,465,029 | 0.45 | 5.74 | 113,619 | 25,635,964 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,334 | 359,843 | 0.65 | 5.74 | 13,401 | 2,066,039 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,521 | 4,445,240 | 0.03 | 5.93 | 9,020 | 26,360,273 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357,509 | 0.05 | 5.93 | 1,061 | 2,120,028 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,010 | 4,443,719 | 0.16 | 5.99 | 41,972 | 26,606,323 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357,330 | 0.23 | 5.99 | 4,952 | 2,139,478 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,772 | 4,436,709 | 0.18 | 5.84 | 45,405 | 25,919,698 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356,503 | 0.27 | 5.84 | 5,527 | 2,082,726 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,248 | 4,428,937 | 0.16 | 5.84 | 42,335 | 25,868,978 | |
2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355,557 | 0.25 | 5.84 | 5,158 | 2,076,773 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,489 | 15,142,074 | 0.05 | 5.97 | 44,701 | 90,381,525 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1,245,661 | 0.07 | 5.97 | 5,444 | 7,435,226 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182,827 | 15,134,585 | 1.22 | 5.97 | 1,091,221 | 90,332,284 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,266 | 1,244,749 | 1.82 | 5.97 | 132,897 | 7,429,409 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,157 | 14,951,758 | 0.06 | 5.95 | 54,518 | 89,018,282 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,115 | 1,222,483 | 0.09 | 5.95 | 6,638 | 7,278,297 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90,674 | 14,942,601 | 0.61 | 5.99 | 542,929 | 89,471,812 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,043 | 1,221,368 | 0.91 | 5.99 | 66,122 | 7,313,185 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,118 | 14,851,927 | 0.05 | 5.99 | 48,599 | 88,912,546 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1,210,325 | 0.08 | 5.99 | 5,921 | 7,245,732 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,154 | 14,843,809 | 0.10 | 5.75 | 87,098 | 85,314,792 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,846 | 1,209,336 | 0.15 | 5.75 | 10,610 | 6,950,659 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93,690 | 14,828,655 | 0.64 | 5.71 | 534,979 | 84,673,103 | |
2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,410 | 1,207,490 | 0.95 | 5.71 | 65,152 | 6,894,889 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30,003 | 4,421,689 | 0.68 | 6.00 | 180,018 | 26,530,134 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,654 | 354,674 | 1.04 | 6.00 | 21,924 | 2,128,044 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4,391,686 | 0.02 | 5.92 | 4,095 | 25,989,998 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351,020 | 0.02 | 5.92 | 497 | 2,077,336 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,501 | 4,390,994 | 0.38 | 6.13 | 101,153 | 26,917,232 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,010 | 350,936 | 0.58 | 6.13 | 12,322 | 2,151,273 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,937 | 4,374,493 | 0.39 | 5.83 | 98,673 | 25,485,359 | |
2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,063 | 348,926 | 0.59 | 5.83 | 12,019 | 2,032,808 | |
2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,676 | 3,676 | |||||
2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22,983 | 2,528,583 | 0.92 | 1.99 | 45,628 | 5,019,996 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2,882 | 256,209 | 1.14 | 1.99 | 5,722 | 508,652 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758,094 | 2,505,600 | 43.38 | 1.95 | 1,478,283 | 4,885,920 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95,060 | 253,327 | 60.06 | 1.95 | 185,367 | 493,988 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101,831 | 1,747,506 | 6.19 | 1.93 | 196,962 | 3,380,026 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12,769 | 158,267 | 8.78 | 1.93 | 24,698 | 306,120 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325,373 | 1,645,675 | 24.64 | 1.70 | 553,134 | 2,797,648 | |
2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40,800 | 145,498 | 38.97 | 1.70 | 69,360 | 247,347 | |
2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2,592,497 | 4,674,392 | 124.53 | 23.00 | 59,627,431 | 107,511,016 | |
2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233,590 | 421,532 | 124.29 | 23.00 | 5,372,570 | 9,695,236 | |
2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29,497 | 29,497 | |||||
2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175,795 | 33,419,055 | 0.53 | 73.31 | 12,887,303 | 2,449,907,477 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14,490 | 2,941,147 | 0.50 | 73.31 | 1,062,243 | 215,611,663 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,017 | 33,243,260 | 0.00 | 71.95 | 73,177 | 2,391,975,557 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2,926,657 | 0.00 | 71.95 | 6,044 | 210,583,800 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,107 | 33,242,243 | 0.08 | 71.90 | 1,805,126 | 2,390,027,518 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,070 | 2,926,573 | 0.07 | 71.90 | 148,827 | 210,412,697 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,147 | 33,217,136 | 0.20 | 71.72 | 4,672,408 | 2,382,366,211 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,370 | 2,924,503 | 0.18 | 71.72 | 385,142 | 209,748,280 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,385 | 33,151,989 | 0.28 | 70.68 | 6,529,310 | 2,343,016,823 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,615 | 2,919,133 | 0.26 | 70.68 | 538,190 | 206,309,725 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,234 | 33,039,604 | 0.28 | 68.07 | 6,278,507 | 2,249,055,404 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,566 | 2,891,518 | 0.26 | 68.07 | 515,029 | 196,829,968 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22,178 | 32,947,370 | 0.07 | 68.43 | 1,517,656 | 2,254,611,592 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,827 | 2,883,952 | 0.06 | 68.43 | 125,023 | 197,350,854 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100,731 | 32,925,192 | 0.31 | 68.37 | 6,886,696 | 2,251,003,187 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,296 | 2,882,125 | 0.29 | 68.37 | 567,174 | 197,042,816 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285,672 | 32,824,461 | 0.88 | 67.74 | 19,352,821 | 2,223,689,828 | |
2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,300 | 32,538,789 | 0.02 | 67.40 | 491,984 | 2,192,951,685 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271,997 | 14,734,965 | 1.88 | 54.57 | 14,843,883 | 804,141,559 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,403 | 1,196,080 | 1.91 | 54.57 | 1,222,615 | 65,274,511 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,174 | 14,462,968 | 0.04 | 53.82 | 278,457 | 778,376,690 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1,173,677 | 0.04 | 53.82 | 22,927 | 63,165,653 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64,119 | 14,457,794 | 0.45 | 54.26 | 3,479,200 | 784,503,035 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,281 | 1,173,251 | 0.45 | 54.26 | 286,556 | 63,662,476 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23,804 | 14,393,675 | 0.17 | 53.73 | 1,279,048 | 773,408,142 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,961 | 1,167,970 | 0.17 | 53.73 | 105,369 | 62,757,948 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,359 | 14,369,871 | 0.04 | 54.16 | 290,217 | 778,200,364 | |
2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1,166,009 | 0.04 | 54.16 | 23,882 | 63,145,217 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182,326 | 32,531,489 | 0.56 | 66.04 | 12,040,390 | 2,148,304,711 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320,526 | 32,349,163 | 1.00 | 66.02 | 21,159,973 | 2,135,575,284 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,985 | 32,028,637 | 0.03 | 66.95 | 735,433 | 2,144,278,813 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265,522 | 32,017,652 | 0.84 | 66.81 | 17,740,295 | 2,139,192,181 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772,751 | 31,752,130 | 2.49 | 67.54 | 52,192,839 | 2,144,589,664 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,100 | 30,979,379 | 0.02 | 67.20 | 409,899 | 2,081,705,841 | |
2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40,164 | 30,973,279 | 0.13 | 66.57 | 2,673,577 | 2,061,782,777 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27,841 | 14,364,512 | 0.19 | 57.22 | 1,593,076 | 821,944,559 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,307 | 1,165,568 | 0.20 | 57.22 | 132,008 | 66,694,384 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,526 | 14,336,671 | 0.08 | 51.61 | 594,898 | 739,967,202 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1,163,261 | 0.08 | 51.61 | 49,188 | 60,040,088 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,119 | 14,325,145 | 0.12 | 50.56 | 865,460 | 724,214,868 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,414 | 1,162,308 | 0.12 | 50.56 | 71,485 | 58,761,062 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,395 | 14,308,026 | 0.16 | 49.70 | 1,113,056 | 711,124,631 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,851 | 1,160,894 | 0.16 | 49.70 | 91,997 | 57,697,709 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54,024 | 14,285,631 | 0.38 | 51.67 | 2,791,490 | 738,157,125 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,465 | 1,159,043 | 0.39 | 51.67 | 230,712 | 59,889,259 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117,291 | 14,231,607 | 0.83 | 51.59 | 6,050,820 | 734,181,565 | |
2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,479 | 14,114,316 | 0.62 | 52.04 | 4,500,497 | 734,530,176 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,500 | 14,027,837 | 0.04 | 58.90 | 323,934 | 826,198,919 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57,547 | 14,022,337 | 0.41 | 58.87 | 3,387,844 | 825,507,599 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,350 | 13,964,790 | 0.07 | 58.76 | 549,368 | 820,513,805 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132,367 | 13,955,440 | 0.96 | 58.13 | 7,693,938 | 811,171,114 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25,900 | 13,823,073 | 0.19 | 57.59 | 1,491,519 | 796,037,599 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,083 | 13,797,173 | 0.85 | 56.86 | 6,601,060 | 784,576,243 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 13,681,090 | 0.01 | 56.60 | 67,914 | 774,281,289 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,750 | 13,679,890 | 0.14 | 56.39 | 1,113,649 | 771,372,061 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31,207 | 13,660,140 | 0.23 | 57.53 | 1,795,292 | 785,847,364 | |
2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102,207 | 13,628,933 | 0.76 | 56.57 | 5,782,279 | 771,045,981 | |
2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193,997 | 30,932,696 | 0.63 | 72.91 | 14,144,224 | 2,255,287,399 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881,875 | 30,738,699 | 2.95 | 72.77 | 64,177,924 | 2,236,990,377 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29,703 | 29,856,824 | 0.10 | 72.00 | 2,138,616 | 2,149,691,328 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139,612 | 29,827,121 | 0.47 | 71.96 | 10,045,795 | 2,146,213,474 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288,368 | 29,687,509 | 0.98 | 71.91 | 20,736,197 | 2,134,793,147 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,382 | 29,399,141 | 0.02 | 71.03 | 382,302 | 2,088,323,882 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,893 | 29,393,759 | 0.03 | 70.24 | 694,840 | 2,064,485,360 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36,476 | 29,383,866 | 0.12 | 69.63 | 2,539,700 | 2,045,898,684 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,352 | 29,347,390 | 0.03 | 68.52 | 640,841 | 2,011,015,226 | |
2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29,338,038 | 0.00 | 67.90 | 58,460 | 1,991,999,972 | |
2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346,863 | ||||||||
2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4,357,556 | ||||||||
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51,399 | 42,947,504 | -0.12 | 161.39 | -8,295,146 | 6,931,181,712 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4,738 | 4,069,762 | -0.12 | 161.39 | -764,653 | 656,807,901 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8,332 | 42,998,903 | -0.02 | 161.34 | -1,344,327 | 6,937,658,005 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4,074,500 | -0.02 | 161.34 | -123,913 | 657,400,202 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25,833 | 43,007,235 | -0.06 | 160.80 | -4,154,029 | 6,915,701,011 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,381 | 4,075,268 | -0.06 | 160.80 | -382,872 | 655,316,135 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,007 | 43,033,068 | 0.00 | 165.68 | -166,844 | 7,129,895,142 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4,077,649 | 0.00 | 165.68 | -15,409 | 675,601,605 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9,618 | 43,034,075 | -0.02 | 164.82 | -1,585,266 | 7,092,996,737 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4,077,742 | -0.02 | 164.82 | -146,033 | 672,104,854 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,337 | 43,043,693 | 0.00 | 163.39 | -218,449 | 7,032,809,999 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4,078,628 | 0.00 | 163.39 | -20,097 | 666,397,648 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20,154 | 43,045,030 | -0.05 | 160.96 | -3,243,986 | 6,928,523,724 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,858 | 4,078,751 | -0.05 | 160.96 | -299,063 | 656,515,353 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29,432 | 43,065,184 | -0.07 | 160.53 | -4,724,631 | 6,913,124,792 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,713 | 4,080,609 | -0.07 | 160.53 | -435,510 | 655,047,921 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5,860 | 43,094,616 | -0.01 | 160.08 | -938,044 | 6,898,400,822 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4,083,322 | -0.01 | 160.08 | -86,441 | 653,640,627 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208,597 | 43,100,476 | -0.48 | 160.00 | -33,375,520 | 6,896,076,160 | |
2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19,226 | 4,083,862 | -0.47 | 160.00 | -3,076,160 | 653,417,920 | |
2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50,000 | 7,053,176 | 0.71 | 4.36 | 218,250 | 30,787,113 | |
2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,932 | 13,526,726 | 0.65 | 95.83 | 8,330,572 | 1,296,247,215 | |
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138,815 | 0 | -100.00 | ||||
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11,184 | 0 | -100.00 | ||||
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13,439,794 | 0.00 | 102.00 | -1,428 | 1,370,858,988 | |
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138,815 | 13,439,808 | 1.04 | 0.01 | 1,388 | 134,398 | |
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1,154,578 | 0.00 | 102.00 | -204 | 117,766,956 | |
2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11,184 | 1,154,580 | 0.98 | 0.01 | 112 | 11,546 | |
2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,153 | 13,300,993 | 0.01 | 94.59 | 109,064 | 1,258,164,870 | |
2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,299,840 | 0.00 | 94.48 | 37,791 | 1,256,535,634 | |
2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,285 | 13,299,440 | 0.23 | 94.38 | 2,858,425 | 1,255,257,005 | |
2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52,201 | 13,269,155 | 0.39 | 93.35 | 4,872,948 | 1,238,671,639 | |
2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,300 | 13,216,954 | 0.04 | 92.88 | 492,279 | 1,227,629,017 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73,635 | 13,211,654 | 0.56 | 87.61 | 6,451,464 | 1,157,527,175 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,396 | 13,138,019 | 0.02 | 87.48 | 209,607 | 1,149,341,492 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,649 | 13,135,623 | 0.04 | 87.07 | 404,793 | 1,143,731,830 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,968 | 13,130,974 | 0.02 | 86.94 | 258,033 | 1,141,587,183 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,128,006 | 0.00 | 89.66 | 35,863 | 1,177,008,444 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,100 | 13,127,606 | 0.01 | 88.16 | 96,982 | 1,157,395,383 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,186 | 13,126,506 | 0.06 | 87.91 | 719,659 | 1,153,995,773 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,898 | 13,118,320 | 0.10 | 87.79 | 1,132,303 | 1,151,644,194 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,764 | 13,105,422 | 0.06 | 85.95 | 667,333 | 1,126,439,853 | |
2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,658 | 0.00 | 84.80 | 33,921 | 1,110,714,143 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,258 | 0.00 | 88.82 | 35,526 | 1,163,232,969 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,269 | 13,096,858 | 0.12 | 88.76 | 1,444,017 | 1,162,461,400 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,595 | 13,080,589 | 0.17 | 88.59 | 1,913,036 | 1,158,770,138 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,086 | 13,058,994 | 0.05 | 88.01 | 535,634 | 1,149,333,815 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,600 | 13,052,908 | 0.04 | 86.44 | 397,646 | 1,128,354,716 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13,048,308 | 0.00 | 85.58 | 25,674 | 1,116,674,199 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,500 | 13,048,008 | 0.03 | 88.00 | 395,990 | 1,148,195,998 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44,700 | 13,043,508 | 0.34 | 86.07 | 3,847,481 | 1,122,699,081 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12,998,808 | 0.00 | 85.72 | 51,434 | 1,114,295,518 | |
2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,723 | 12,998,208 | 0.03 | 84.39 | 314,185 | 1,096,922,673 | |
2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3,960,811 | 3,960,811 | |||||
2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3,960,811 | 0 | -100.00 | ||||
2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315,777 | 315,777 | |||||
2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315,777 | 0 | -100.00 | ||||
2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1,320,302 | 1,320,302 | 15.00 | 19,804,530 | 19,804,530 | ||
2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104,698 | 104,698 | 15.00 | 1,570,470 | 1,570,470 | ||
2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66,474 | 66,474 | |||||
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,368 | 7,368 | |||||
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121,612 | 12,994,485 | 0.94 | 92.75 | 11,279,014 | 1,205,185,206 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,009 | 12,872,873 | 0.05 | 91.64 | 642,276 | 1,179,617,303 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,353 | 12,865,864 | 0.17 | 90.20 | 2,016,332 | 1,160,553,683 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,603 | 12,843,511 | 0.04 | 89.74 | 413,070 | 1,152,566,402 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,221 | 12,838,908 | 0.24 | 90.70 | 2,741,157 | 1,164,536,460 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 12,808,687 | 0.01 | 90.40 | 108,474 | 1,157,841,261 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,731 | 12,807,487 | 0.09 | 90.39 | 1,060,378 | 1,157,682,838 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,847 | 12,795,756 | 0.03 | 89.90 | 345,828 | 1,150,282,163 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,079 | 12,791,909 | 0.06 | 89.87 | 636,196 | 1,149,620,375 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,459 | 12,784,830 | 0.08 | 91.87 | 960,845 | 1,174,514,205 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,445 | 12,774,371 | 0.18 | 91.80 | 2,060,393 | 1,172,654,044 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,170 | 12,751,926 | 0.08 | 90.76 | 923,046 | 1,157,386,482 | |
2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,200 | 12,741,756 | 0.04 | 90.27 | 469,420 | 1,150,237,814 | |
2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23,274 | 23,274 | |||||
2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23,344 | 23,344 | |||||
2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,996 | 34,996 | |||||
2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40,000 | 40,000 | |||||
2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8,010 | 8,010 | |||||
2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,462 | 3,462 | |||||
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,334,516 | 0.07 | 18.97 | 379,400 | 556,475,769 | |
2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 2,870,749 | 0.70 | 18.97 | 379,400 | 54,458,109 | |
2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47,200 | 47,200 | |||||
2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315,516 | ||||||||
2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3,094,590 | ||||||||
2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6,423 | 6,423 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,427,576 | 27,511,741 | 30.49 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,438 | 2,345,481 | 29.65 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,286,794 | 21,084,165 | 52.81 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,414 | 1,809,043 | 42.15 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1,941 | 5,420 | 55.79 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,654,603 | 13,797,371 | 93.17 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598,860 | 1,272,629 | 88.88 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,142,768 | 7,142,768 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673,769 | 673,769 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3,479 | 3,479 | |||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9,191,433 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767,106 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10,420,117 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767,072 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2,776 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9,516,082 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856,370 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10,214,159 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963,490 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4,975 | 0 | -100.00 | ||||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5,792,538 | 7,003,176 | 478.47 | 16.00 | 92,680,608 | 112,050,816 | |
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457,462 | 571,659 | 400.59 | 16.00 | 7,319,392 | 9,146,544 | |
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9,191,433 | 9,191,433 | 8.55 | 78,586,752 | 78,586,752 | ||
2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767,106 | 767,106 | 8.55 | 6,558,756 | 6,558,756 | ||
2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,456 | 23,277 | -87.19 | ||||
2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,460 | 23,280 | -87.19 | ||||
2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114,197 | ||||||||
2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1,210,638 | ||||||||
2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154,222 | 5,212,371 | 3.05 | 60.00 | 9,253,320 | 312,742,260 | |
2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12,444 | 509,480 | 2.50 | 60.00 | 746,640 | 30,568,800 | |
2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332,622 | ||||||||
2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3,953,416 | ||||||||
2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1,200,369 | ||||||||
2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13,413,895 | ||||||||
2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111,094 | 10,699,954 | -1.03 | 220.50 | -24,496,227 | 2,359,339,857 | |
2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10,060 | 968,943 | -1.03 | 220.50 | -2,218,230 | 213,651,932 | |
2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518,555 | 10,283,888 | 5.31 | ||||
2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38,974 | 1,199,122 | 3.36 | ||||
2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394,360 | 3,501,691 | 12.69 | 15.25 | 6,013,990 | 53,400,788 | |
2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29,640 | 320,049 | 10.21 | 15.25 | 452,010 | 4,880,747 | |
2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616,846 | 616,846 | 89.99 | 55,509,972 | 55,509,972 | ||
2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49,820 | 49,820 | 89.99 | 4,483,302 | 4,483,302 | ||
2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,386,033 | 10,811,048 | -11.36 | 220.50 | -305,620,276 | 2,383,836,084 | |
2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125,513 | 979,003 | -11.36 | 220.50 | -27,675,616 | 215,870,162 | |
2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,411,619 | 12,736,556 | 12.46 | 108.00 | 152,454,852 | 1,375,548,048 | |
2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,158 | 1,143,396 | 11.31 | 108.00 | 12,545,064 | 123,486,768 | |
2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382,884 | 5,058,149 | 8.19 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382,884 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30,349 | 497,036 | 6.50 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30,349 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574,327 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45,524 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2,698,424 | 4,675,265 | 136.50 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2,698,424 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247,034 | 466,687 | 112.47 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247,034 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4,047,634 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370,552 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1,976,841 | 1,976,841 | |||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1,976,841 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219,653 | 219,653 | |||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219,653 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2,965,263 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329,478 | 0 | -100.00 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1,474,319 | 9,247,763 | 18.97 | 19.00 | 28,012,061 | 175,707,497 | |
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104,628 | 870,873 | 13.65 | 19.00 | 1,987,932 | 16,546,587 | |
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574,327 | 7,773,444 | 7.98 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45,524 | 766,245 | 6.32 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4,047,634 | 7,199,117 | 128.44 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370,552 | 720,721 | 105.82 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2,965,263 | 3,151,483 | 1,592.34 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329,478 | 350,169 | 1,592.37 | ||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46,688 | 46,688 | |||||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957,211 | 957,211 | 14.52 | 13,898,321 | 13,898,321 | ||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75,873 | 75,873 | 14.52 | 1,101,646 | 1,101,646 | ||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3,373,029 | 3,373,029 | 3.93 | 13,264,099 | 13,264,099 | ||
2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308,793 | 308,793 | 3.93 | 1,214,298 | 1,214,298 | ||
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,843 | 11,324,937 | 0.07 | 58.09 | 455,565 | 657,814,628 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1,027,238 | 0.05 | 58.09 | 32,354 | 59,667,633 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,235 | 11,317,094 | 0.17 | 56.92 | 1,094,854 | 644,167,859 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,365 | 1,026,681 | 0.13 | 56.92 | 77,696 | 58,438,580 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,705 | 11,297,859 | 0.04 | 56.76 | 267,055 | 641,265,347 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1,025,316 | 0.03 | 56.76 | 18,958 | 58,196,834 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,153 | 11,293,154 | 0.12 | 55.35 | 728,057 | 625,108,824 | |
2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1,024,982 | 0.09 | 55.35 | 51,644 | 56,735,726 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,327 | 11,280,001 | 0.26 | 52.11 | 1,528,374 | 587,856,124 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,081 | 1,024,049 | 0.20 | 52.11 | 108,451 | 53,368,211 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,306 | 11,250,674 | 0.04 | 51.41 | 221,368 | 578,388,150 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1,021,968 | 0.03 | 51.41 | 15,731 | 52,538,557 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74,381 | 11,246,368 | 0.67 | 52.44 | 3,900,235 | 589,713,428 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,278 | 1,021,662 | 0.52 | 52.44 | 276,757 | 53,571,766 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,467 | 11,171,987 | 0.09 | 52.40 | 548,468 | 585,408,767 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1,016,384 | 0.07 | 52.40 | 38,933 | 53,258,217 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,120 | 11,161,520 | 0.01 | 51.97 | 58,206 | 580,064,194 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1,015,641 | 0.01 | 51.97 | 4,158 | 52,782,863 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,361 | 11,160,400 | 0.20 | 51.98 | 1,162,235 | 580,072,950 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,587 | 1,015,561 | 0.16 | 51.98 | 82,486 | 52,784,799 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36,647 | 11,138,039 | 0.33 | 50.15 | 1,837,909 | 558,591,591 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,601 | 1,013,974 | 0.26 | 50.15 | 130,445 | 50,852,520 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,983 | 11,101,392 | 0.10 | 49.72 | 546,102 | 551,988,964 | |
2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1,011,373 | 0.08 | 49.72 | 38,734 | 50,287,994 | |
2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20,691 | ||||||||
2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186,220 | ||||||||
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,172 | 11,090,409 | 0.14 | 47.47 | 720,200 | 526,450,625 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,220 | 1,010,594 | 0.12 | 47.47 | 57,912 | 47,971,887 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76,473 | 11,075,237 | 0.70 | 47.39 | 3,623,857 | 524,826,686 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,151 | 1,009,374 | 0.61 | 47.39 | 291,480 | 47,831,609 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,807 | 10,998,764 | 0.14 | 47.04 | 743,482 | 517,326,865 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,272 | 1,003,223 | 0.13 | 47.04 | 59,829 | 47,186,594 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10,982,957 | 0.00 | 45.88 | 8,487 | 503,843,152 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1,001,951 | 0.00 | 45.88 | 688 | 45,964,502 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,101 | 10,982,772 | 0.08 | 47.50 | 432,281 | 521,661,901 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1,001,936 | 0.07 | 47.50 | 33,819 | 47,590,157 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26,238 | 10,973,671 | 0.24 | 47.26 | 1,239,984 | 518,605,815 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,054 | 1,001,224 | 0.21 | 47.26 | 97,070 | 47,316,945 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,319 | 10,947,433 | 0.27 | 46.62 | 1,366,767 | 510,337,579 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,295 | 999,170 | 0.23 | 46.62 | 106,986 | 46,578,408 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,132 | 10,918,114 | 0.11 | 45.30 | 549,535 | 494,550,167 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996,875 | 0.10 | 45.30 | 43,031 | 45,154,749 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32,088 | 10,905,982 | 0.30 | 49.00 | 1,572,312 | 534,393,118 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,512 | 995,925 | 0.25 | 49.00 | 123,088 | 48,800,325 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77,456 | 10,873,894 | 0.72 | 47.60 | 3,686,658 | 517,562,558 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,062 | 993,413 | 0.61 | 47.60 | 288,532 | 47,283,280 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,987 | 10,796,438 | 0.03 | 47.45 | 141,725 | 512,260,753 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987,351 | 0.02 | 47.45 | 11,103 | 46,847,040 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,359 | 10,793,451 | 0.02 | 46.97 | 110,798 | 506,947,886 | |
2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987,117 | 0.02 | 46.97 | 8,689 | 46,363,010 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83,832 | 10,791,092 | 0.78 | 49.08 | 4,114,734 | 529,660,248 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,645 | 986,932 | 0.68 | 49.08 | 326,157 | 48,441,682 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,286 | 10,707,260 | 0.02 | 48.74 | 111,430 | 521,922,177 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980,287 | 0.02 | 48.74 | 8,823 | 47,783,796 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,714 | 10,704,974 | 0.40 | 47.74 | 2,039,256 | 511,077,939 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,386 | 980,106 | 0.35 | 47.74 | 161,655 | 46,792,319 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10,662,260 | 0.01 | 47.82 | 36,058 | 509,896,995 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976,720 | 0.01 | 47.82 | 2,869 | 46,709,290 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41,155 | 10,661,506 | 0.39 | 47.72 | 1,963,970 | 508,780,926 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,262 | 976,660 | 0.34 | 47.72 | 155,667 | 46,607,485 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,640 | 10,620,351 | 0.10 | 46.50 | 494,716 | 493,802,778 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973,398 | 0.09 | 46.50 | 39,196 | 45,259,016 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,576 | 10,609,711 | 0.03 | 46.30 | 165,575 | 491,248,717 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972,555 | 0.03 | 46.30 | 13,103 | 45,031,047 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,585 | 10,606,135 | 0.03 | 46.99 | 168,447 | 498,345,162 | |
2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972,272 | 0.03 | 46.99 | 13,344 | 45,683,658 | |
2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,335,362 | 11,638,314 | 12.96 | 21.00 | 28,042,602 | 244,404,594 | |
2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93,210 | 1,143,650 | 8.87 | 21.00 | 1,957,410 | 24,016,650 | |
2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13,589,904 | 18,840,379 | 258.83 | 14.23 | 193,395,206 | 268,113,665 | |
2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994,276 | 1,021,851 | 3,605.72 | 14.23 | 14,149,343 | 14,541,757 | |
2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,106 | 7,106 | |||||
2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11,158 | 11,158 | |||||
2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90,766 | 90,766 | |||||
2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4,135 | 4,135 | |||||
2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10,514 | 10,514 | |||||
2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3,171 | 3,171 | |||||
2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,602,312 | 43,288,836 | -3.57 | 160.00 | -256,369,920 | 6,926,213,760 | |
2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147,688 | 4,082,851 | -3.49 | 160.00 | -23,630,080 | 653,256,160 | |
2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,465,603 | 10,302,952 | 16.58 | 18.25 | 26,747,255 | 188,028,874 | |
2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134,397 | 1,050,440 | 14.67 | 18.25 | 2,452,745 | 19,170,530 | |
2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9,000 | 9,000 | |||||
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457,803 | 44,891,148 | -1.01 | 158.50 | -72,561,776 | 7,115,246,958 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42,197 | 4,230,539 | -0.99 | 158.50 | -6,688,224 | 670,540,432 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,343 | 45,348,951 | -0.01 | 166.15 | -721,610 | 7,534,941,349 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4,272,736 | -0.01 | 166.15 | -66,462 | 709,935,168 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48,880 | 45,353,294 | -0.11 | 164.96 | -8,063,118 | 7,481,361,460 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,505 | 4,273,136 | -0.11 | 164.96 | -743,133 | 704,885,404 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84,663 | 45,402,174 | -0.19 | 164.19 | -13,901,157 | 7,454,764,558 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7,805 | 4,277,641 | -0.18 | 164.19 | -1,281,534 | 702,362,986 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,159 | 45,486,837 | -0.04 | 163.41 | -2,640,610 | 7,433,195,079 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,489 | 4,285,446 | -0.03 | 163.41 | -243,324 | 700,302,730 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41,072 | 45,502,996 | -0.09 | 166.62 | -6,843,564 | 7,581,873,004 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3,786 | 4,286,935 | -0.09 | 166.62 | -630,837 | 714,304,543 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91,613 | 45,544,068 | -0.20 | 165.70 | -15,180,641 | 7,546,834,244 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8,444 | 4,290,721 | -0.20 | 165.70 | -1,399,205 | 710,989,633 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178,862 | 45,635,681 | -0.39 | 164.60 | -29,440,041 | 7,511,468,804 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,485 | 4,299,165 | -0.38 | 164.60 | -2,713,372 | 707,627,082 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45,606 | 45,814,543 | -0.10 | 164.06 | -7,482,107 | 7,516,320,180 | |
2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,204 | 4,315,650 | -0.10 | 164.06 | -689,707 | 708,024,244 | |
2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42,473 | 38,433,977 | 0.11 | 34.47 | 1,463,896 | 1,324,684,668 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,837 | 3,470,609 | 0.11 | 34.47 | 132,248 | 119,619,745 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33,464 | 38,391,504 | 0.09 | 33.63 | 1,125,465 | 1,291,186,902 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,023 | 3,466,772 | 0.09 | 33.63 | 101,670 | 116,594,823 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,201 | 38,358,040 | 0.01 | 32.85 | 72,302 | 1,260,053,942 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3,463,749 | 0.01 | 32.85 | 6,537 | 113,783,462 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46,225 | 38,355,839 | 0.12 | 32.61 | 1,507,268 | 1,250,676,513 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,175 | 3,463,550 | 0.12 | 32.61 | 136,135 | 112,936,668 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38,309,614 | 0.00 | 31.94 | 8,782 | 1,223,417,523 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3,459,375 | 0.00 | 31.94 | 798 | 110,475,141 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93,006 | 38,309,339 | 0.24 | 33.86 | 3,149,406 | 1,297,246,161 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,402 | 3,459,350 | 0.24 | 33.86 | 284,512 | 117,141,893 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,223 | 38,216,333 | 0.06 | 32.32 | 782,873 | 1,235,128,953 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,188 | 3,450,948 | 0.06 | 32.32 | 70,715 | 111,532,569 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29,624 | 38,192,110 | 0.08 | 32.19 | 953,620 | 1,229,434,575 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,676 | 3,448,760 | 0.08 | 32.19 | 86,143 | 111,018,343 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,612 | 38,162,486 | 0.02 | 31.83 | 242,290 | 1,214,711,929 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3,446,084 | 0.02 | 31.83 | 21,899 | 109,688,854 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,212 | 38,154,874 | 0.11 | 31.74 | 1,371,359 | 1,210,867,819 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,903 | 3,445,396 | 0.11 | 31.74 | 123,864 | 109,341,709 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,913 | 38,111,662 | 0.01 | 31.00 | 121,285 | 1,181,290,020 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3,441,493 | 0.01 | 31.00 | 10,941 | 106,670,796 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631,281 | 38,107,749 | 1.68 | 31.51 | 19,893,937 | 1,200,912,359 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57,022 | 3,441,140 | 1.68 | 31.51 | 1,796,968 | 108,442,710 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,503 | 37,476,468 | 0.01 | 31.19 | 171,613 | 1,168,714,898 | |
2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3,384,118 | 0.01 | 31.19 | 15,499 | 105,534,735 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,602,550 | 0.09 | 38.38 | 352,019 | 406,922,688 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971,988 | 0.09 | 38.38 | 31,778 | 37,304,608 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,237 | 10,593,378 | 0.06 | 37.75 | 235,433 | 399,876,714 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971,160 | 0.06 | 37.75 | 21,252 | 36,659,153 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,058 | 10,587,141 | 0.16 | 36.69 | 625,914 | 388,477,141 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,542 | 970,597 | 0.16 | 36.69 | 56,581 | 35,614,407 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,570,083 | 0.09 | 38.98 | 357,570 | 412,074,686 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969,055 | 0.09 | 38.98 | 32,280 | 37,778,609 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95,934 | 10,560,911 | 0.92 | 39.97 | 3,834,588 | 422,131,230 | |
2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,666 | 968,227 | 0.90 | 39.97 | 346,390 | 38,701,098 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,731 | 7,841,556 | 0.19 | 83.14 | 1,224,797 | 651,979,900 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,331 | 994,296 | 0.13 | 83.14 | 110,665 | 82,669,945 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,321 | 7,826,825 | 0.02 | 82.92 | 109,537 | 648,995,633 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992,965 | 0.01 | 82.92 | 9,867 | 82,336,062 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,928 | 7,825,504 | 0.20 | 82.13 | 1,308,149 | 642,700,035 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,439 | 992,846 | 0.15 | 82.13 | 118,183 | 81,541,350 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25,640 | 7,809,576 | 0.33 | 81.79 | 2,097,003 | 638,717,107 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,314 | 991,407 | 0.23 | 81.79 | 189,254 | 81,083,609 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,203 | 7,783,936 | 0.05 | 81.47 | 342,438 | 634,193,850 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989,093 | 0.04 | 81.47 | 30,960 | 80,586,055 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,815 | 7,779,733 | 0.16 | 81.09 | 1,039,177 | 630,863,995 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,158 | 988,713 | 0.12 | 81.09 | 93,903 | 80,175,429 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,298 | 7,766,918 | 0.04 | 80.91 | 266,845 | 628,431,432 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987,555 | 0.03 | 80.91 | 24,112 | 79,904,359 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,285 | 7,763,620 | 0.13 | 79.87 | 821,429 | 620,054,709 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987,257 | 0.09 | 79.87 | 74,196 | 78,848,959 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,022 | 7,753,335 | 0.34 | 79.72 | 2,074,362 | 618,062,527 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,351 | 986,328 | 0.24 | 79.72 | 187,412 | 78,625,827 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,888 | 7,727,313 | 0.04 | 79.29 | 228,980 | 612,673,148 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983,977 | 0.03 | 79.29 | 20,694 | 78,016,289 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,191 | 7,724,425 | 0.05 | 79.16 | 331,760 | 611,467,028 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983,716 | 0.04 | 79.16 | 30,002 | 77,871,155 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7,720,234 | 0.01 | 78.66 | 44,443 | 607,273,606 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983,337 | 0.01 | 78.66 | 4,012 | 77,349,288 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65,505 | 7,719,669 | 0.86 | 76.67 | 5,022,445 | 591,887,865 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,917 | 983,286 | 0.61 | 76.67 | 453,672 | 75,391,192 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27,866 | 7,654,164 | 0.37 | 76.10 | 2,120,480 | 582,448,202 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,517 | 977,369 | 0.26 | 76.10 | 191,533 | 74,373,480 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62,129 | 7,626,298 | 0.82 | 79.76 | 4,955,720 | 608,311,660 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,612 | 974,852 | 0.58 | 79.76 | 447,641 | 77,759,070 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133,042 | 7,564,169 | 1.79 | 79.14 | 10,529,170 | 598,641,194 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,017 | 969,240 | 1.26 | 79.14 | 951,046 | 76,707,301 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,612 | 7,431,127 | 0.10 | 77.94 | 593,260 | 579,163,461 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957,223 | 0.07 | 77.94 | 53,621 | 74,603,568 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,309 | 7,423,515 | 0.11 | 77.89 | 647,203 | 578,230,946 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956,535 | 0.08 | 77.89 | 58,419 | 74,506,233 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32,228 | 7,415,206 | 0.44 | 75.66 | 2,438,422 | 561,046,350 | |
2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,911 | 955,785 | 0.31 | 75.66 | 220,251 | 72,316,222 | |
2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18,000 | 18,000 | |||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82,740 | 10,464,977 | 0.80 | 57.82 | 4,783,944 | 605,074,505 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,460 | 959,561 | 0.78 | 57.82 | 431,330 | 55,480,857 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,989 | 10,382,237 | 0.09 | 59.61 | 535,824 | 618,873,727 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952,101 | 0.09 | 59.61 | 48,343 | 56,753,693 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,631 | 10,373,248 | 0.14 | 59.99 | 877,642 | 622,240,319 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,319 | 951,290 | 0.14 | 59.99 | 79,120 | 57,063,226 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145,994 | 10,358,617 | 1.43 | 57.68 | 8,421,518 | 597,526,463 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,164 | 949,971 | 1.41 | 57.68 | 759,352 | 54,798,127 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,051 | 10,212,623 | 0.14 | 57.22 | 803,980 | 584,353,012 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,267 | 936,807 | 0.14 | 57.22 | 72,496 | 53,602,879 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,402 | 10,198,572 | 0.14 | 58.80 | 846,819 | 599,662,775 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,298 | 935,540 | 0.14 | 58.80 | 76,321 | 55,008,536 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,623 | 10,184,170 | 0.08 | 60.77 | 524,043 | 618,919,508 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934,242 | 0.08 | 60.77 | 47,220 | 56,776,409 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,788 | 10,175,547 | 0.07 | 58.54 | 397,393 | 595,711,118 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933,465 | 0.07 | 58.54 | 35,829 | 54,648,215 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,122 | 10,168,759 | 0.07 | 58.39 | 415,826 | 593,714,180 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932,853 | 0.07 | 58.39 | 37,484 | 54,465,649 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,577 | 10,161,637 | 0.04 | 57.62 | 206,108 | 585,517,589 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932,211 | 0.03 | 57.62 | 18,611 | 53,714,371 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,301 | 10,158,060 | 0.21 | 56.69 | 1,207,513 | 575,841,121 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,921 | 931,888 | 0.21 | 56.69 | 108,898 | 52,826,960 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,804 | 10,136,759 | 0.06 | 56.62 | 328,631 | 573,958,500 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929,967 | 0.06 | 56.62 | 29,613 | 52,656,126 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,121 | 10,130,955 | 0.10 | 56.25 | 569,277 | 569,836,839 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929,444 | 0.10 | 56.25 | 51,297 | 52,278,530 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10,120,834 | 0.00 | 55.45 | 5,102 | 561,225,547 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928,532 | 0.00 | 55.45 | 444 | 51,489,421 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,813 | 10,120,742 | 0.02 | 55.77 | 101,117 | 564,468,192 | |
2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928,524 | 0.02 | 55.77 | 9,147 | 51,786,940 | |
2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10,000 | 10,000 | |||||
2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9,765,333 | 9,765,333 | |||||
2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1,160,148 | 1,161,048 | 128,905.33 | ||||
2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9,765,333 | 3,107,331 | -75.86 | ||||
2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1,160,148 | 290,409 | -79.98 | ||||
2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2,767,505 | 12,872,664 | 27.39 | 8.40 | 23,247,042 | 108,130,378 | |
2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250,037 | 1,450,557 | 20.83 | 8.40 | 2,100,311 | 12,184,679 | |
2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,743,993 | 10,118,929 | 20.82 | 46.00 | 80,223,678 | 465,470,734 | |
2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158,180 | 928,360 | 20.54 | 46.00 | 7,276,280 | 42,704,560 | |
2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22,000 | 22,000 | |||||
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1,217,279 | 0.03 | 67.28 | 24,894 | 81,898,531 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244,595 | 0.15 | 67.28 | 24,894 | 16,456,352 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160,223 | 0.23 | 67.28 | 24,894 | 10,779,803 | |
2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2,081,895 | 2,081,895 | |||||
2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2,081,895 | 0 | -100.00 | ||||
2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187,942 | 187,942 | |||||
2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187,942 | 0 | -100.00 | ||||
2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2,883,204 | 2,883,204 | 16.00 | 46,131,264 | 46,131,264 | ||
2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260,796 | 260,796 | 16.00 | 4,172,736 | 4,172,736 | ||
2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,494,025 | 37,470,965 | 4.15 | 40.00 | 59,761,000 | 1,498,838,600 | |
2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68,475 | 3,383,621 | 2.07 | 40.00 | 2,739,000 | 135,344,840 | |
2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138,815 | 0.00 | ||||
2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8,374,936 | 0.00 | 0.01 | 0 | 83,749 | |
2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12,100 | 12,100 | |||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,341 | 95,289 | 9.59 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,340 | 95,289 | 9.59 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8,866 | 43,361 | -16.98 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7,815 | 165,610 | -4.51 | ||||
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50,436 | 10,105,159 | 0.50 | 3.15 | 159,020 | 31,860,556 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,564 | 1,200,520 | 0.38 | 3.15 | 14,390 | 3,785,120 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209,382 | 10,054,723 | 2.13 | 3.02 | 633,255 | 30,409,504 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18,943 | 1,195,956 | 1.61 | 3.02 | 57,291 | 3,617,049 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,869 | 9,845,341 | 0.06 | 2.96 | 17,358 | 29,118,581 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1,177,013 | 0.05 | 2.96 | 1,570 | 3,481,134 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65,568 | 9,839,472 | 0.67 | 2.85 | 186,666 | 28,011,993 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,932 | 1,176,482 | 0.51 | 2.85 | 16,888 | 3,349,327 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,445 | 9,773,904 | 0.10 | 2.83 | 26,756 | 27,687,515 | |
2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1,170,550 | 0.07 | 2.83 | 2,422 | 3,315,934 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1,390,806 | 0.03 | 58.86 | 24,957 | 81,862,841 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418,122 | 0.10 | 58.86 | 24,957 | 24,610,661 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333,750 | 0.13 | 58.86 | 24,957 | 19,644,525 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226,124 | 0.19 | 58.86 | 24,957 | 13,309,659 | |
2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1,904,850 | 5,444,957 | 53.81 | 17.00 | 32,382,450 | 92,564,269 | |
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95,150 | 489,234 | 24.14 | 17.00 | 1,617,550 | 8,316,978 | |
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3,540,107 | 3,540,107 | |||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3,540,107 | 0 | -100.00 | ||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394,084 | 394,084 | |||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394,084 | 0 | -100.00 | ||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920,361 | 0 | -100.00 | ||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89,878 | 0 | -100.00 | ||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2,302,669 | 0 | -100.00 | ||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219,852 | 0 | -100.00 | ||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3,223,030 | 3,223,030 | |||||
2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309,730 | 309,730 | |||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13,166 | 13,166 | |||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 1,390,382 | 0.14 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 417,698 | 0.46 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 333,326 | 0.58 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 225,700 | 0.85 | ||||
2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1,002,483 | 4,302,354 | -18.90 | ||||
2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200,423 | 98,980 | -66.94 | ||||
2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421,756 | 3,315,146 | -11.29 | ||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6,009 | 0 | -100.00 | ||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11,337 | 0 | -100.00 | ||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42,724 | 0 | -100.00 | ||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59,267 | 0 | -100.00 | ||||
2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178,967 | 347,757 | -33.98 | ||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582,200 | 18,591 | -96.91 | ||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182,539 | 1,028,034 | -15.08 | ||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129,220 | 129,220 | |||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692,706 | 0 | -100.00 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1,603,238 | 2,826,766 | -36.19 | ||||
2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24,747 | 24,747 | |||||
2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,720 | 7,382,978 | -0.31 | 120.77 | -2,743,928 | 891,653,328 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,729 | 952,874 | -0.29 | 120.77 | -329,585 | 115,080,022 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13,213 | 7,405,698 | -0.18 | 122.31 | -1,616,054 | 905,775,370 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,587 | 955,603 | -0.17 | 122.31 | -194,103 | 116,877,796 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,355 | 7,418,911 | -0.21 | 120.12 | -1,844,459 | 891,167,750 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,845 | 957,190 | -0.19 | 120.12 | -221,623 | 114,978,716 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35,796 | 7,434,266 | -0.48 | 122.37 | -4,380,432 | 909,746,742 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,300 | 959,035 | -0.45 | 122.37 | -526,200 | 117,359,127 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30,766 | 7,470,062 | -0.41 | 123.06 | -3,786,036 | 919,259,107 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3,696 | 963,335 | -0.38 | 123.06 | -454,826 | 118,547,138 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39,732 | 7,500,828 | -0.53 | 121.37 | -4,822,189 | 910,359,743 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,772 | 967,031 | -0.49 | 121.37 | -579,168 | 117,366,522 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71,819 | 7,540,560 | -0.94 | 127.06 | -9,125,258 | 958,096,767 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8,627 | 971,803 | -0.88 | 127.06 | -1,096,139 | 123,476,415 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,886 | 7,612,379 | -0.30 | 125.05 | -2,861,901 | 951,930,278 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,749 | 980,430 | -0.28 | 125.05 | -343,763 | 122,603,066 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,541 | 7,635,265 | -0.20 | 126.25 | -1,962,085 | 963,969,004 | |
2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,867 | 983,179 | -0.19 | 126.25 | -235,713 | 124,128,512 | |
2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529,758 | 529,758 | |||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529,758 | 0 | -100.00 | ||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60,194 | 60,194 | |||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60,194 | 0 | -100.00 | ||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2,905,359 | 2,905,359 | |||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2,905,359 | 0 | -100.00 | ||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324,421 | 324,421 | |||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324,421 | 0 | -100.00 | ||||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820,729 | 820,729 | 14.00 | 11,490,206 | 11,490,206 | ||
2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72,128 | 72,128 | 14.00 | 1,009,792 | 1,009,792 | ||
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,232 | 7,639,338 | -0.12 | 65.32 | -603,070 | 499,031,352 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,417 | 1,214,575 | -0.12 | 65.32 | -92,564 | 79,340,776 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241,891 | -0.10 | 65.32 | -15,939 | 15,801,263 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157,519 | -0.09 | 65.32 | -9,276 | 10,289,755 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49,893 | -0.02 | 65.32 | -719 | 3,259,205 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171,091 | -0.09 | 65.32 | -10,321 | 11,176,331 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,775 | 7,648,570 | -0.83 | 67.13 | -4,281,177 | 513,443,915 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,791 | 1,215,992 | -0.80 | 67.13 | -657,264 | 81,628,813 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,688 | 242,135 | -0.69 | 67.13 | -113,314 | 16,254,377 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157,661 | -0.62 | 67.13 | -65,720 | 10,583,688 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49,904 | -0.15 | 67.13 | -4,968 | 3,350,026 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,093 | 171,249 | -0.63 | 67.13 | -73,372 | 11,495,843 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173,085 | 7,712,345 | -2.19 | 64.62 | -11,184,701 | 498,369,420 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26,575 | 1,225,783 | -2.12 | 64.62 | -1,717,269 | 79,209,730 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,581 | 243,823 | -1.84 | 64.62 | -296,023 | 15,755,769 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,656 | 158,640 | -1.65 | 64.62 | -171,630 | 10,251,269 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49,978 | -0.40 | 64.62 | -13,053 | 3,229,563 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,966 | 172,342 | -1.69 | 64.62 | -191,662 | 11,136,688 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106,054 | 7,885,430 | -1.33 | 66.61 | -7,063,981 | 525,227,990 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,282 | 1,252,358 | -1.28 | 66.61 | -1,084,502 | 83,416,310 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,807 | 248,404 | -1.12 | 66.61 | -186,967 | 16,545,545 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,628 | 161,296 | -1.00 | 66.61 | -108,437 | 10,743,507 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50,180 | -0.25 | 66.61 | -8,259 | 3,342,359 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,817 | 175,308 | -1.03 | 66.61 | -121,026 | 11,676,810 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60,618 | 7,991,484 | -0.75 | 67.42 | -4,086,914 | 538,792,244 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,307 | 1,268,640 | -0.73 | 67.42 | -627,485 | 85,532,724 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,604 | 251,211 | -0.63 | 67.42 | -108,143 | 16,936,847 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162,924 | -0.57 | 67.42 | -62,701 | 10,984,466 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50,304 | -0.14 | 67.42 | -4,787 | 3,391,536 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,039 | 177,125 | -0.58 | 67.42 | -70,050 | 11,941,909 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,832 | 8,052,102 | -0.13 | 69.12 | -748,735 | 556,581,420 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,663 | 1,277,947 | -0.13 | 69.12 | -114,951 | 88,334,892 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252,815 | -0.11 | 69.12 | -19,838 | 17,475,205 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163,854 | -0.10 | 69.12 | -11,474 | 11,325,998 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50,375 | -0.03 | 69.12 | -899 | 3,482,046 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178,164 | -0.10 | 69.12 | -12,788 | 12,315,141 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102,618 | 8,062,934 | -1.26 | 68.70 | -7,049,918 | 553,928,404 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,755 | 1,279,610 | -1.22 | 68.70 | -1,082,378 | 87,909,975 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,716 | 253,102 | -1.06 | 68.70 | -186,591 | 17,388,259 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,575 | 164,020 | -0.95 | 68.70 | -108,203 | 11,268,272 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50,388 | -0.24 | 68.70 | -8,244 | 3,461,686 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,758 | 178,349 | -0.98 | 68.70 | -120,776 | 12,252,683 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,543 | 8,165,552 | -0.19 | 67.68 | -1,051,888 | 552,611,897 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,386 | 1,295,365 | -0.18 | 67.68 | -161,475 | 87,665,122 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255,818 | -0.16 | 67.68 | -27,815 | 17,312,739 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165,595 | -0.14 | 67.68 | -16,175 | 11,206,807 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50,508 | -0.04 | 67.68 | -1,218 | 3,418,179 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180,107 | -0.15 | 67.68 | -18,002 | 12,188,921 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,813 | 8,181,095 | -0.02 | 67.87 | -123,047 | 555,244,373 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1,297,751 | -0.02 | 67.87 | -18,868 | 88,077,322 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256,229 | -0.02 | 67.87 | -3,258 | 17,390,057 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165,834 | -0.02 | 67.87 | -1,900 | 11,255,021 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,526 | 0.00 | 67.87 | -136 | 3,429,159 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180,373 | -0.02 | 67.87 | -2,104 | 12,241,771 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,661 | 8,182,908 | -0.23 | 67.90 | -1,267,017 | 555,590,813 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,865 | 1,298,029 | -0.22 | 67.90 | -194,523 | 88,131,626 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256,277 | -0.19 | 67.90 | -33,541 | 17,400,311 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165,862 | -0.17 | 67.90 | -19,418 | 11,261,449 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50,528 | -0.04 | 67.90 | -1,494 | 3,430,674 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180,404 | -0.18 | 67.90 | -21,727 | 12,248,800 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,863 | 8,201,569 | -0.52 | 68.72 | -2,945,370 | 563,578,195 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,581 | 1,300,894 | -0.50 | 68.72 | -452,219 | 89,392,102 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,134 | 256,771 | -0.44 | 68.72 | -77,924 | 17,644,250 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166,148 | -0.39 | 68.72 | -45,215 | 11,417,009 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50,550 | -0.10 | 68.72 | -3,436 | 3,473,589 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180,724 | -0.40 | 68.72 | -50,437 | 12,418,612 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,116 | 8,244,432 | -0.26 | 68.63 | -1,449,147 | 565,798,055 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,242 | 1,307,475 | -0.25 | 68.63 | -222,492 | 89,729,264 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257,905 | -0.22 | 68.63 | -38,363 | 17,699,479 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166,806 | -0.19 | 68.63 | -22,235 | 11,447,545 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50,600 | -0.05 | 68.63 | -1,716 | 3,472,572 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181,458 | -0.20 | 68.63 | -24,843 | 12,453,081 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66,784 | 8,265,548 | -0.80 | 66.64 | -4,450,459 | 550,812,813 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,253 | 1,310,717 | -0.78 | 66.64 | -683,256 | 87,345,657 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,768 | 258,464 | -0.68 | 66.64 | -117,819 | 17,223,938 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,025 | 167,130 | -0.61 | 66.64 | -68,306 | 11,137,476 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50,625 | -0.15 | 66.64 | -5,198 | 3,373,630 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,145 | 181,820 | -0.63 | 66.64 | -76,302 | 12,116,412 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80,146 | 8,332,332 | -0.95 | 68.90 | -5,521,963 | 574,087,676 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,305 | 1,320,970 | -0.92 | 68.90 | -847,800 | 91,013,248 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,121 | 260,232 | -0.81 | 68.90 | -146,134 | 17,929,673 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,230 | 168,155 | -0.73 | 68.90 | -84,746 | 11,585,678 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50,703 | -0.18 | 68.90 | -6,408 | 3,493,376 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,374 | 182,965 | -0.75 | 68.90 | -94,667 | 12,606,069 | |
2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 4,288,031 | 0.10 | 2.59 | 10,777 | 11,106,000 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1,507,172 | 0.02 | 66.84 | 19,918 | 100,739,376 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436,250 | 0.07 | 66.84 | 19,918 | 29,158,950 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343,282 | 0.09 | 66.84 | 19,918 | 22,944,969 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224,693 | 0.13 | 66.84 | 19,918 | 15,018,480 | |
2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,678 | 8,412,180 | -0.55 | 74.71 | -3,487,122 | 628,439,478 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,167 | 1,332,977 | -0.53 | 74.71 | -535,417 | 99,581,246 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,235 | 262,055 | -0.47 | 74.71 | -92,262 | 19,577,055 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169,087 | -0.42 | 74.71 | -53,489 | 12,631,797 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50,498 | -0.11 | 74.71 | -4,109 | 3,772,499 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184,041 | -0.43 | 74.71 | -59,765 | 13,748,949 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86,620 | 8,500,139 | -1.01 | 74.63 | -6,464,529 | 634,373,024 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,298 | 1,346,482 | -0.98 | 74.63 | -992,442 | 100,489,163 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,293 | 264,382 | -0.86 | 74.63 | -171,129 | 19,731,067 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 170,437 | -0.77 | 74.63 | -99,184 | 12,719,867 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50,601 | -0.20 | 74.63 | -7,538 | 3,776,398 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,485 | 185,548 | -0.79 | 74.63 | -110,827 | 13,847,614 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90,251 | 8,586,759 | -1.04 | 74.19 | -6,695,487 | 637,029,325 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,856 | 1,359,780 | -1.01 | 74.19 | -1,027,941 | 100,878,543 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,388 | 266,675 | -0.89 | 74.19 | -177,160 | 19,783,925 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,385 | 171,766 | -0.80 | 74.19 | -102,750 | 12,742,873 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50,702 | -0.21 | 74.19 | -7,864 | 3,761,450 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,547 | 187,033 | -0.82 | 74.19 | -114,768 | 13,875,492 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8,677,010 | 0.00 | 74.56 | -30,795 | 647,001,251 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1,373,636 | 0.00 | 74.56 | -4,698 | 102,425,168 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269,063 | 0.00 | 74.56 | -820 | 20,062,683 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173,151 | 0.00 | 74.56 | -447 | 12,911,004 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188,580 | 0.00 | 74.56 | -522 | 14,061,468 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,124 | 8,677,423 | -0.48 | 74.50 | -3,138,238 | 646,468,014 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,467 | 1,373,699 | -0.47 | 74.50 | -481,792 | 102,340,576 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,115 | 269,074 | -0.41 | 74.50 | -83,068 | 20,046,013 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173,157 | -0.37 | 74.50 | -48,202 | 12,900,196 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50,808 | -0.10 | 74.50 | -3,650 | 3,785,196 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188,587 | -0.38 | 74.50 | -53,789 | 14,049,732 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,068 | 8,719,547 | -0.04 | 76.57 | -234,915 | 667,649,610 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1,380,166 | -0.03 | 76.57 | -36,064 | 105,678,345 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270,189 | -0.03 | 76.57 | -6,202 | 20,688,183 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173,804 | -0.03 | 76.57 | -3,599 | 13,308,051 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50,857 | -0.01 | 76.57 | -306 | 3,894,085 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189,309 | -0.03 | 76.57 | -3,982 | 14,495,258 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 8,722,615 | -0.02 | 76.03 | -125,301 | 663,197,864 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,380,637 | -0.02 | 76.03 | -19,236 | 104,972,592 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270,270 | -0.02 | 76.03 | -3,345 | 20,549,169 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173,851 | -0.01 | 76.03 | -1,901 | 13,218,239 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,861 | 0.00 | 76.03 | -152 | 3,867,064 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189,361 | -0.01 | 76.03 | -2,129 | 14,397,496 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51,987 | 8,724,263 | -0.59 | 76.50 | -3,977,031 | 667,410,482 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,982 | 1,380,890 | -0.57 | 76.50 | -610,627 | 105,638,775 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,375 | 270,314 | -0.51 | 76.50 | -105,188 | 20,679,156 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173,876 | -0.46 | 76.50 | -61,047 | 13,301,601 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50,863 | -0.12 | 76.50 | -4,667 | 3,891,045 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189,389 | -0.47 | 76.50 | -68,162 | 14,488,353 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8,776,250 | 0.00 | 75.40 | -18,624 | 661,729,250 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1,388,872 | 0.00 | 75.40 | -2,941 | 104,720,949 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271,689 | 0.00 | 75.40 | -528 | 20,485,351 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50,924 | 0.00 | 75.40 | -75 | 3,839,670 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,047 | 8,776,497 | -0.71 | 75.92 | -4,786,390 | 666,292,344 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,679 | 1,388,911 | -0.69 | 75.92 | -734,808 | 105,443,068 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,668 | 271,696 | -0.61 | 75.92 | -126,631 | 20,626,563 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174,678 | -0.55 | 75.92 | -73,413 | 13,261,169 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50,925 | -0.14 | 75.92 | -5,542 | 3,866,114 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,080 | 190,284 | -0.56 | 75.92 | -81,991 | 14,445,943 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,832 | 8,839,544 | -0.03 | 76.05 | -215,369 | 672,232,294 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1,398,590 | -0.03 | 76.05 | -33,081 | 106,360,392 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273,364 | -0.03 | 76.05 | -5,704 | 20,788,867 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175,645 | -0.02 | 76.05 | -3,270 | 13,357,504 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50,998 | -0.01 | 76.05 | -228 | 3,878,311 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191,364 | -0.03 | 76.05 | -3,726 | 14,552,907 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61,122 | 8,842,376 | -0.69 | 75.63 | -4,622,669 | 668,750,665 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,384 | 1,399,025 | -0.67 | 75.63 | -709,714 | 105,808,541 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,618 | 273,439 | -0.59 | 75.63 | -122,370 | 20,680,246 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175,688 | -0.53 | 75.63 | -70,941 | 13,287,319 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51,001 | -0.14 | 75.63 | -5,370 | 3,857,216 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,047 | 191,413 | -0.54 | 75.63 | -79,185 | 14,476,603 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 8,903,498 | -0.04 | 74.03 | -244,007 | 659,137,531 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,408,409 | -0.04 | 74.03 | -37,460 | 104,266,349 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275,057 | -0.03 | 74.03 | -6,441 | 20,362,827 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176,626 | -0.03 | 74.03 | -3,776 | 13,075,852 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51,072 | -0.01 | 74.03 | -296 | 3,780,927 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192,460 | -0.03 | 74.03 | -4,146 | 14,248,064 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37,107 | 8,906,794 | -0.41 | 75.08 | -2,786,101 | 668,747,923 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,697 | 1,408,915 | -0.40 | 75.08 | -427,747 | 105,785,424 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275,144 | -0.36 | 75.08 | -73,731 | 20,658,609 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176,677 | -0.32 | 75.08 | -42,722 | 13,265,422 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51,076 | -0.08 | 75.08 | -3,229 | 3,834,934 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192,516 | -0.33 | 75.08 | -47,828 | 14,454,660 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,703 | 8,943,901 | -0.21 | 73.55 | -1,375,551 | 657,797,981 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,872 | 1,414,612 | -0.20 | 73.55 | -211,227 | 104,040,610 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276,126 | -0.18 | 73.55 | -36,406 | 20,308,267 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177,246 | -0.16 | 73.55 | -21,108 | 13,035,929 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51,119 | -0.04 | 73.55 | -1,618 | 3,759,654 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193,153 | -0.17 | 73.55 | -23,609 | 14,205,843 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,647 | 8,962,604 | -0.02 | 73.72 | -121,421 | 660,745,573 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,417,484 | -0.02 | 73.72 | -18,652 | 104,500,464 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276,621 | -0.02 | 73.72 | -3,244 | 20,393,192 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177,533 | -0.01 | 73.72 | -1,843 | 13,088,177 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,141 | 0.00 | 73.72 | -147 | 3,770,242 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193,474 | -0.01 | 73.72 | -2,138 | 14,263,387 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,486 | 8,964,251 | -0.09 | 77.04 | -653,755 | 690,598,726 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,303 | 1,417,737 | -0.09 | 77.04 | -100,382 | 109,221,324 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276,665 | -0.08 | 77.04 | -17,334 | 21,314,050 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177,558 | -0.07 | 77.04 | -10,015 | 13,678,926 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,143 | -0.02 | 77.04 | -770 | 3,940,016 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193,503 | -0.08 | 77.04 | -11,248 | 14,907,316 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,914 | 8,972,737 | -0.25 | 76.49 | -1,752,680 | 686,320,167 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,518 | 1,419,040 | -0.25 | 76.49 | -269,090 | 108,541,660 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276,890 | -0.22 | 76.49 | -46,429 | 21,179,178 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177,688 | -0.20 | 76.49 | -26,924 | 13,591,266 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,153 | -0.05 | 76.49 | -2,065 | 3,912,667 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193,649 | -0.20 | 76.49 | -30,060 | 14,812,115 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58,412 | 8,995,651 | -0.65 | 77.15 | -4,506,626 | 694,036,064 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,968 | 1,422,558 | -0.63 | 77.15 | -691,903 | 109,753,764 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,546 | 277,497 | -0.55 | 77.15 | -119,278 | 21,409,560 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178,040 | -0.50 | 77.15 | -69,129 | 13,736,213 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51,180 | -0.13 | 77.15 | -5,246 | 3,948,660 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,001 | 194,042 | -0.51 | 77.15 | -77,230 | 14,970,806 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,909 | 9,054,063 | -0.08 | 77.64 | -536,386 | 702,919,424 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,060 | 1,431,526 | -0.07 | 77.64 | -82,294 | 111,137,666 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279,043 | -0.07 | 77.64 | -14,207 | 21,663,727 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178,936 | -0.06 | 77.64 | -8,307 | 13,891,840 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,248 | -0.02 | 77.64 | -621 | 3,978,679 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195,043 | -0.06 | 77.64 | -9,161 | 15,142,319 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,060,972 | -0.01 | 76.20 | -37,565 | 690,423,414 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,432,586 | -0.01 | 76.20 | -5,791 | 109,159,472 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279,226 | 0.00 | 76.20 | -991 | 21,276,323 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179,043 | 0.00 | 76.20 | -610 | 13,642,629 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,256 | 0.00 | 76.20 | -76 | 3,905,579 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195,161 | 0.00 | 76.20 | -686 | 14,870,780 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9,061,465 | -0.01 | 76.20 | -56,540 | 690,483,633 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1,432,662 | -0.01 | 76.20 | -8,687 | 109,168,844 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279,239 | -0.01 | 76.20 | -1,524 | 21,278,012 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179,051 | -0.01 | 76.20 | -838 | 13,643,686 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,257 | 0.00 | 76.20 | -76 | 3,905,783 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195,170 | -0.01 | 76.20 | -991 | 14,871,954 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31,482 | 9,062,207 | -0.35 | 76.66 | -2,413,501 | 694,735,069 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,833 | 1,432,776 | -0.34 | 76.66 | -370,512 | 109,840,763 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279,259 | -0.30 | 76.66 | -63,860 | 21,408,805 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179,062 | -0.27 | 76.66 | -37,105 | 13,727,412 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51,258 | -0.07 | 76.66 | -2,837 | 3,929,587 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195,183 | -0.28 | 76.66 | -41,321 | 14,963,295 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9,093,689 | -0.01 | 77.81 | -48,239 | 707,539,019 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1,437,609 | -0.01 | 77.81 | -7,392 | 111,853,887 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280,092 | -0.01 | 77.81 | -1,245 | 21,792,698 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179,546 | -0.01 | 77.81 | -778 | 13,969,666 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,295 | 0.00 | 77.81 | -78 | 3,991,033 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195,722 | -0.01 | 77.81 | -856 | 15,228,248 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,506 | 9,094,309 | -0.07 | 78.13 | -508,342 | 710,577,468 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1,437,704 | -0.07 | 78.13 | -78,056 | 112,333,996 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280,108 | -0.06 | 78.13 | -13,439 | 21,886,043 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179,556 | -0.06 | 78.13 | -7,813 | 14,029,482 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,296 | -0.02 | 78.13 | -625 | 4,007,977 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195,733 | -0.06 | 78.13 | -8,751 | 15,293,461 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,818,475 | 8,837,349 | 25.91 | ||||
2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181,525 | 916,043 | 24.71 | ||||
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,634 | 9,092,565 | -0.15 | 70.55 | -961,887 | 641,485,916 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,093 | 1,430,453 | -0.15 | 70.55 | -147,662 | 100,919,317 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280,280 | -0.13 | 70.55 | -25,469 | 19,773,922 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179,656 | -0.12 | 70.55 | -14,816 | 12,674,839 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,304 | -0.03 | 70.55 | -1,129 | 3,619,528 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195,845 | -0.12 | 70.55 | -16,509 | 13,816,982 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,660 | 9,106,199 | -0.27 | 71.35 | -1,759,553 | 649,750,064 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,786 | 1,432,546 | -0.26 | 71.35 | -270,141 | 102,215,738 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280,641 | -0.23 | 71.35 | -46,593 | 20,024,437 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179,866 | -0.21 | 71.35 | -26,971 | 12,833,889 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51,320 | -0.06 | 71.35 | -2,069 | 3,661,810 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196,079 | -0.22 | 71.35 | -30,182 | 13,990,727 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75,736 | 9,130,859 | -0.82 | 72.20 | -5,468,397 | 659,279,065 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,627 | 1,436,332 | -0.80 | 72.20 | -839,509 | 103,708,054 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,004 | 281,294 | -0.71 | 72.20 | -144,696 | 20,310,383 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,162 | 180,244 | -0.64 | 72.20 | -83,900 | 13,014,230 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,349 | -0.17 | 72.20 | -6,426 | 3,707,572 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,298 | 196,502 | -0.66 | 72.20 | -93,720 | 14,188,113 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65,426 | 9,206,595 | -0.71 | 72.02 | -4,711,967 | 663,057,131 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,044 | 1,447,959 | -0.69 | 72.02 | -723,367 | 104,281,718 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,732 | 283,298 | -0.61 | 72.02 | -124,738 | 20,403,065 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,004 | 181,406 | -0.55 | 72.02 | -72,308 | 13,064,824 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51,438 | -0.15 | 72.02 | -5,474 | 3,704,554 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,121 | 197,800 | -0.56 | 72.02 | -80,734 | 14,245,516 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 9,272,021 | -0.02 | 73.46 | -121,054 | 681,076,303 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,458,003 | -0.02 | 73.46 | -18,584 | 107,097,610 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285,030 | -0.02 | 73.46 | -3,232 | 20,936,879 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182,410 | -0.01 | 73.46 | -1,836 | 13,398,927 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,514 | 0.00 | 73.46 | -147 | 3,783,961 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198,921 | -0.01 | 73.46 | -2,057 | 14,611,742 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29,260 | 9,273,669 | -0.31 | 70.52 | -2,063,313 | 653,946,680 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,492 | 1,458,256 | -0.31 | 70.52 | -316,760 | 102,831,109 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285,074 | -0.27 | 70.52 | -54,580 | 20,102,421 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182,435 | -0.25 | 70.52 | -31,732 | 12,864,678 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51,516 | -0.07 | 70.52 | -2,398 | 3,632,728 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198,949 | -0.25 | 70.52 | -35,399 | 14,029,187 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,521 | 9,302,929 | -0.45 | 71.00 | -3,018,995 | 660,508,889 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,529 | 1,462,748 | -0.44 | 71.00 | -463,560 | 103,855,254 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,125 | 285,848 | -0.39 | 71.00 | -79,875 | 20,295,237 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182,885 | -0.36 | 71.00 | -46,292 | 12,984,853 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51,550 | -0.10 | 71.00 | -3,550 | 3,660,055 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199,451 | -0.36 | 71.00 | -51,759 | 14,161,041 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,547 | 9,345,450 | -0.11 | 71.61 | -755,298 | 669,251,973 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,619 | 1,469,277 | -0.11 | 71.61 | -115,941 | 105,218,746 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286,973 | -0.10 | 71.61 | -19,980 | 20,550,883 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183,537 | -0.09 | 71.61 | -11,601 | 13,143,562 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51,600 | -0.02 | 71.61 | -859 | 3,695,210 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200,180 | -0.09 | 71.61 | -12,962 | 14,335,410 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 9,355,997 | -0.15 | 72.23 | -981,964 | 675,781,792 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,470,896 | -0.14 | 72.23 | -150,744 | 106,242,524 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287,252 | -0.13 | 72.23 | -26,003 | 20,748,155 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183,699 | -0.11 | 72.23 | -15,096 | 13,268,542 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,612 | -0.03 | 72.23 | -1,156 | 3,727,924 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200,361 | -0.12 | 72.23 | -16,830 | 14,472,035 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132,363 | 9,369,592 | -1.39 | 72.79 | -9,634,226 | 681,978,871 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20,322 | 1,472,983 | -1.36 | 72.79 | -1,479,165 | 107,213,130 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,503 | 287,612 | -1.20 | 72.79 | -254,971 | 20,934,242 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,031 | 183,908 | -1.09 | 72.79 | -147,829 | 13,386,001 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51,628 | -0.30 | 72.79 | -11,282 | 3,757,816 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,268 | 200,594 | -1.12 | 72.79 | -165,080 | 14,600,515 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149,754 | 9,501,955 | -1.55 | 70.79 | -10,601,295 | 672,656,697 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,991 | 1,493,305 | -1.52 | 70.79 | -1,627,565 | 105,713,152 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,963 | 291,115 | -1.34 | 70.79 | -280,546 | 20,608,438 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,298 | 185,939 | -1.22 | 70.79 | -162,679 | 13,162,882 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51,783 | -0.34 | 70.79 | -12,388 | 3,665,791 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,566 | 202,862 | -1.25 | 70.79 | -181,651 | 14,360,885 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,651,709 | -0.01 | 70.07 | -34,545 | 676,311,658 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,516,296 | -0.01 | 70.07 | -5,325 | 106,249,438 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295,078 | 0.00 | 70.07 | -911 | 20,676,617 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188,237 | 0.00 | 70.07 | -561 | 13,190,087 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,958 | 0.00 | 70.07 | -70 | 3,640,785 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205,428 | 0.00 | 70.07 | -631 | 14,394,689 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23,462 | 9,652,202 | -0.24 | 70.22 | -1,647,574 | 677,807,546 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,602 | 1,516,372 | -0.24 | 70.22 | -252,944 | 106,484,343 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295,091 | -0.21 | 70.22 | -43,609 | 20,722,205 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188,245 | -0.19 | 70.22 | -25,280 | 13,219,147 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,959 | -0.05 | 70.22 | -1,896 | 3,648,722 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205,437 | -0.20 | 70.22 | -28,230 | 14,426,423 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,392 | 9,675,664 | -0.09 | 70.28 | -589,772 | 679,985,347 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,288 | 1,519,974 | -0.08 | 70.28 | -90,518 | 106,820,581 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295,712 | -0.08 | 70.28 | -15,602 | 20,782,018 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188,605 | -0.07 | 70.28 | -9,066 | 13,254,763 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,986 | -0.02 | 70.28 | -703 | 3,653,467 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205,839 | -0.07 | 70.28 | -10,120 | 14,465,933 | |
2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1,695,159 | 0.02 | 64.41 | 19,967 | 109,185,191 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225,893 | 0.14 | 64.41 | 19,967 | 14,549,768 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362,631 | 0.09 | 64.41 | 19,967 | 23,357,063 | |
2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29,421,884 | 0.00 | 63.59 | 18,950 | 1,870,937,604 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,243 | 9,683,746 | -0.16 | 73.09 | -1,114,047 | 707,744,323 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,340 | 1,520,952 | -0.15 | 73.09 | -171,021 | 111,159,994 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295,624 | -0.14 | 73.09 | -29,454 | 21,605,917 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188,424 | -0.12 | 73.09 | -17,102 | 13,771,119 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51,686 | -0.03 | 73.09 | -1,316 | 3,777,513 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205,673 | -0.13 | 73.09 | -19,148 | 15,031,776 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,627 | 9,698,989 | -0.13 | 71.81 | -906,797 | 696,524,166 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,939 | 1,523,292 | -0.13 | 71.81 | -139,248 | 109,393,844 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296,027 | -0.11 | 71.81 | -23,986 | 21,258,913 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188,658 | -0.10 | 71.81 | -13,932 | 13,548,304 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51,704 | -0.03 | 71.81 | -1,077 | 3,713,076 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205,935 | -0.10 | 71.81 | -15,512 | 14,789,037 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34,794 | 9,711,616 | -0.36 | 74.88 | -2,605,510 | 727,243,681 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,342 | 1,525,231 | -0.35 | 74.88 | -400,030 | 114,215,246 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296,361 | -0.31 | 74.88 | -68,968 | 22,192,667 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188,852 | -0.28 | 74.88 | -39,988 | 14,141,974 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51,719 | -0.08 | 74.88 | -3,070 | 3,872,920 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206,151 | -0.29 | 74.88 | -44,706 | 15,437,391 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,718 | 9,746,410 | -0.08 | 73.83 | -569,813 | 719,568,679 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,185 | 1,530,573 | -0.08 | 73.83 | -87,487 | 113,000,827 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297,282 | -0.07 | 73.83 | -15,061 | 21,948,063 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189,386 | -0.06 | 73.83 | -8,712 | 13,982,198 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51,760 | -0.02 | 73.83 | -664 | 3,821,394 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206,748 | -0.06 | 73.83 | -9,745 | 15,264,019 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84,418 | 9,754,128 | -0.86 | 76.15 | -6,428,768 | 742,815,864 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,961 | 1,531,758 | -0.84 | 76.15 | -987,032 | 116,649,499 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,234 | 297,486 | -0.75 | 76.15 | -170,128 | 22,654,749 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,296 | 189,504 | -0.68 | 76.15 | -98,696 | 14,431,488 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51,769 | -0.19 | 76.15 | -7,539 | 3,942,416 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,447 | 206,880 | -0.69 | 76.15 | -110,195 | 15,754,740 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76,364 | 9,838,546 | -0.77 | 75.46 | -5,762,481 | 742,423,568 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,724 | 1,544,719 | -0.75 | 75.46 | -884,701 | 116,565,577 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,021 | 299,720 | -0.67 | 75.46 | -152,506 | 22,617,081 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,172 | 190,800 | -0.61 | 75.46 | -88,440 | 14,397,902 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,868 | -0.17 | 75.46 | -6,716 | 3,913,996 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,309 | 208,327 | -0.62 | 75.46 | -98,778 | 15,720,501 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,538 | 9,914,910 | -0.03 | 77.75 | -197,318 | 770,839,635 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1,556,443 | -0.03 | 77.75 | -30,321 | 121,006,439 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301,741 | -0.02 | 77.75 | -5,209 | 23,459,005 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191,972 | -0.02 | 77.75 | -3,032 | 14,924,959 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51,957 | -0.01 | 77.75 | -233 | 4,039,423 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209,636 | -0.02 | 77.75 | -3,343 | 16,298,256 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,493 | 9,917,448 | -0.06 | 73.81 | -405,449 | 732,025,680 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1,556,833 | -0.05 | 73.81 | -62,223 | 114,912,802 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301,808 | -0.05 | 73.81 | -10,777 | 22,277,022 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192,011 | -0.04 | 73.81 | -6,200 | 14,172,697 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51,960 | -0.01 | 73.81 | -443 | 3,835,266 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209,679 | -0.05 | 73.81 | -7,012 | 15,476,805 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,604 | 9,922,941 | -0.19 | 75.83 | -1,410,758 | 752,465,547 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,856 | 1,557,676 | -0.18 | 75.83 | -216,573 | 118,119,973 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301,954 | -0.16 | 75.83 | -37,309 | 22,897,444 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192,095 | -0.15 | 75.83 | -21,688 | 14,566,737 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51,966 | -0.04 | 75.83 | -1,592 | 3,940,629 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209,774 | -0.15 | 75.83 | -24,190 | 15,907,351 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9,941,545 | 0.00 | 77.11 | -28,608 | 766,592,535 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1,560,532 | 0.00 | 77.11 | -4,395 | 120,332,623 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302,446 | 0.00 | 77.11 | -771 | 23,321,611 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,987 | 0.00 | 77.11 | -77 | 4,008,718 | |
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10,731 | 0 | -100.00 | ||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489,977 | 0 | -100.00 | ||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,178,823 | 35,976,940 | 45.08 | 17.00 | 190,039,991 | 611,607,980 | |
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585,882 | 3,736,902 | 18.59 | 17.00 | 9,959,994 | 63,527,334 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9,941,916 | 0.00 | 76.62 | -18,925 | 761,724,749 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1,560,589 | 0.00 | 76.62 | -2,911 | 119,568,428 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302,456 | 0.00 | 76.62 | -460 | 23,173,423 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,988 | 0.00 | 76.62 | -77 | 3,983,191 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32,598 | 9,942,163 | -0.33 | 77.52 | -2,527,147 | 770,762,210 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,005 | 1,560,627 | -0.32 | 77.52 | -388,011 | 120,986,984 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302,462 | -0.28 | 77.52 | -66,904 | 23,448,246 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192,391 | -0.26 | 77.52 | -38,762 | 14,915,035 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51,989 | -0.07 | 77.52 | -2,946 | 4,030,426 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210,103 | -0.27 | 77.52 | -43,336 | 16,288,151 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89,047 | 9,974,761 | -0.88 | 78.05 | -6,950,074 | 778,525,109 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,671 | 1,565,632 | -0.87 | 78.05 | -1,067,015 | 122,196,795 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,357 | 303,325 | -0.77 | 78.05 | -183,963 | 23,674,365 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,367 | 192,891 | -0.70 | 78.05 | -106,694 | 15,055,046 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52,027 | -0.20 | 78.05 | -8,117 | 4,060,681 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,526 | 210,662 | -0.72 | 78.05 | -119,104 | 16,442,064 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44,659 | 10,063,808 | -0.44 | 80.09 | -3,576,721 | 806,006,357 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,856 | 1,579,303 | -0.43 | 80.09 | -549,094 | 126,485,746 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,182 | 305,682 | -0.39 | 80.09 | -94,666 | 24,481,949 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194,258 | -0.35 | 80.09 | -54,861 | 15,558,046 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52,131 | -0.10 | 80.09 | -4,165 | 4,175,151 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212,188 | -0.36 | 80.09 | -61,269 | 16,994,052 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129,121 | 10,108,467 | -1.26 | 79.07 | -10,209,675 | 799,282,551 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,824 | 1,586,159 | -1.23 | 79.07 | -1,567,496 | 125,418,544 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,417 | 306,864 | -1.10 | 79.07 | -270,184 | 24,263,921 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,981 | 194,943 | -1.01 | 79.07 | -156,639 | 15,414,260 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52,183 | -0.29 | 79.07 | -11,940 | 4,126,141 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,214 | 212,953 | -1.03 | 79.07 | -175,062 | 16,838,321 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39,591 | 10,237,588 | -0.39 | 79.63 | -3,152,536 | 815,194,562 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,078 | 1,605,983 | -0.38 | 79.63 | -483,977 | 127,880,572 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,048 | 310,281 | -0.34 | 79.63 | -83,450 | 24,706,931 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196,924 | -0.31 | 79.63 | -48,414 | 15,680,586 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52,334 | -0.09 | 79.63 | -3,663 | 4,167,231 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215,167 | -0.31 | 79.63 | -53,988 | 17,133,232 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,257 | 10,277,179 | -0.29 | 77.61 | -2,348,376 | 797,656,054 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,646 | 1,612,061 | -0.29 | 77.61 | -360,596 | 125,118,986 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311,329 | -0.26 | 77.61 | -62,169 | 24,163,582 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197,532 | -0.23 | 77.61 | -36,091 | 15,331,308 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52,380 | -0.07 | 77.61 | -2,717 | 4,065,437 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215,845 | -0.24 | 77.61 | -40,204 | 16,752,659 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,994 | 10,307,436 | -0.12 | 78.80 | -945,149 | 812,244,510 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,841 | 1,616,707 | -0.11 | 78.80 | -145,074 | 127,399,422 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312,130 | -0.10 | 78.80 | -24,980 | 24,596,406 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197,997 | -0.09 | 78.80 | -14,500 | 15,602,520 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52,415 | -0.03 | 78.80 | -1,103 | 4,130,396 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216,363 | -0.10 | 78.80 | -16,233 | 17,049,794 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,976 | 10,319,430 | -0.75 | 76.81 | -5,989,017 | 792,593,109 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,972 | 1,618,548 | -0.73 | 76.81 | -919,520 | 124,314,036 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,064 | 312,447 | -0.66 | 76.81 | -158,527 | 23,997,773 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,197 | 198,181 | -0.60 | 76.81 | -91,937 | 15,221,470 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,429 | -0.17 | 76.81 | -6,989 | 4,026,857 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,335 | 216,569 | -0.61 | 76.81 | -102,536 | 16,633,777 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 10,397,406 | -0.13 | 74.01 | -1,006,150 | 769,499,541 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,630,520 | -0.13 | 74.01 | -154,456 | 120,672,829 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314,511 | -0.11 | 74.01 | -26,643 | 23,276,582 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199,378 | -0.10 | 74.01 | -15,468 | 14,755,727 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52,520 | -0.03 | 74.01 | -1,184 | 3,886,942 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217,904 | -0.11 | 74.01 | -17,244 | 16,126,814 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57,979 | 10,411,001 | -0.55 | 74.71 | -4,331,524 | 777,790,268 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,901 | 1,632,607 | -0.54 | 74.71 | -664,980 | 121,969,620 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,534 | 314,871 | -0.48 | 74.71 | -114,603 | 23,523,540 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199,587 | -0.44 | 74.71 | -66,491 | 14,910,845 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52,536 | -0.13 | 74.71 | -5,080 | 3,924,886 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218,137 | -0.45 | 74.71 | -74,260 | 16,296,688 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56,764 | 10,468,980 | -0.54 | 75.27 | -4,272,831 | 788,037,813 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,715 | 1,641,508 | -0.53 | 75.27 | -656,009 | 123,562,217 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,502 | 316,405 | -0.47 | 75.27 | -113,061 | 23,816,943 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200,477 | -0.43 | 75.27 | -65,563 | 15,090,626 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52,604 | -0.13 | 75.27 | -4,968 | 3,959,692 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219,131 | -0.44 | 75.27 | -73,241 | 16,494,779 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,652 | 10,525,744 | -0.35 | 73.76 | -2,703,294 | 776,333,617 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,627 | 1,650,223 | -0.34 | 73.76 | -415,023 | 121,713,353 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317,907 | -0.30 | 73.76 | -71,543 | 23,447,453 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201,348 | -0.28 | 73.76 | -41,524 | 14,850,563 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52,670 | -0.08 | 73.76 | -3,171 | 3,884,713 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220,104 | -0.28 | 73.76 | -46,319 | 16,233,925 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,558 | 10,562,396 | -0.73 | 74.24 | -5,758,092 | 784,177,629 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,907 | 1,655,850 | -0.71 | 74.24 | -884,004 | 122,934,278 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,052 | 318,877 | -0.64 | 74.24 | -152,345 | 23,674,194 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,190 | 201,911 | -0.59 | 74.24 | -88,348 | 14,990,357 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,713 | -0.17 | 74.24 | -6,756 | 3,913,540 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 220,732 | -0.60 | 74.24 | -98,668 | 16,387,673 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,204 | 10,639,954 | -0.08 | 74.05 | -607,484 | 787,859,866 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,260 | 1,667,757 | -0.08 | 74.05 | -93,300 | 123,492,903 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320,929 | -0.07 | 74.05 | -16,068 | 23,763,926 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203,101 | -0.06 | 74.05 | -9,330 | 15,039,081 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52,804 | -0.02 | 74.05 | -740 | 3,909,994 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222,061 | -0.06 | 74.05 | -10,441 | 16,443,017 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,487 | 10,648,158 | -0.23 | 74.36 | -1,820,848 | 791,794,899 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,759 | 1,669,017 | -0.22 | 74.36 | -279,518 | 124,107,770 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321,146 | -0.20 | 74.36 | -48,185 | 23,880,352 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203,227 | -0.18 | 74.36 | -27,959 | 15,111,919 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52,814 | -0.05 | 74.36 | -2,082 | 3,927,238 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222,202 | -0.19 | 74.36 | -31,157 | 16,522,896 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55,365 | 10,672,645 | -0.52 | 76.35 | -4,227,024 | 814,838,302 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,499 | 1,672,776 | -0.51 | 76.35 | -648,884 | 127,713,604 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,466 | 321,794 | -0.45 | 76.35 | -111,927 | 24,568,425 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203,603 | -0.42 | 76.35 | -64,896 | 15,544,743 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52,842 | -0.12 | 76.35 | -4,963 | 4,034,397 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222,621 | -0.42 | 76.35 | -72,455 | 16,996,735 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,646 | 10,728,010 | -0.15 | 77.66 | -1,292,763 | 833,159,785 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,556 | 1,681,275 | -0.15 | 77.66 | -198,504 | 130,571,347 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323,260 | -0.14 | 77.66 | -34,171 | 25,105,050 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204,453 | -0.12 | 77.66 | -19,804 | 15,878,249 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52,907 | -0.04 | 77.66 | -1,476 | 4,108,869 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223,570 | -0.13 | 77.66 | -22,134 | 17,362,916 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38,330 | 10,744,656 | -0.36 | 79.13 | -3,033,110 | 850,240,746 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,885 | 1,683,831 | -0.35 | 79.13 | -465,689 | 133,244,073 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,014 | 323,700 | -0.31 | 79.13 | -80,239 | 25,614,867 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204,708 | -0.29 | 79.13 | -46,529 | 16,198,851 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52,926 | -0.08 | 79.13 | -3,561 | 4,188,114 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223,855 | -0.29 | 79.13 | -51,989 | 17,713,982 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 10,782,986 | -0.03 | 80.09 | -263,978 | 863,613,662 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,689,716 | -0.03 | 80.09 | -40,526 | 135,330,030 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324,714 | -0.03 | 80.09 | -6,968 | 26,006,474 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205,296 | -0.02 | 80.09 | -4,085 | 16,442,239 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52,971 | -0.01 | 80.09 | -320 | 4,242,469 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224,512 | -0.02 | 80.09 | -4,485 | 17,981,256 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53,013 | 10,786,282 | -0.49 | 80.07 | -4,244,714 | 863,650,049 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,139 | 1,690,222 | -0.48 | 80.07 | -651,684 | 135,334,892 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,403 | 324,801 | -0.43 | 80.07 | -112,337 | 26,006,589 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205,347 | -0.39 | 80.07 | -65,176 | 16,441,991 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52,975 | -0.12 | 80.07 | -4,964 | 4,241,671 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224,568 | -0.40 | 80.07 | -72,703 | 17,981,003 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99,280 | 10,839,295 | -0.91 | 78.09 | -7,752,428 | 846,402,609 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,242 | 1,698,361 | -0.89 | 78.09 | -1,190,194 | 132,619,066 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,628 | 326,204 | -0.80 | 78.09 | -205,211 | 25,472,129 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,524 | 206,161 | -0.73 | 78.09 | -119,004 | 16,098,391 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53,037 | -0.22 | 78.09 | -8,980 | 4,141,474 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,702 | 225,476 | -0.75 | 78.09 | -132,903 | 17,606,632 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,014 | 10,938,575 | -0.14 | 81.26 | -1,220,038 | 888,868,604 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,305 | 1,713,603 | -0.13 | 81.26 | -187,304 | 139,247,380 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328,832 | -0.12 | 81.26 | -32,260 | 26,720,888 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207,685 | -0.11 | 81.26 | -18,690 | 16,876,483 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,152 | -0.03 | 81.26 | -1,463 | 4,319,132 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227,178 | -0.11 | 81.26 | -20,884 | 18,460,484 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,511 | 10,953,589 | -0.42 | 81.16 | -3,774,912 | 889,011,904 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,140 | 1,715,908 | -0.41 | 81.16 | -579,495 | 139,266,010 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,231 | 329,229 | -0.37 | 81.16 | -99,910 | 26,720,785 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207,915 | -0.34 | 81.16 | -57,949 | 16,874,735 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53,170 | -0.10 | 81.16 | -4,383 | 4,315,368 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227,435 | -0.35 | 81.16 | -64,605 | 18,459,011 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,533 | 11,000,100 | -0.07 | 80.51 | -606,473 | 885,604,851 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,156 | 1,723,048 | -0.07 | 80.51 | -93,068 | 138,720,527 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330,460 | -0.06 | 80.51 | -16,021 | 26,604,938 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208,629 | -0.06 | 80.51 | -9,339 | 16,796,470 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,224 | -0.02 | 80.51 | -725 | 4,285,000 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228,231 | -0.06 | 80.51 | -10,386 | 18,374,604 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,877 | 11,007,633 | -0.11 | 80.38 | -954,711 | 884,828,765 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,824 | 1,724,204 | -0.11 | 80.38 | -146,619 | 138,597,035 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330,659 | -0.09 | 80.38 | -25,240 | 26,579,429 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208,745 | -0.09 | 80.38 | -14,630 | 16,779,591 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53,233 | -0.03 | 80.38 | -1,125 | 4,279,039 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228,360 | -0.09 | 80.38 | -16,398 | 18,356,308 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,367 | 11,019,510 | -0.18 | 85.11 | -1,648,296 | 937,853,967 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,973 | 1,726,028 | -0.17 | 85.11 | -253,028 | 146,899,654 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330,973 | -0.15 | 85.11 | -43,661 | 28,168,616 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208,927 | -0.14 | 85.11 | -25,277 | 17,781,464 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53,247 | -0.04 | 85.11 | -1,957 | 4,531,772 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228,564 | -0.15 | 85.11 | -28,256 | 19,452,739 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112,010 | 11,038,877 | -1.00 | 82.06 | -9,191,025 | 905,799,468 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,198 | 1,729,001 | -0.98 | 82.06 | -1,411,189 | 141,873,869 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,964 | 331,486 | -0.89 | 82.06 | -243,212 | 27,200,216 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,720 | 209,224 | -0.82 | 82.06 | -141,135 | 17,167,959 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53,270 | -0.24 | 82.06 | -10,585 | 4,371,091 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,919 | 228,896 | -0.83 | 82.06 | -157,464 | 18,782,153 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,157 | 11,150,887 | -0.07 | 82.55 | -673,321 | 920,452,198 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,252 | 1,746,199 | -0.07 | 82.55 | -103,347 | 144,140,346 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334,450 | -0.06 | 82.55 | -17,830 | 27,607,242 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210,944 | -0.06 | 82.55 | -10,318 | 17,412,415 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,399 | -0.02 | 82.55 | -743 | 4,407,831 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230,815 | -0.06 | 82.55 | -11,556 | 19,052,670 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,159,044 | -0.04 | 83.90 | -345,678 | 936,271,689 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,747,451 | -0.04 | 83.90 | -53,110 | 146,615,508 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334,666 | -0.03 | 83.90 | -9,145 | 28,079,314 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211,069 | -0.03 | 83.90 | -5,286 | 17,709,217 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,408 | -0.01 | 83.90 | -420 | 4,481,065 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230,955 | -0.03 | 83.90 | -5,957 | 19,377,702 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62,929 | 11,163,164 | -0.56 | 83.20 | -5,235,598 | 928,758,500 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,661 | 1,748,084 | -0.55 | 83.20 | -803,781 | 145,437,967 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,665 | 334,775 | -0.49 | 83.20 | -138,526 | 27,852,778 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211,132 | -0.46 | 83.20 | -80,370 | 17,565,866 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53,413 | -0.14 | 83.20 | -6,157 | 4,443,881 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,078 | 231,026 | -0.46 | 83.20 | -89,688 | 19,221,017 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,602 | 11,226,093 | -0.16 | 85.87 | -1,511,565 | 964,036,246 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,702 | 1,757,745 | -0.15 | 85.87 | -232,033 | 150,945,649 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336,440 | -0.14 | 85.87 | -40,018 | 28,891,650 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212,098 | -0.13 | 85.87 | -23,186 | 18,213,831 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53,487 | -0.04 | 85.87 | -1,803 | 4,593,175 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232,104 | -0.13 | 85.87 | -25,934 | 19,931,838 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,243,695 | -0.04 | 82.00 | -337,840 | 921,982,990 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,760,447 | -0.04 | 82.00 | -51,906 | 144,356,654 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336,906 | -0.03 | 82.00 | -8,938 | 27,626,292 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212,368 | -0.03 | 82.00 | -5,166 | 17,414,176 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,508 | -0.01 | 82.00 | -410 | 4,387,656 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232,406 | -0.03 | 82.00 | -5,822 | 19,057,292 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,565 | 11,247,815 | -0.01 | 83.85 | -131,227 | 943,138,286 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1,761,080 | -0.01 | 83.85 | -20,124 | 147,667,967 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337,015 | -0.01 | 83.85 | -3,522 | 28,258,977 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212,431 | -0.01 | 83.85 | -2,012 | 17,812,509 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53,513 | 0.00 | 83.85 | -168 | 4,487,108 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232,477 | -0.01 | 83.85 | -2,264 | 19,493,382 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,301 | 11,249,380 | -0.08 | 84.84 | -789,121 | 954,426,648 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,428 | 1,761,320 | -0.08 | 84.84 | -121,155 | 149,434,968 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337,057 | -0.07 | 84.84 | -20,871 | 28,596,792 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212,455 | -0.07 | 84.84 | -12,132 | 18,025,235 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53,515 | -0.02 | 84.84 | -933 | 4,540,352 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232,504 | -0.07 | 84.84 | -13,490 | 19,726,244 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,423 | 11,258,681 | -0.19 | 89.34 | -1,913,901 | 1,005,834,798 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,289 | 1,762,748 | -0.19 | 89.34 | -293,835 | 157,481,438 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337,303 | -0.17 | 89.34 | -50,655 | 30,134,178 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212,598 | -0.15 | 89.34 | -29,392 | 18,993,208 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53,526 | -0.05 | 89.34 | -2,233 | 4,781,938 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232,663 | -0.16 | 89.34 | -32,787 | 20,785,787 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,555 | 11,280,104 | -0.27 | 85.15 | -2,601,670 | 960,468,143 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,692 | 1,766,037 | -0.26 | 85.15 | -399,510 | 150,372,929 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337,870 | -0.24 | 85.15 | -68,884 | 28,768,651 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212,927 | -0.22 | 85.15 | -40,019 | 18,130,117 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53,551 | -0.07 | 85.15 | -3,150 | 4,559,712 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233,030 | -0.22 | 85.15 | -44,447 | 19,841,829 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,174 | 11,310,659 | -0.32 | 85.78 | -3,102,970 | 970,217,018 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,554 | 1,770,729 | -0.31 | 85.78 | -476,417 | 151,891,363 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338,679 | -0.28 | 85.78 | -82,091 | 29,051,546 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213,397 | -0.26 | 85.78 | -47,607 | 18,304,981 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53,588 | -0.08 | 85.78 | -3,603 | 4,596,725 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233,552 | -0.26 | 85.78 | -53,183 | 20,033,857 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,663 | 11,346,833 | -0.03 | 87.30 | -319,780 | 990,579,656 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1,776,283 | -0.03 | 87.30 | -49,063 | 155,069,684 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339,636 | -0.03 | 87.30 | -8,468 | 29,650,257 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213,952 | -0.03 | 87.30 | -4,889 | 18,678,031 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53,630 | -0.01 | 87.30 | -349 | 4,681,904 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234,172 | -0.03 | 87.30 | -5,500 | 20,443,239 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,306 | 11,350,496 | -0.04 | 88.38 | -380,544 | 1,003,104,624 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1,776,845 | -0.04 | 88.38 | -58,416 | 157,029,388 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339,733 | -0.03 | 88.38 | -10,075 | 30,024,040 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214,008 | -0.03 | 88.38 | -5,833 | 18,913,043 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,634 | -0.01 | 88.38 | -442 | 4,739,926 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234,235 | -0.03 | 88.38 | -6,540 | 20,700,612 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,798 | 11,354,802 | -0.14 | 83.94 | -1,326,160 | 953,176,583 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,425 | 1,777,506 | -0.14 | 83.94 | -203,566 | 149,212,386 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339,847 | -0.12 | 83.94 | -35,089 | 28,528,388 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214,074 | -0.11 | 83.94 | -20,315 | 17,970,399 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,639 | -0.03 | 83.94 | -1,511 | 4,502,715 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234,309 | -0.12 | 83.94 | -22,749 | 19,669,022 | |
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3,660,993 | 0 | -100.00 | ||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294,948 | 0 | -100.00 | ||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4,627,208 | 0 | -100.00 | ||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372,792 | 0 | -100.00 | ||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,248,102 | 8,374,935 | 36.69 | 10.00 | 22,481,020 | 83,749,350 | |
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251,898 | 770,180 | 48.60 | 10.00 | 2,518,980 | 7,701,800 | |
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767,427 | 6,126,833 | 14.32 | ||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86,501 | 518,282 | 20.03 | ||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732,198 | 5,359,406 | 15.82 | 5.00 | 3,660,990 | 26,797,030 | |
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58,989 | 431,781 | 15.82 | 5.00 | 294,945 | 2,158,905 | |
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4,627,208 | 4,627,208 | |||||
2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372,792 | 372,792 | |||||
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11,544,497 | 0.00 | 70.18 | 19,931 | 810,192,799 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1,953,828 | 0.01 | 70.18 | 19,931 | 137,119,649 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227,554 | 0.12 | 70.18 | 19,931 | 15,969,740 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388,213 | 0.07 | 70.18 | 19,931 | 27,244,788 | |
2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 4,280,212 | 0.05 | 8.71 | 20,381 | 37,280,647 | |
2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1,269,837 | 0.02 | 69.08 | 18,997 | 87,720,340 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131,007 | 24,798,117 | 0.53 | 19.09 | 2,501,238 | 473,455,569 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,555 | 3,151,020 | 0.46 | 19.09 | 277,890 | 60,160,534 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,207 | 24,667,110 | 0.16 | 19.01 | 726,353 | 468,946,428 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,245 | 3,136,465 | 0.14 | 19.01 | 80,702 | 59,627,336 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920,495 | 24,628,903 | 3.88 | 18.64 | 17,154,897 | 458,999,014 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102,267 | 3,132,220 | 3.38 | 18.64 | 1,905,909 | 58,373,931 | |
2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5,231,900 | 5,250,491 | 28,142.11 | 108.00 | 565,045,200 | 567,053,028 | |
2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582,200 | 600,791 | 3,131.62 | 108.00 | 62,877,600 | 64,885,428 | |
2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 34,222,983 | 0.05 | 1.32 | 21,626 | 45,174,338 | |
2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1,953,544 | 0.02 | 50.40 | 19,958 | 98,458,618 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227,270 | 0.17 | 50.40 | 19,958 | 11,454,408 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387,929 | 0.10 | 50.40 | 19,958 | 19,551,622 | |
2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,884 | 34,884 | |||||
2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14,658,102 | 14,658,102 | |||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14,658,102 | 0 | -100.00 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1,399,516 | 1,399,516 | |||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1,399,516 | 0 | -100.00 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,284,771 | 7,018,874 | 87.97 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3,284,771 | 0 | -100.00 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313,621 | 734,518 | 74.51 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313,621 | 0 | -100.00 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,734,103 | 3,734,103 | |||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3,734,103 | 0 | -100.00 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420,897 | 420,897 | |||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420,897 | 0 | -100.00 | ||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2,700,597 | 2,700,597 | 18.00 | 48,610,746 | 48,610,746 | ||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299,403 | 299,403 | 18.00 | 5,389,254 | 5,389,254 | ||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3,734,103 | 3,734,103 | |||||
2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420,897 | 420,897 | |||||
2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126,399 | 45,825,986 | 0.28 | 54.02 | 6,828,339 | 2,475,615,998 | |
2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,715 | 45,699,587 | 0.28 | 53.70 | 6,966,305 | 2,454,282,610 | |
2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204,537 | 45,569,872 | 0.45 | 52.68 | 10,775,582 | 2,400,748,453 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,105 | 45,365,335 | 0.02 | 54.42 | 495,488 | 2,468,749,775 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,442 | 45,356,230 | 0.05 | 52.26 | 1,120,576 | 2,370,352,865 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,400 | 45,334,788 | 0.08 | 52.33 | 1,957,022 | 2,372,224,385 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,000 | 45,297,388 | 0.00 | 51.88 | 103,750 | 2,349,802,002 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,951 | 45,295,388 | 0.01 | 52.33 | 311,418 | 2,370,321,243 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,963 | 45,289,437 | 0.08 | 52.06 | 1,976,213 | 2,357,600,519 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,270 | 45,251,474 | 0.13 | 51.37 | 2,941,708 | 2,324,369,113 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,500 | 45,194,204 | 0.02 | 51.36 | 539,280 | 2,321,174,317 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,700 | 45,183,704 | 0.05 | 51.30 | 1,164,424 | 2,317,752,317 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,533 | 45,161,004 | 0.16 | 51.26 | 3,717,693 | 2,314,736,292 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 45,088,471 | 0.22 | 51.14 | 5,114,000 | 2,305,824,407 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168,097 | 44,978,471 | 0.38 | 51.25 | 8,614,786 | 2,305,097,162 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52,700 | 44,810,374 | 0.12 | 51.07 | 2,691,173 | 2,288,282,078 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248,121 | 44,757,674 | 0.56 | 51.03 | 12,661,069 | 2,283,885,637 | |
2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154,218 | 44,509,553 | 0.35 | 50.90 | 7,849,897 | 2,265,594,110 | |
2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1,249,279 | 0.02 | 83.33 | 18,999 | 104,102,419 | |
2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999,514 | 7,480,182 | 15.42 | 4.50 | 4,497,813 | 33,660,819 | |
2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111,597 | 845,858 | 15.20 | 4.50 | 502,186 | 3,806,361 | |
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439,036 | 0 | -100.00 | ||||
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17,626,445 | 0 | -100.00 | ||||
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2,250,846 | 0 | -100.00 | ||||
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439,036 | 602,867 | 267.98 | 0.47 | 206,347 | 283,347 | |
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17,626,445 | 34,193,251 | 106.40 | 0.47 | 8,284,429 | 16,070,828 | |
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2,250,846 | 4,102,796 | 121.54 | 0.47 | 1,057,898 | 1,928,314 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,456,543 | 44,355,335 | 8.45 | 52.00 | 179,740,236 | 2,306,477,420 | |
2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389,610 | 5,278,174 | 7.97 | 52.00 | 20,259,720 | 274,465,048 | |
2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,645,148 | 5,121,404 | 47.33 | 101.00 | 166,159,948 | 517,261,804 | |
2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335,050 | 708,025 | 89.83 | 101.00 | 33,840,050 | 71,510,525 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,136 | 58,131 | -6.64 | 7.91 | -32,715 | 459,799 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265,708 | 3,734,776 | -6.64 | 7.91 | -2,101,671 | 29,540,958 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25,517 | 358,671 | -6.64 | 7.91 | -201,832 | 2,836,980 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,548 | 62,267 | -6.81 | 8.12 | -36,910 | 505,340 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292,168 | 4,000,484 | -6.81 | 8.12 | -2,371,148 | 32,466,728 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28,058 | 384,188 | -6.81 | 8.12 | -227,710 | 3,117,955 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3,649 | 66,815 | -5.18 | 8.63 | -31,476 | 576,340 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234,437 | 4,292,652 | -5.18 | 8.63 | -2,022,230 | 37,027,987 | |
2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22,514 | 412,246 | -5.18 | 8.63 | -194,204 | 3,555,993 | |
2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39,378 | 0 | -100.00 | ||||
2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1,941 | 489,977 | -0.39 | 28.00 | -54,348 | 13,719,356 | |
2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39,378 | 491,918 | 8.70 | 1.38 | 54,342 | 678,847 | |
2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1,618,684 | 1,618,684 | 13.00 | 21,041,273 | 21,041,273 | ||
2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304,392 | 304,392 | 13.00 | 3,956,792 | 3,956,792 | ||
2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5,996 | 0 | -100.00 | ||||
2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249,801 | 0 | -100.00 | ||||
2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24,466 | 0 | -100.00 | ||||
2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5,996 | 35,999 | 19.98 | 7.86 | 47,129 | 282,952 | |
2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249,801 | 2,372,218 | 11.77 | 7.86 | 1,963,436 | 18,645,633 | |
2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24,466 | 141,244 | 20.95 | 7.86 | 192,303 | 1,110,178 | |
2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,204,652 | 16,557,473 | 77.03 | 1.50 | 10,806,978 | 24,836,210 | |
2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795,348 | 1,842,617 | 75.94 | 1.50 | 1,193,022 | 2,763,926 | |
2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1,426,590 | 0 | -100.00 | ||||
2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55,457 | 23,708,408 | -0.23 | 35.40 | -1,963,178 | 839,277,643 | |
2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1,426,590 | 23,763,865 | 6.39 | 1.38 | 1,968,694 | 32,794,134 | |
2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49,200 | 0 | -100.00 | ||||
2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9,913,242 | 0 | -100.00 | ||||
2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760,829 | 0 | -100.00 | ||||
2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797,191 | 1,878,242 | 73.74 | 17.00 | 13,552,247 | 31,930,114 | |
2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87,809 | 170,778 | 105.83 | 17.00 | 1,492,753 | 2,903,226 | |
2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1,081,051 | 1,081,051 | |||||
2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82,969 | 82,969 | |||||
2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,029 | 789,416 | 0.26 | 132.00 | 267,828 | 104,202,912 | |
2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85,402 | 29,247,347 | 0.29 | 132.00 | 11,273,064 | 3,860,649,804 | |
2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,569 | 4,386,818 | 0.29 | 132.00 | 1,659,108 | 579,059,976 | |
2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158,279 | 3,476,256 | 4.77 | 71.00 | 11,237,809 | 246,814,176 | |
2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17,777 | 372,975 | 5.00 | 71.00 | 1,262,167 | 26,481,225 | |
2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3,109,063 | 3,109,063 | 8.50 | 26,427,036 | 26,427,036 | ||
2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349,760 | 349,760 | 8.50 | 2,972,960 | 2,972,960 | ||
2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329,491 | 0.19 | 32.55 | 19,986 | 10,724,932 | |
2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787,387 | 0.02 | 125.91 | 18,886 | 99,139,897 | |
2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,560 | 7,317,906 | 0.31 | 117.95 | 2,660,914 | 863,134,572 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,564 | 647,367 | 0.40 | 117.95 | 302,419 | 76,355,837 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197,126 | 7,295,346 | 2.78 | 117.51 | 23,163,488 | 857,246,927 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,399 | 644,803 | 3.60 | 117.51 | 2,632,017 | 75,768,221 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,172 | 7,098,220 | 0.46 | 117.22 | 3,771,228 | 832,059,027 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,656 | 622,404 | 0.59 | 117.22 | 428,559 | 72,958,695 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65,264 | 7,066,048 | 0.93 | 117.01 | 7,636,802 | 826,826,541 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,416 | 618,748 | 1.21 | 117.01 | 867,776 | 72,402,178 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7,000,784 | 0.01 | 116.96 | 105,030 | 818,811,697 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611,332 | 0.02 | 116.96 | 11,930 | 71,501,391 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31,974 | 6,999,886 | 0.46 | 116.71 | 3,731,542 | 816,925,196 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,634 | 611,230 | 0.60 | 116.71 | 424,108 | 71,333,903 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12,726 | 6,967,912 | 0.18 | 116.37 | 1,480,897 | 810,840,590 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,446 | 607,596 | 0.24 | 116.37 | 168,268 | 70,704,610 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385,774 | 6,955,186 | 5.87 | 116.37 | 44,891,517 | 809,356,911 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,835 | 606,150 | 7.80 | 116.37 | 5,100,965 | 70,536,100 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,976 | 6,569,412 | 0.03 | 116.18 | 229,562 | 763,202,753 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562,315 | 0.04 | 116.18 | 26,023 | 65,327,058 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169,897 | 6,567,436 | 2.66 | 115.77 | 19,668,568 | 760,296,304 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,305 | 562,091 | 3.56 | 115.77 | 2,234,894 | 65,071,926 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207,814 | 6,397,539 | 3.36 | 115.71 | 24,046,636 | 740,273,952 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23,614 | 542,786 | 4.55 | 115.71 | 2,732,430 | 62,807,016 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18,678 | 6,189,725 | 0.30 | 115.06 | 2,149,048 | 712,175,522 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,122 | 519,172 | 0.41 | 115.06 | 244,152 | 59,734,736 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64,455 | 6,171,047 | 1.06 | 114.33 | 7,369,301 | 705,551,231 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,324 | 517,050 | 1.44 | 114.33 | 837,371 | 59,115,619 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160,000 | 980,146 | 19.51 | 117.71 | 18,832,960 | 115,369,065 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,200 | 820,146 | 14.39 | 117.63 | 12,139,416 | 96,473,774 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,008 | 716,946 | 4.67 | 117.60 | 3,764,067 | 84,311,201 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684,938 | 0.04 | 116.75 | 35,025 | 79,966,512 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,747 | 7,645,906 | 0.05 | 116.75 | 437,462 | 892,659,526 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684,638 | 0.06 | 116.75 | 49,736 | 79,931,486 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44,898 | 7,642,159 | 0.59 | 117.50 | 5,275,484 | 897,948,333 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,102 | 684,212 | 0.75 | 117.50 | 599,481 | 80,394,431 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,373 | 7,597,261 | 0.07 | 117.21 | 629,790 | 890,504,591 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679,110 | 0.09 | 117.21 | 71,618 | 79,601,132 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217,305 | 7,591,888 | 2.95 | 117.05 | 25,434,638 | 888,598,604 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,692 | 678,499 | 3.78 | 117.05 | 2,890,095 | 79,415,458 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,950 | 7,374,583 | 0.12 | 116.95 | 1,046,720 | 862,471,494 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,017 | 653,807 | 0.16 | 116.95 | 118,940 | 76,463,971 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39,473 | 7,365,633 | 0.54 | 116.65 | 4,604,506 | 859,197,407 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,485 | 652,790 | 0.69 | 116.65 | 523,173 | 76,147,627 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,310 | 7,326,160 | 0.06 | 116.54 | 502,277 | 853,773,836 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648,305 | 0.08 | 116.54 | 57,103 | 75,551,974 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,944 | 7,321,850 | 0.05 | 118.00 | 465,392 | 863,978,300 | |
2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647,815 | 0.07 | 118.00 | 52,864 | 76,442,170 | |
2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,559,338 | 0.03 | ||||
2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,106,592 | 0.03 | ||||
2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36,000 | 36,000 | |||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399,984 | 399,984 | |||||
2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1,226,510 | 0.01 | 133.67 | 18,981 | 163,947,592 | |
2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151,177 | 4,527,089 | 3.45 | 12.00 | 1,814,124 | 54,325,068 | |
2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,489 | 434,760 | 3.69 | 12.00 | 185,868 | 5,217,120 | |
2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6,050,000 | 0 | -100.00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5,674,000 | 0 | -100.00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243,450,000 | 0 | -100.00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228,326,000 | 0 | -100.00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121,672 | 767,095 | 18.85 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111,514 | 645,423 | 20.89 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,896,067 | 29,141,653 | 20.19 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,487,412 | 24,245,586 | 22.71 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502,779 | 4,353,957 | 13.06 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491,338 | 3,851,178 | 14.62 | ||||
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32,051 | 9,764,459 | 0.33 | 17.76 | 569,226 | 173,416,792 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,389 | 1,169,695 | 0.29 | 17.76 | 60,189 | 20,773,783 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235,169 | 9,732,408 | 2.48 | 17.60 | 4,138,880 | 171,286,488 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24,871 | 1,166,306 | 2.18 | 17.60 | 437,720 | 20,526,519 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35,360 | 9,497,239 | 0.37 | 16.31 | 576,555 | 154,855,331 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,739 | 1,141,435 | 0.33 | 16.31 | 60,966 | 18,611,440 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,006 | 9,461,879 | 0.05 | 15.62 | 78,207 | 147,819,151 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1,137,696 | 0.05 | 15.62 | 8,264 | 17,773,770 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,148 | 9,456,873 | 0.16 | 15.13 | 229,189 | 143,082,488 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,602 | 1,137,167 | 0.14 | 15.13 | 24,238 | 17,205,337 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,143 | 9,441,725 | 0.10 | 16.20 | 148,089 | 152,927,620 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1,135,565 | 0.09 | 16.20 | 15,662 | 18,392,746 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8,671 | 9,432,582 | 0.09 | 15.35 | 133,078 | 144,766,552 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1,134,598 | 0.08 | 15.35 | 14,074 | 17,413,243 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,442 | 9,423,911 | 0.03 | 16.85 | 41,156 | 158,823,999 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1,133,681 | 0.02 | 16.85 | 4,348 | 19,106,266 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,305 | 9,421,469 | 0.12 | 15.32 | 173,204 | 144,346,327 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,195 | 1,133,423 | 0.11 | 15.32 | 18,309 | 17,365,174 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,697 | 9,410,164 | 0.06 | 16.74 | 95,365 | 157,521,440 | |
2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1,132,228 | 0.05 | 16.74 | 10,094 | 18,952,931 | |
2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533,909 | 0.04 | 100.27 | 18,951 | 53,535,055 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1,363,375 | 0.05 | 29.39 | 19,985 | 40,069,591 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319,993 | 0.21 | 29.39 | 19,985 | 9,404,594 | |
2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,594,671 | 3,317,977 | 92.54 | 32.00 | 51,029,472 | 106,175,264 | |
2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165,824 | 355,198 | 87.56 | 32.00 | 5,306,368 | 11,366,336 | |
2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664,259 | 6,480,668 | 11.42 | 6.00 | 3,985,554 | 38,884,008 | |
2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69,074 | 734,261 | 10.38 | 6.00 | 414,444 | 4,405,566 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294,178 | 40,885,092 | 0.72 | 59.46 | 17,493,177 | 2,431,215,642 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,122 | 4,874,864 | 0.66 | 59.46 | 1,910,122 | 289,881,838 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,667 | 40,590,914 | 0.12 | 58.74 | 2,976,321 | 2,384,423,943 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,533 | 4,842,742 | 0.11 | 58.74 | 325,024 | 284,476,225 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,616 | 40,540,247 | 0.05 | 55.99 | 1,042,351 | 2,269,937,618 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,039 | 4,837,209 | 0.04 | 55.99 | 114,168 | 270,845,974 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,854 | 40,521,631 | 0.04 | 56.42 | 950,861 | 2,286,129,117 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,846 | 4,835,170 | 0.04 | 56.42 | 104,147 | 272,788,203 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143,016 | 40,504,777 | 0.35 | 56.48 | 8,078,001 | 2,287,839,420 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,662 | 4,833,324 | 0.33 | 56.48 | 884,640 | 273,001,606 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40,361,761 | 0.00 | 56.49 | 20,393 | 2,280,035,879 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4,817,662 | 0.00 | 56.49 | 2,203 | 272,149,726 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40,361,400 | 0.00 | 56.55 | 25,788 | 2,282,558,254 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4,817,623 | 0.00 | 56.55 | 2,828 | 272,451,034 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341,438 | 40,360,944 | 0.85 | 56.91 | 19,430,383 | 2,296,840,421 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,392 | 4,817,573 | 0.78 | 56.91 | 2,127,885 | 274,156,035 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,280 | 40,019,506 | 0.24 | 55.84 | 5,320,673 | 2,234,789,264 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,434 | 4,780,181 | 0.22 | 55.84 | 582,661 | 266,937,257 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,335 | 39,924,226 | 0.01 | 55.87 | 186,336 | 2,230,686,279 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4,769,747 | 0.01 | 55.87 | 20,394 | 266,500,074 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,289 | 39,920,891 | 0.02 | 56.12 | 352,915 | 2,240,208,704 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4,769,382 | 0.01 | 56.12 | 38,664 | 267,639,594 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26,381 | 39,914,602 | 0.07 | 56.13 | 1,480,758 | 2,240,394,636 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,889 | 4,768,693 | 0.06 | 56.13 | 162,159 | 267,665,307 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289,278 | 39,888,221 | 0.73 | 56.26 | 16,274,202 | 2,244,031,537 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,679 | 4,765,804 | 0.67 | 56.26 | 1,782,197 | 268,114,601 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,884 | 39,598,943 | 0.01 | 51.83 | 149,479 | 2,052,425,095 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4,734,125 | 0.01 | 51.83 | 16,378 | 245,371,119 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,434 | 39,596,059 | 0.01 | 53.33 | 129,815 | 2,111,812,251 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4,733,809 | 0.01 | 53.33 | 14,187 | 252,472,496 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,717 | 39,593,625 | 0.08 | 53.66 | 1,755,578 | 2,124,574,121 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,583 | 4,733,543 | 0.08 | 53.66 | 192,262 | 253,999,551 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,332 | 39,560,908 | 0.10 | 54.37 | 2,192,976 | 2,151,049,207 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,417 | 4,729,960 | 0.09 | 54.37 | 240,166 | 257,182,588 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39,520,576 | 0.00 | 54.51 | 50,365 | 2,154,183,605 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,725,543 | 0.00 | 54.51 | 5,505 | 257,579,425 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,803 | 39,519,652 | 0.00 | 54.61 | 98,455 | 2,158,021,973 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4,725,442 | 0.00 | 54.61 | 10,757 | 258,038,903 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85,353 | 39,517,849 | 0.22 | 54.93 | 4,688,039 | 2,170,529,712 | |
2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,347 | 4,725,245 | 0.20 | 54.93 | 513,387 | 259,535,499 | |
2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,928,596 | 9,309,333 | 45.90 | 2.00 | 5,857,192 | 18,618,666 | |
2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321,404 | 1,003,781 | 47.10 | 2.00 | 642,808 | 2,007,562 | |
2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533,720 | 0.04 | 94.29 | 18,952 | 50,324,459 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319,313 | 0.22 | 28.92 | 19,955 | 9,234,532 | |
2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,550 | 1,131,625 | 1.12 | 13.15 | 165,029 | 14,880,529 | |
2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,476,348 | 9,404,467 | 35.74 | 12.25 | 30,335,263 | 115,204,721 | |
2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294,707 | 1,119,075 | 35.75 | 12.25 | 3,610,161 | 13,708,669 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,339 | 39,432,496 | 0.06 | 51.55 | 1,254,571 | 2,032,575,609 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,730 | 4,715,898 | 0.06 | 51.55 | 140,720 | 243,084,264 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58,541 | 39,408,157 | 0.15 | 51.41 | 3,009,341 | 2,025,803,896 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,565 | 4,713,168 | 0.14 | 51.41 | 337,478 | 242,283,700 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,349,616 | 0.00 | 50.64 | 45,523 | 1,992,546,505 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,706,603 | 0.00 | 50.64 | 5,114 | 238,328,256 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,804 | 39,348,717 | 0.06 | 50.42 | 1,099,388 | 1,984,017,399 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,445 | 4,706,502 | 0.05 | 50.42 | 123,280 | 237,308,420 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,290 | 39,326,913 | 0.05 | 50.41 | 1,073,191 | 1,982,398,896 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,388 | 4,704,057 | 0.05 | 50.41 | 120,375 | 237,123,046 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39,305,623 | 0.00 | 50.00 | 4,500 | 1,965,281,150 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4,701,669 | 0.00 | 50.00 | 500 | 235,083,450 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,305,533 | 0.00 | 49.84 | 44,802 | 1,958,791,237 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,701,659 | 0.00 | 49.84 | 5,033 | 234,307,176 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,380 | 39,304,634 | 0.02 | 50.99 | 427,266 | 2,004,001,791 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,701,558 | 0.02 | 50.99 | 47,927 | 239,715,517 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,338 | 39,296,254 | 0.01 | 50.48 | 118,029 | 1,983,788,861 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4,700,618 | 0.01 | 50.48 | 13,227 | 237,300,828 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,241 | 39,293,916 | 0.08 | 51.25 | 1,703,751 | 2,013,990,018 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,728 | 4,700,356 | 0.08 | 51.25 | 191,077 | 240,914,397 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,440 | 39,260,675 | 0.06 | 50.33 | 1,179,656 | 1,975,856,286 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,637 | 4,696,628 | 0.06 | 50.33 | 132,711 | 236,365,319 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170,652 | 39,237,235 | 0.44 | 50.38 | 8,597,226 | 1,976,720,891 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,201 | 4,693,991 | 0.41 | 50.38 | 967,321 | 236,477,164 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,944 | 39,066,583 | 0.02 | 51.05 | 405,541 | 1,994,349,062 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4,674,790 | 0.02 | 51.05 | 45,639 | 238,648,030 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28,271 | 39,058,639 | 0.07 | 50.55 | 1,428,963 | 1,974,226,720 | |
2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,181 | 4,673,896 | 0.07 | 50.55 | 160,784 | 236,243,008 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,893 | 39,030,368 | 0.09 | 50.48 | 1,710,844 | 1,970,167,110 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,813 | 4,670,715 | 0.08 | 50.48 | 192,472 | 235,767,418 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,036 | 38,996,475 | 0.12 | 50.10 | 2,406,829 | 1,953,906,681 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,405 | 4,666,902 | 0.12 | 50.10 | 270,816 | 233,833,725 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101,290 | 38,948,439 | 0.26 | 50.05 | 5,069,433 | 1,949,318,739 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,397 | 4,661,497 | 0.25 | 50.05 | 570,405 | 233,301,865 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,581 | 38,847,149 | 0.01 | 49.46 | 276,030 | 1,921,337,258 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4,650,100 | 0.01 | 49.46 | 31,060 | 229,988,831 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38,841,568 | 0.00 | 49.18 | 46,427 | 1,910,267,156 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4,649,472 | 0.00 | 49.18 | 5,213 | 228,665,682 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,825 | 38,840,624 | 0.04 | 48.61 | 672,033 | 1,888,042,733 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,556 | 4,649,366 | 0.03 | 48.61 | 75,637 | 226,005,681 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12,955 | 38,826,799 | 0.03 | 48.95 | 634,191 | 1,900,703,822 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,457 | 4,647,810 | 0.03 | 48.95 | 71,325 | 227,526,102 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38,813,844 | 0.00 | 47.27 | 25,904 | 1,834,718,762 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4,646,353 | 0.00 | 47.27 | 2,931 | 219,631,712 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 38,813,296 | 0.03 | 48.16 | 562,550 | 1,869,225,047 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,314 | 4,646,291 | 0.03 | 48.16 | 63,281 | 223,762,587 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,598 | 38,801,615 | 0.02 | 48.44 | 416,460 | 1,879,426,065 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4,644,977 | 0.02 | 48.44 | 46,838 | 224,987,822 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,930 | 38,793,017 | 0.02 | 48.29 | 286,332 | 1,873,132,464 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4,644,010 | 0.01 | 48.29 | 32,206 | 224,237,416 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84,331 | 4,643,343 | 1.85 | 46.17 | 3,893,638 | 214,387,325 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,600 | 4,559,012 | 0.08 | 45.10 | 162,369 | 205,623,295 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35,263 | 4,555,412 | 0.78 | 45.39 | 1,600,457 | 206,753,296 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,360 | 4,520,149 | 0.19 | 46.10 | 385,414 | 208,388,813 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,735 | 4,511,789 | 0.06 | 44.98 | 123,025 | 202,948,842 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,074 | 4,509,054 | 0.20 | 45.80 | 415,623 | 206,531,357 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9,418,390 | -0.01 | 4.29 | -3,645 | 40,392,649 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1,551,387 | -0.01 | 4.29 | -600 | 6,653,433 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343,583 | 9,419,240 | -3.52 | 4.83 | -1,658,681 | 45,472,323 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56,417 | 1,551,527 | -3.51 | 4.83 | -272,359 | 7,490,152 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296,856 | 9,762,823 | -2.95 | 5.25 | -1,559,711 | 51,294,848 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48,744 | 1,607,944 | -2.94 | 5.25 | -256,106 | 8,448,299 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2,834,561 | 10,059,679 | -21.98 | 5.00 | -14,172,805 | 50,298,395 | |
2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465,439 | 1,656,688 | -21.93 | 5.00 | -2,327,195 | 8,283,440 | |
2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89,896 | 11,348,958 | 0.80 | 27.02 | 2,428,621 | 306,602,314 | |
2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,104 | 1,758,289 | 0.58 | 27.02 | 272,969 | 47,501,760 | |
2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,169,877 | 22,337,275 | 5.53 | 33.00 | 38,605,941 | 737,130,075 | |
2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133,153 | 3,029,953 | 4.60 | 33.00 | 4,394,049 | 99,988,449 | |
2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23,803,844 | 0.00 | 79.98 | 18,955 | 1,903,831,443 | |
2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26,500 | 26,500 | |||||
2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,318 | 30,003 | -7.17 | 9.56 | -22,157 | 286,787 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158,684 | 2,122,417 | -6.96 | 9.56 | -1,516,797 | 20,287,335 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9,056 | 116,778 | -7.20 | 9.56 | -86,563 | 1,116,234 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5,111 | 32,321 | -13.65 | 9.40 | -48,043 | 303,817 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349,919 | 2,281,101 | -13.30 | 9.40 | -3,289,239 | 21,442,349 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19,970 | 125,834 | -13.70 | 9.40 | -187,718 | 1,182,840 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,154 | 37,432 | -5.44 | 9.21 | -19,844 | 344,839 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147,529 | 2,631,020 | -5.31 | 9.21 | -1,359,096 | 24,238,009 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8,417 | 145,804 | -5.46 | 9.21 | -77,541 | 1,343,205 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4,201 | 39,586 | -9.59 | 9.44 | -39,648 | 373,605 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275,506 | 2,778,549 | -9.02 | 9.44 | -2,600,171 | 26,223,390 | |
2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16,493 | 154,221 | -9.66 | 9.44 | -155,658 | 1,455,507 | |
2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 317,877 | 2.66 | 10.73 | 88,522 | 3,410,820 | |
2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,294 | 2,294 | |||||
2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1,232,130 | 0 | -100.00 | ||||
2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101,204 | 0 | -100.00 | ||||
2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179,531 | 976,214 | 22.53 | 18.00 | 3,231,558 | 17,571,852 | |
2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20,469 | 85,906 | 31.28 | 18.00 | 368,442 | 1,546,308 | |
2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796,683 | 796,683 | |||||
2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65,437 | 65,437 | |||||
2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 7,110,113 | 0.15 | 1.97 | 21,252 | 14,006,923 | |
2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3,268,830 | 0.00 | 6.74 | 923 | 22,031,914 | |
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3,479 | 0 | -100.00 | ||||
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310,003 | 0 | -100.00 | ||||
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3,479 | 43,787 | 8.63 | 6.74 | 23,448 | 295,124 | |
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310,003 | 3,054,055 | 11.30 | 6.74 | 2,089,420 | 20,584,331 | |
2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6.74 | 923 | 923 | ||
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262,253 | 21,167,398 | 1.25 | 28.55 | 7,486,904 | 604,295,345 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,647 | 2,896,800 | 1.00 | 28.55 | 817,826 | 82,699,005 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,818 | 20,905,145 | 0.05 | 27.82 | 300,959 | 581,585,315 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,182 | 2,868,153 | 0.04 | 27.82 | 32,883 | 79,792,590 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318,969 | 20,894,327 | 1.55 | 27.72 | 8,840,959 | 579,134,330 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34,844 | 2,866,971 | 1.23 | 27.72 | 965,782 | 79,464,695 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60,587 | 20,575,358 | 0.30 | 27.56 | 1,669,705 | 567,032,176 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,618 | 2,832,127 | 0.23 | 27.56 | 182,384 | 78,050,022 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,433 | 20,514,771 | 0.14 | 26.55 | 755,024 | 544,759,487 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,106 | 2,825,509 | 0.11 | 26.55 | 82,478 | 75,029,979 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180,122 | 20,486,338 | 0.89 | 26.49 | 4,772,224 | 542,773,234 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,676 | 2,822,403 | 0.70 | 26.49 | 521,304 | 74,777,874 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,433 | 20,306,216 | 0.07 | 26.28 | 353,086 | 533,748,888 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,467 | 2,802,727 | 0.05 | 26.28 | 38,560 | 73,669,679 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,775 | 20,292,783 | 0.07 | 25.61 | 378,343 | 519,637,294 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,614 | 2,801,260 | 0.06 | 25.61 | 41,330 | 71,731,865 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16,057 | 2,799,646 | 0.58 | 26.35 | 423,057 | 73,762,833 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37,882 | 2,783,589 | 1.38 | 25.98 | 983,985 | 72,303,724 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408,607 | 2,745,707 | 17.48 | 25.92 | 10,593,014 | 71,181,630 | |
2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92,140 | 38,783,387 | 0.24 | 31.73 | 2,923,547 | 1,230,573,599 | |
2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,034 | 4,496,280 | 0.22 | 31.73 | 318,373 | 142,664,267 | |
2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,741 | 38,691,247 | 0.05 | 32.41 | 639,713 | 1,253,801,466 | |
2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,150 | 4,486,246 | 0.05 | 32.41 | 69,671 | 145,378,148 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 206,421,153 | 0.01 | 3.86 | 77,200 | 796,785,651 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90,179 | 19,757,285 | 0.46 | 62.59 | 5,644,024 | 1,236,547,221 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,821 | 3,358,951 | 0.29 | 62.59 | 614,666 | 210,226,330 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127,964 | 19,667,106 | 0.65 | 61.38 | 7,854,149 | 1,207,123,699 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,936 | 3,349,130 | 0.42 | 61.38 | 855,361 | 205,562,231 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24,431 | 19,539,142 | 0.13 | 61.03 | 1,490,975 | 1,192,434,758 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,660 | 3,335,194 | 0.08 | 61.03 | 162,334 | 203,540,219 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,659 | 19,514,711 | 0.11 | 60.95 | 1,259,178 | 1,189,433,344 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,250 | 3,332,534 | 0.07 | 60.95 | 137,139 | 203,119,947 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97,484 | 19,494,052 | 0.50 | 60.85 | 5,931,960 | 1,186,224,761 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,616 | 3,330,284 | 0.32 | 60.85 | 645,990 | 202,649,780 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,182 | 19,376,568 | 0.01 | 65.29 | 77,176 | 1,265,142,628 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3,299,668 | 0.00 | 65.29 | 8,423 | 215,443,243 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179,176 | 19,375,386 | 0.93 | 65.80 | 11,789,387 | 1,274,857,773 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,513 | 3,299,539 | 0.59 | 65.80 | 1,283,912 | 217,102,407 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180,358 | 19,196,210 | 0.95 | 67.15 | 12,110,607 | 1,288,979,431 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,642 | 3,280,026 | 0.60 | 67.15 | 1,318,913 | 220,245,874 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,484 | 38,671,506 | 0.52 | 31.60 | 6,272,531 | 1,222,104,667 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,616 | 4,484,096 | 0.48 | 31.60 | 683,113 | 141,707,299 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,810 | 38,473,022 | 0.09 | 31.86 | 1,045,205 | 1,225,608,131 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,573 | 4,462,480 | 0.08 | 31.86 | 113,823 | 142,158,102 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,627 | 38,440,212 | 0.02 | 31.50 | 271,712 | 1,210,693,697 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,458,907 | 0.02 | 31.50 | 29,606 | 140,435,505 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273,381 | 38,431,585 | 0.72 | 31.89 | 8,719,077 | 1,225,717,756 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,772 | 4,457,967 | 0.67 | 31.89 | 949,533 | 142,180,171 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145,272 | 38,158,204 | 0.38 | 31.74 | 4,611,296 | 1,211,236,790 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,821 | 4,428,195 | 0.36 | 31.74 | 502,198 | 140,561,980 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,560 | 38,012,932 | 0.17 | 31.50 | 2,002,401 | 1,197,563,211 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,922 | 4,412,374 | 0.16 | 31.50 | 218,071 | 139,007,872 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387,336 | 37,949,372 | 1.03 | 32.31 | 12,514,051 | 1,226,068,311 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,182 | 4,405,452 | 0.97 | 32.31 | 1,362,816 | 142,331,343 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107,260 | 37,562,036 | 0.29 | 33.77 | 3,622,063 | 1,268,432,394 | |
2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 4,363,270 | 0.27 | 33.77 | 394,456 | 147,343,265 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128,975 | 6,928,119 | 1.90 | 8.16 | 1,051,920 | 56,505,739 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,046 | 824,368 | 1.73 | 8.16 | 114,559 | 6,723,545 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185,413 | 6,799,144 | 2.80 | 7.91 | 1,466,320 | 53,770,350 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,192 | 810,322 | 2.56 | 7.91 | 159,686 | 6,408,351 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,840 | 6,613,731 | 0.18 | 7.70 | 91,160 | 50,921,099 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,289 | 790,130 | 0.16 | 7.70 | 9,924 | 6,083,448 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68,132 | 6,601,891 | 1.04 | 8.03 | 546,807 | 52,984,797 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,420 | 788,841 | 0.95 | 8.03 | 59,551 | 6,331,001 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30,986 | 6,533,759 | 0.48 | 7.88 | 244,126 | 51,476,874 | |
2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,374 | 781,421 | 0.43 | 7.88 | 26,582 | 6,156,503 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,874 | 37,454,776 | 0.01 | 32.34 | 157,646 | 1,211,448,511 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4,351,589 | 0.01 | 32.34 | 17,692 | 140,749,100 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147,831 | 37,449,902 | 0.40 | 33.15 | 4,900,997 | 1,241,565,366 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,608 | 4,351,042 | 0.38 | 33.15 | 550,600 | 144,248,790 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,289 | 37,302,071 | 0.06 | 32.96 | 767,582 | 1,229,438,958 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,616 | 4,334,434 | 0.06 | 32.96 | 86,221 | 142,858,610 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,682 | 37,278,782 | 0.26 | 32.41 | 3,100,652 | 1,208,048,754 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,749 | 4,331,818 | 0.25 | 32.41 | 348,330 | 140,376,028 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165,237 | 37,183,100 | 0.45 | 32.30 | 5,337,915 | 1,201,185,172 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,563 | 4,321,069 | 0.43 | 32.30 | 599,670 | 139,590,406 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36,589 | 37,017,863 | 0.10 | 31.15 | 1,139,842 | 1,153,202,679 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,111 | 4,302,506 | 0.10 | 31.15 | 128,068 | 134,034,248 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,272 | 36,981,274 | 0.26 | 32.12 | 3,124,484 | 1,187,879,200 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,927 | 4,298,395 | 0.25 | 32.12 | 350,987 | 138,069,176 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53,734 | 36,884,002 | 0.15 | 32.47 | 1,744,598 | 1,197,523,958 | |
2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,037 | 4,287,468 | 0.14 | 32.47 | 196,005 | 139,202,510 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 286,671,473 | 0.00 | 4.18 | 41,800 | 1,198,286,757 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,732 | 36,830,268 | 0.24 | ||||
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,968 | 4,281,431 | 0.23 | ||||
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,996 | 36,741,536 | 0.13 | ||||
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,504 | 4,271,463 | 0.13 | ||||
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 36,692,540 | 0.03 | 4.18 | 41,800 | 153,374,817 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,157 | 36,682,540 | 0.04 | 33.72 | 477,445 | 1,237,118,662 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,590 | 4,255,959 | 0.04 | 33.72 | 53,623 | 143,532,217 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,921 | 36,668,383 | 0.11 | 33.68 | 1,378,043 | 1,234,833,465 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,597 | 4,254,369 | 0.11 | 33.68 | 154,807 | 143,268,854 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,550 | 36,627,462 | 0.60 | 32.49 | 7,101,280 | 1,190,125,135 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,908 | 4,249,772 | 0.57 | 32.49 | 776,835 | 138,086,567 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41,104 | 36,408,912 | 0.11 | 31.68 | 1,302,257 | 1,153,507,150 | |
2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,496 | 4,225,864 | 0.11 | 31.68 | 142,442 | 133,883,823 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,492 | 36,367,808 | 0.16 | 32.24 | 1,918,022 | 1,172,498,130 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,508 | 4,221,368 | 0.15 | 32.24 | 209,818 | 136,096,904 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301,066 | 36,308,316 | 0.84 | 32.76 | 9,862,139 | 1,189,366,031 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,934 | 4,214,860 | 0.79 | 32.76 | 1,078,832 | 138,067,855 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,814 | 36,007,250 | 0.06 | 31.24 | 681,563 | 1,125,021,321 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,386 | 4,181,926 | 0.06 | 31.24 | 74,549 | 130,661,351 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172,462 | 35,985,436 | 0.48 | 30.34 | 5,232,928 | 1,091,888,092 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,866 | 4,179,540 | 0.45 | 30.34 | 572,442 | 126,817,692 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54,439 | 35,812,974 | 0.15 | 30.55 | 1,663,024 | 1,094,029,055 | |
2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,955 | 4,160,674 | 0.14 | 30.55 | 181,916 | 127,101,934 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,022 | 19,015,852 | 0.03 | 74.00 | 445,628 | 1,407,173,048 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3,260,384 | 0.02 | 74.00 | 50,172 | 241,268,416 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,492 | 19,009,830 | 0.11 | 69.70 | 1,428,282 | 1,324,975,646 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,308 | 3,259,706 | 0.07 | 69.70 | 160,866 | 227,199,878 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23,157 | 18,989,338 | 0.12 | 70.50 | 1,632,684 | 1,338,843,276 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,608 | 3,257,398 | 0.08 | 70.50 | 183,877 | 229,662,846 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,111 | 18,966,181 | 0.04 | 71.96 | 583,702 | 1,364,886,043 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3,254,790 | 0.03 | 71.96 | 65,775 | 234,228,359 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,815 | 35,758,535 | 0.11 | 30.13 | 1,199,793 | 1,077,554,845 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,485 | 4,154,719 | 0.11 | 30.13 | 135,152 | 125,199,133 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128,255 | 35,718,720 | 0.36 | 29.86 | 3,830,118 | 1,066,678,851 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,447 | 4,150,234 | 0.35 | 29.86 | 431,435 | 123,939,683 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67,407 | 35,590,465 | 0.19 | 28.52 | 1,922,670 | 1,015,157,510 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,593 | 4,135,787 | 0.18 | 28.52 | 216,577 | 117,966,293 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,134 | 35,523,058 | 0.01 | 28.46 | 117,674 | 1,011,163,846 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4,128,194 | 0.01 | 28.46 | 13,265 | 117,509,042 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,056 | 35,518,924 | 0.12 | 29.77 | 1,281,975 | 1,057,561,755 | |
2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,850 | 4,127,728 | 0.12 | 29.77 | 144,407 | 122,901,450 | |
2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,768 | 35,475,868 | 0.62 | 30.21 | 6,610,053 | 1,071,899,804 | |
2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,643 | 4,122,878 | 0.60 | 30.21 | 744,586 | 124,572,346 | |
2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456,849 | 35,257,100 | 1.31 | 29.20 | 13,339,991 | 1,029,507,320 | |
2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,677 | 4,098,235 | 1.23 | 29.20 | 1,450,568 | 119,668,462 | |
2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226,865 | 34,800,251 | 0.66 | 29.94 | 6,791,816 | 1,041,839,474 | |
2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,669 | 4,048,558 | 0.61 | 29.94 | 738,533 | 121,204,515 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726,291 | 34,573,386 | 2.15 | 31.25 | 22,694,197 | 1,080,304,220 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,976 | 4,023,889 | 2.00 | 31.25 | 2,467,739 | 125,733,252 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33,847,095 | 0.00 | 29.50 | 26,609 | 998,489,302 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3,944,913 | 0.00 | 29.50 | 2,891 | 116,374,934 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106,444 | 33,846,193 | 0.32 | 29.19 | 3,107,590 | 988,126,066 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,575 | 3,944,815 | 0.29 | 29.19 | 337,927 | 115,167,296 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,144 | 33,739,749 | 0.45 | 30.27 | 4,574,645 | 1,021,194,235 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,435 | 3,933,240 | 0.42 | 30.27 | 497,435 | 119,046,588 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33,588,605 | 0.00 | 27.93 | 17,626 | 938,227,145 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3,916,805 | 0.00 | 27.93 | 1,927 | 109,407,722 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,073 | 33,587,974 | 0.22 | 27.28 | 1,966,043 | 916,229,549 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,909 | 3,916,736 | 0.20 | 27.28 | 215,746 | 106,842,683 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87,049 | 33,515,901 | 0.26 | 28.07 | 2,443,831 | 940,932,108 | |
2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,551 | 3,908,827 | 0.24 | 28.07 | 268,137 | 109,737,191 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,187 | 18,958,070 | 0.08 | 69.45 | 1,054,742 | 1,316,643,649 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,651 | 3,253,876 | 0.05 | 69.45 | 114,662 | 225,982,664 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,250 | 18,942,883 | 0.04 | 70.86 | 584,597 | 1,342,296,478 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3,252,225 | 0.03 | 70.86 | 63,562 | 230,453,314 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67,373 | 18,934,633 | 0.36 | 69.54 | 4,684,923 | 1,316,659,468 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,326 | 3,251,328 | 0.23 | 69.54 | 509,429 | 226,087,920 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124,057 | 18,867,260 | 0.66 | 70.21 | 8,710,228 | 1,324,698,625 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,490 | 3,244,002 | 0.42 | 70.21 | 947,153 | 227,766,246 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397,079 | 18,743,203 | 2.16 | 71.10 | 28,233,945 | 1,332,718,580 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43,178 | 3,230,512 | 1.35 | 71.10 | 3,070,133 | 229,702,648 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149,927 | 18,346,124 | 0.82 | 67.94 | 10,186,595 | 1,246,503,545 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16,450 | 3,187,334 | 0.52 | 67.94 | 1,117,674 | 216,559,265 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38,117 | 18,196,197 | 0.21 | 63.98 | 2,438,547 | 1,164,107,162 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4,183 | 3,170,884 | 0.13 | 63.98 | 267,609 | 202,858,255 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168,055 | 18,158,080 | 0.93 | 64.87 | 10,902,350 | 1,177,981,834 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18,441 | 3,166,701 | 0.59 | 64.87 | 1,196,336 | 205,435,611 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541,340 | 17,990,025 | 3.10 | 65.80 | 35,621,958 | 1,183,803,012 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59,401 | 3,148,260 | 1.92 | 65.80 | 3,908,782 | 207,165,897 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49,021 | 17,448,685 | 0.28 | 66.68 | 3,268,823 | 1,163,514,958 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,379 | 3,088,859 | 0.17 | 66.68 | 358,683 | 205,971,605 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72,894 | 17,399,664 | 0.42 | 67.68 | 4,933,706 | 1,177,666,678 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,999 | 3,083,480 | 0.26 | 67.68 | 541,399 | 208,700,102 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,939 | 17,326,770 | 0.04 | 60.85 | 422,220 | 1,054,288,905 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3,075,481 | 0.02 | 60.85 | 46,305 | 187,135,023 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57,865 | 17,319,831 | 0.34 | 61.73 | 3,572,047 | 1,069,165,292 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,349 | 3,074,720 | 0.21 | 61.73 | 391,928 | 189,804,618 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136,793 | 17,261,966 | 0.80 | 58.13 | 7,952,133 | 1,003,482,965 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,010 | 3,068,371 | 0.49 | 58.13 | 872,570 | 178,372,384 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114,908 | 17,125,173 | 0.68 | 59.01 | 6,780,526 | 1,010,527,346 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,609 | 3,053,361 | 0.41 | 59.01 | 744,036 | 180,173,642 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,309 | 17,010,265 | 0.39 | 60.40 | 3,944,513 | 1,027,380,882 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,166 | 3,040,752 | 0.24 | 60.40 | 432,810 | 183,654,427 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113,546 | 16,944,956 | 0.67 | 61.40 | 6,971,475 | 1,040,383,019 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,459 | 3,033,586 | 0.41 | 61.40 | 764,955 | 186,255,507 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289,755 | 16,831,410 | 1.75 | 62.56 | 18,126,986 | 1,052,967,960 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31,795 | 3,021,127 | 1.06 | 62.56 | 1,989,086 | 189,000,799 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176,647 | 16,541,655 | 1.08 | 63.37 | 11,194,368 | 1,048,267,836 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,383 | 2,989,332 | 0.65 | 63.37 | 1,228,328 | 189,438,154 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235,734 | 16,365,008 | 1.46 | 64.46 | 15,195,814 | 1,054,916,236 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,869 | 2,969,949 | 0.88 | 64.46 | 1,667,560 | 191,447,961 | |
2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45,000 | 12,894,240 | 0.35 | 6.33 | 284,656 | 81,565,094 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56,853 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2,296,890 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238,850 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26,292,961 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1,912,167 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582,747 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44,572,171 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4,382,118 | 0 | -100.00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,723,306 | 1,723,306 | 24.00 | 41,359,344 | 41,359,344 | ||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189,374 | 189,374 | 24.00 | 4,544,976 | 4,544,976 | ||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56,853 | 639,600 | 9.76 | 0.68 | 38,376 | 431,730 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2,296,890 | 73,162,022 | 3.24 | 0.68 | 1,550,401 | 49,384,365 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238,850 | 6,533,135 | 3.79 | 0.68 | 161,224 | 4,409,866 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26,292,961 | 70,865,132 | 58.99 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1,912,167 | 6,294,285 | 43.64 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582,747 | 582,747 | |||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44,572,171 | 44,572,171 | |||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4,382,118 | 4,382,118 | |||||
2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,800 | 12,849,240 | 0.19 | 6.65 | 164,915 | 85,444,876 | |
2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,187 | 12,824,440 | 0.72 | 6.29 | 573,311 | 80,629,819 | |
2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,728 | 12,733,253 | 0.73 | 6.52 | 598,360 | 83,061,556 | |
2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,641,525 | 0.20 | 6.88 | 172,015 | 86,981,277 | |
2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63,345 | 12,616,525 | 0.50 | 6.98 | 441,971 | 88,028,018 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,581 | 6,502,773 | 0.06 | 11.00 | 39,377 | 71,504,492 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778,047 | 0.05 | 11.00 | 4,343 | 8,555,405 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66,345 | 6,499,192 | 1.03 | 10.80 | 716,745 | 70,212,721 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,318 | 777,652 | 0.95 | 10.80 | 79,059 | 8,401,208 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,522 | 6,432,847 | 0.04 | 11.20 | 28,257 | 72,075,548 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770,334 | 0.04 | 11.20 | 3,115 | 8,631,053 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,503 | 6,430,325 | 0.07 | 10.98 | 49,423 | 70,576,032 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770,056 | 0.06 | 10.98 | 5,455 | 8,451,750 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,833 | 6,425,822 | 0.04 | 11.23 | 31,822 | 72,178,688 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769,559 | 0.04 | 11.23 | 3,505 | 8,644,148 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25,650 | 6,422,989 | 0.40 | 10.69 | 274,219 | 68,666,891 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,810 | 769,247 | 0.37 | 10.69 | 30,041 | 8,223,866 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6,397,339 | 0.00 | 10.60 | 1,654 | 67,811,793 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766,437 | 0.00 | 10.60 | 180 | 8,124,232 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,021 | 6,397,183 | 0.06 | 10.69 | 42,999 | 68,409,556 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766,420 | 0.06 | 10.69 | 4,705 | 8,195,866 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17,221 | 6,393,162 | 0.27 | 10.78 | 185,666 | 68,927,237 | |
2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,887 | 765,980 | 0.25 | 10.78 | 20,345 | 8,258,337 | |
2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,200 | 12,553,180 | 0.03 | 7.00 | 22,389 | 87,829,579 | |
2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,600 | 12,549,980 | 0.83 | 7.29 | 755,368 | 91,504,414 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,734 | 6,375,941 | 0.03 | 8.90 | 15,433 | 56,745,875 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764,093 | 0.02 | 8.90 | 1,691 | 6,800,428 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27,996 | 6,374,207 | 0.44 | 8.96 | 250,766 | 57,095,047 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,067 | 763,903 | 0.40 | 8.96 | 27,472 | 6,842,432 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13,789 | 6,346,211 | 0.22 | 8.96 | 123,493 | 56,836,031 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,511 | 760,836 | 0.20 | 8.96 | 13,532 | 6,813,971 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57,453 | 6,332,422 | 0.92 | 9.89 | 567,934 | 62,597,258 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6,294 | 759,325 | 0.84 | 9.89 | 62,217 | 7,506,079 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,313 | 6,274,969 | 0.23 | 9.15 | 131,017 | 57,439,184 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,568 | 753,031 | 0.21 | 9.15 | 14,353 | 6,893,020 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10,123 | 6,260,656 | 0.16 | 9.21 | 93,282 | 57,691,319 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,109 | 751,463 | 0.15 | 9.21 | 10,219 | 6,924,656 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45,903 | 6,250,533 | 0.74 | 9.08 | 416,602 | 56,727,962 | |
2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,029 | 750,354 | 0.67 | 9.08 | 45,642 | 6,809,988 | |
2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1,325 | 12,446,380 | 0.01 | 6.94 | 9,197 | 86,396,547 | |
2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51,370 | 12,445,055 | 0.41 | 6.87 | 352,974 | 85,512,462 | |
2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92,200 | 12,393,685 | 0.75 | 7.12 | 656,750 | 88,281,458 | |
2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,301,485 | 0.20 | 7.49 | 187,332 | 92,178,718 | |
2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175,000 | 12,276,485 | 1.45 | 7.45 | 1,303,890 | 91,469,634 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 6,348,612 | 0.11 | 3.00 | 21,246 | 19,045,836 | |
2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666,111 | 0.03 | 108.45 | 18,979 | 72,239,738 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482,740 | 0.12 | 35.20 | 19,994 | 16,992,448 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11,423,179 | 0.00 | 35.20 | 19,994 | 402,095,901 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196,132 | 0.29 | 35.20 | 19,994 | 6,903,846 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356,791 | 0.16 | 35.20 | 19,994 | 12,559,043 | |
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 33,428,852 | 0.45 | 44.00 | 6,600,000 | 1,470,869,488 | |
2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,647 | 33,278,852 | 0.10 | 43.87 | 1,388,259 | 1,459,843,401 | |
2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,461 | 33,247,205 | 0.17 | 43.93 | 2,524,015 | 1,460,406,753 | |
2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75,612 | 33,189,744 | 0.23 | 43.93 | 3,321,363 | 1,457,905,971 | |
2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,000 | 33,114,132 | 0.01 | 43.00 | 172,000 | 1,423,907,676 | |
2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,638 | 33,110,132 | 0.03 | 43.84 | 466,321 | 1,451,395,880 | |
2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,400 | 33,099,494 | 0.03 | 44.00 | 413,600 | 1,456,377,736 | |
2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33,090,094 | 0.00 | 43.00 | 34,400 | 1,422,874,042 | |
2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407,800 | 33,089,294 | 1.25 | 43.71 | 17,823,388 | 1,446,207,301 | |
2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,700 | 32,681,494 | 0.30 | 44.00 | 4,342,800 | 1,437,985,736 | |
2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196,490 | 32,582,794 | 0.61 | 41.31 | 8,117,179 | 1,346,024,545 | |
2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221,434 | 32,386,304 | 0.69 | 42.51 | 9,412,318 | 1,376,618,715 | |
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512,845 | 0.03 | 110.33 | 18,977 | 56,582,189 | |
2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972,118 | 0.02 | 110.33 | 18,977 | 107,253,779 | |
2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16,282,190 | 0.00 | 110.33 | 18,977 | 1,796,414,023 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11,422,611 | 0.01 | 21.34 | 19,974 | 243,758,519 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1,911,734 | 0.05 | 21.34 | 19,974 | 40,796,404 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195,564 | 0.48 | 21.34 | 19,974 | 4,173,336 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356,223 | 0.26 | 21.34 | 19,974 | 7,601,799 | |
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892,000 | 0 | -100.00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31,967,000 | 0 | -100.00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7,587,000 | 0 | -100.00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65,000 | 0 | -100.00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64,000 | 0 | -100.00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101,652 | 512,673 | 24.73 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3,642,962 | 16,128,927 | 29.18 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864,614 | 2,943,733 | 41.59 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,406 | 61,049 | 13.81 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,292 | 58,632 | 14.20 | ||||
2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100.00 | ||||
2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139,220 | 2,744,052 | 5.34 | 45.00 | 6,264,900 | 123,482,340 | |
2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10,780 | 170,714 | 6.74 | 45.00 | 485,100 | 7,682,130 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346,000 | 32,164,870 | 1.09 | 48.44 | 16,761,728 | 1,558,204,612 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,000 | 31,818,870 | 0.16 | 47.40 | 2,370,000 | 1,508,214,438 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160,453 | 31,768,870 | 0.51 | 48.60 | 7,798,690 | 1,544,100,511 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,320 | 31,608,417 | 0.11 | 47.98 | 1,598,614 | 1,516,495,987 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,386 | 31,575,097 | 0.05 | 47.54 | 683,847 | 1,500,941,181 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,600 | 31,560,711 | 0.01 | 47.24 | 75,577 | 1,490,798,589 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,500 | 31,559,111 | 0.06 | 46.31 | 949,351 | 1,461,496,119 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,950 | 31,538,611 | 0.01 | 44.68 | 87,130 | 1,409,201,909 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,843 | 31,536,661 | 0.29 | 45.28 | 4,067,696 | 1,427,841,249 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212,983 | 31,446,818 | 0.68 | 46.81 | 9,969,500 | 1,471,990,959 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,818 | 31,233,835 | 0.03 | 46.74 | 458,905 | 1,459,906,929 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,331 | 31,224,017 | 0.01 | 45.63 | 106,368 | 1,424,814,344 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,513 | 31,221,686 | 0.01 | 45.43 | 159,601 | 1,418,448,028 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,897 | 31,218,173 | 0.04 | 45.00 | 625,359 | 1,404,805,298 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,649 | 31,204,276 | 0.13 | 42.14 | 1,713,148 | 1,315,101,092 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,063 | 31,163,627 | 0.03 | 44.40 | 357,971 | 1,383,565,315 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,391 | 31,155,564 | 0.05 | 40.67 | 625,950 | 1,267,093,672 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191,321 | 31,140,173 | 0.62 | 41.06 | 7,856,214 | 1,278,708,924 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,640 | 30,948,852 | 0.29 | 42.44 | 3,761,802 | 1,313,441,425 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183,073 | 30,860,212 | 0.60 | 43.28 | 7,923,253 | 1,335,605,287 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274,814 | 30,677,139 | 0.90 | 44.63 | 12,265,553 | 1,369,188,203 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,100 | 30,402,325 | 0.01 | 40.55 | 125,706 | 1,232,823,399 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,300 | 30,399,225 | 0.04 | 41.13 | 464,823 | 1,250,466,041 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,612 | 30,387,925 | 0.14 | 43.60 | 1,901,322 | 1,324,801,095 | |
2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,338,927 | 30,344,313 | 12.36 | 41.00 | 136,896,007 | 1,244,116,833 | |
2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,213,469 | 6,022,104 | 58.12 | 15.50 | 34,308,770 | 93,342,612 | |
2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266,563 | 725,228 | 58.12 | 15.50 | 4,131,726 | 11,241,034 | |
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,329 | 2,329 | |||||
2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229,436 | 90,538 | -71.70 | 1.09 | -250,659 | 98,913 | |
2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,411,311 | 3,153,539 | -74.90 | 1.09 | -10,281,857 | 3,445,241 | |
2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,359,253 | 467,436 | -74.41 | 1.09 | -1,484,984 | 510,674 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307,339 | 0.24 | 27.34 | 19,958 | 8,402,648 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1,350,721 | 0.05 | 27.34 | 19,958 | 36,928,712 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481,236 | 0.15 | 27.34 | 19,958 | 13,156,992 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11,421,675 | 0.01 | 27.34 | 19,958 | 312,268,594 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194,628 | 0.38 | 27.34 | 19,958 | 5,321,130 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355,287 | 0.21 | 27.34 | 19,958 | 9,713,547 | |
2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826,200 | 0.02 | 104.21 | 18,966 | 86,098,302 | |
2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411,021 | 0.04 | 104.21 | 18,966 | 42,832,498 | |
2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549,414 | 0.03 | 104.21 | 18,966 | 57,254,433 | |
2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6,103,033 | 6,103,033 | |||||
2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506,166 | 506,166 | |||||
2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94,412 | 94,412 | |||||
2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66,154 | 66,154 | |||||
2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65,811 | 65,811 | |||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9,184,771 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680,187 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143,462 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200,526 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21,196 | 100,003 | 26.90 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211,614 | 12,250 | -94.53 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 78,807 | 0.63 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100,490 | 12,250 | -89.13 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40,449 | 78,310 | 106.84 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1,068,128 | 680,187 | -61.09 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5,543 | 37,861 | 17.15 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55,479 | 12,250 | -81.91 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12,500 | 32,318 | 63.07 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165,213 | 12,250 | -93.10 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19,318 | 19,818 | 3,863.60 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206,800 | 12,250 | -94.41 | ||||
2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,802 | 27,005,386 | 0.74 | 43.27 | 8,602,242 | 1,168,533,854 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,202 | 26,816,266 | 0.21 | 43.29 | 2,476,343 | 1,160,908,335 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,300 | 26,759,064 | 0.06 | 43.67 | 711,775 | 1,168,493,400 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,155 | 26,742,764 | 0.34 | 43.62 | 3,932,723 | 1,166,567,503 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 26,652,609 | 0.57 | 42.93 | 6,439,500 | 1,144,196,504 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,200 | 26,492,927 | 0.03 | 40.95 | 376,718 | 1,084,821,778 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52,381 | 26,483,727 | 0.20 | 41.54 | 2,176,038 | 1,100,200,229 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139,683 | 26,431,346 | 0.53 | 42.68 | 5,961,908 | 1,128,134,781 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13,352 | 26,291,663 | 0.05 | 42.97 | 573,749 | 1,129,779,051 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2,300 | 26,278,311 | 0.01 | 42.15 | 96,949 | 1,107,675,482 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,382 | 26,276,011 | 0.03 | 41.24 | 304,410 | 1,083,538,610 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,500 | 26,268,629 | 0.02 | 41.07 | 184,815 | 1,078,852,593 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,100 | 26,264,129 | 0.34 | 40.57 | 3,614,475 | 1,065,443,789 | |
2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120,529 | 26,175,029 | 0.46 | 41.09 | 4,951,958 | 1,075,406,301 | |
2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,100 | 26,040,800 | 0.00 | 37.07 | 40,777 | 965,332,456 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,617 | 26,039,700 | 0.18 | 37.15 | 1,732,013 | 967,481,618 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,334 | 25,993,083 | 0.03 | 35.85 | 298,745 | 931,761,050 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,118 | 25,984,749 | 0.50 | 36.40 | 4,700,515 | 945,969,590 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137,800 | 25,855,631 | 0.54 | 36.25 | 4,995,250 | 937,266,624 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155,731 | 25,717,831 | 0.61 | 36.67 | 5,710,048 | 942,972,563 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23,012 | 25,562,100 | 0.09 | 35.91 | 826,437 | 918,019,366 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354,300 | 25,539,088 | 1.41 | 34.76 | 12,315,078 | 887,710,606 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,973 | 25,184,788 | 0.24 | 34.61 | 2,075,833 | 871,716,030 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,330 | 25,124,815 | 0.02 | 33.99 | 147,177 | 853,992,462 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,397 | 25,120,485 | 0.36 | 34.56 | 3,123,949 | 868,116,233 | |
2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,952 | 25,030,088 | 0.09 | 34.52 | 757,888 | 864,158,782 | |
2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,880 | 25,008,136 | 0.01 | 34.72 | 99,986 | 868,217,461 | |
2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,439 | 25,005,256 | 0.03 | 34.47 | 221,935 | 861,863,660 | |
2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158,771 | 24,998,817 | 0.64 | 34.69 | 5,507,401 | 867,151,464 | |
2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116,946 | 24,840,046 | 0.47 | 34.62 | 4,049,208 | 860,076,657 | |
2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,600 | 24,723,100 | 0.08 | 34.82 | 682,537 | 860,939,928 | |
2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,021 | 24,703,500 | 0.02 | 34.79 | 139,882 | 859,380,417 | |
2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213,820 | 24,699,479 | 0.87 | 34.76 | 7,432,169 | 858,529,191 | |
2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211,400 | 24,485,659 | 0.87 | 34.92 | 7,382,532 | 855,090,632 | |
2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,000 | 24,274,259 | 0.00 | 35.60 | 35,595 | 864,042,249 | |
2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62,650 | 24,273,259 | 0.26 | 34.46 | 2,159,163 | 836,551,171 | |
2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163,054 | 24,210,609 | 0.68 | 33.80 | 5,510,818 | 818,258,058 | |
2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,995 | 24,047,555 | 0.02 | 33.60 | 167,830 | 807,985,824 | |
2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,416 | 24,042,560 | 0.21 | 33.65 | 1,662,843 | 809,029,740 | |
2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,898,409 | 6,323,855 | 343.64 | 3.75 | 18,369,034 | 23,714,456 | |
2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434,924 | 625,495 | 228.22 | 3.75 | 1,630,965 | 2,345,606 | |
2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390,935 | 2,604,832 | 17.66 | 20.00 | 7,818,700 | 52,096,640 | |
2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34,065 | 159,934 | 27.06 | 20.00 | 681,300 | 3,198,680 | |
2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,000,000 | 9,184,771 | 12.22 | 94.19 | 94,190,000 | 865,113,580 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,441 | 345,074 | -5.85 | 3.86 | -82,762 | 1,331,986 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859,988 | 12,589,950 | -6.39 | 3.86 | -3,319,554 | 48,597,207 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,571 | 1,851,789 | -6.02 | 3.86 | -457,684 | 7,147,906 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,548 | 366,515 | -5.55 | 3.81 | -82,130 | 1,396,972 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863,100 | 13,449,938 | -6.03 | 3.81 | -3,289,706 | 51,264,439 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,652 | 1,970,360 | -5.68 | 3.81 | -452,242 | 7,510,027 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,554 | 388,063 | -1.16 | 3.55 | -16,184 | 1,379,059 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182,454 | 14,313,038 | -1.26 | 3.55 | -648,387 | 50,864,243 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25,092 | 2,089,012 | -1.19 | 3.55 | -89,169 | 7,423,722 | |
2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 1,425,446 | 0.28 | 4.90 | 19,242 | 6,984,685 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305,953 | 0.20 | 31.97 | 19,949 | 9,781,317 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,349,335 | 0.05 | 31.97 | 19,949 | 43,138,240 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11,420,289 | 0.01 | 31.97 | 19,949 | 365,106,639 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,909,412 | 0.03 | 31.97 | 19,949 | 61,043,902 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193,242 | 0.32 | 31.97 | 19,949 | 6,177,947 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353,901 | 0.18 | 31.97 | 19,949 | 11,314,215 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,415 | 392,617 | -2.10 | 3.65 | -30,711 | 1,432,856 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,123 | 14,495,492 | -2.27 | 3.65 | -1,230,330 | 52,901,298 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,362 | 2,114,104 | -2.15 | 3.65 | -169,198 | 7,715,423 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,746 | 401,032 | -1.17 | 3.68 | -17,447 | 1,474,274 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190,117 | 14,832,615 | -1.27 | 3.68 | -698,908 | 54,527,659 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26,137 | 2,160,466 | -1.20 | 3.68 | -96,085 | 7,942,305 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2,825 | 405,778 | -0.69 | 3.71 | -10,482 | 1,505,680 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112,855 | 15,022,732 | -0.75 | 3.71 | -418,760 | 55,743,349 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15,420 | 2,186,603 | -0.70 | 3.71 | -57,217 | 8,113,609 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16,182 | 408,603 | -3.81 | 4.21 | -68,102 | 1,719,606 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647,781 | 15,135,587 | -4.10 | 4.21 | -2,726,186 | 63,698,118 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88,937 | 2,202,023 | -3.88 | 4.21 | -374,291 | 9,267,214 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3,558 | 424,785 | -0.83 | 4.29 | -15,260 | 1,821,903 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142,543 | 15,783,368 | -0.90 | 4.29 | -611,367 | 67,694,865 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19,599 | 2,290,960 | -0.85 | 4.29 | -84,060 | 9,825,927 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14,753 | 428,343 | -3.33 | 4.31 | -63,571 | 1,845,730 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590,638 | 15,925,911 | -3.58 | 4.31 | -2,545,059 | 68,624,750 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81,109 | 2,310,559 | -3.39 | 4.31 | -349,499 | 9,956,199 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,900 | 23,993,144 | 0.02 | 31.97 | 124,679 | 767,036,821 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23,989,244 | 0.00 | 30.80 | 15,400 | 738,868,715 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,685 | 23,988,744 | 0.21 | 31.82 | 1,581,096 | 763,379,407 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,855,894 | 23,939,059 | 8.40 | 31.94 | 59,276,698 | 764,606,363 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597,000 | 22,083,165 | 2.78 | 31.75 | 18,954,631 | 701,136,072 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305,532 | 21,486,165 | 1.44 | 31.68 | 9,680,415 | 680,763,355 | |
2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70,867 | 21,180,633 | 0.34 | 31.41 | 2,226,244 | 665,376,877 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6,874 | 443,096 | -1.53 | 4.27 | -29,358 | 1,892,419 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274,734 | 16,516,549 | -1.64 | 4.27 | -1,173,361 | 70,540,529 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37,592 | 2,391,668 | -1.55 | 4.27 | -160,552 | 10,214,575 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,908 | 449,970 | -2.15 | 4.45 | -44,093 | 2,002,456 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396,496 | 16,791,283 | -2.31 | 4.45 | -1,764,486 | 74,724,568 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54,396 | 2,429,260 | -2.19 | 4.45 | -242,073 | 10,810,693 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5,457 | 459,878 | -1.17 | 4.71 | -25,724 | 2,167,865 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218,383 | 17,187,779 | -1.25 | 4.71 | -1,029,457 | 81,023,190 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29,960 | 2,483,656 | -1.19 | 4.71 | -141,231 | 11,707,954 | |
2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,429 | 465,335 | -1.78 | 4.62 | -38,907 | 2,147,940 | |
2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,541 | 17,406,162 | -1.90 | 4.62 | -1,558,056 | 80,345,103 | |
2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,383 | 2,513,616 | -1.81 | 4.62 | -214,099 | 11,602,600 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 21,109,766 | 0.48 | 34.95 | 3,495,000 | 737,786,322 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354,000 | 21,009,766 | 1.71 | 34.27 | 12,131,651 | 720,008,883 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,772 | 20,655,766 | 0.07 | 34.53 | 510,114 | 713,295,239 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,378 | 20,640,994 | 0.91 | 34.33 | 6,364,935 | 708,706,465 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 107,504 | 39.62 | ||||
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 3,993,087 | 0.77 | ||||
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399,208 | 0 | -100.00 | ||||
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,500 | 20,455,616 | 0.03 | 33.90 | 186,438 | 693,400,380 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80,430 | 20,450,116 | 0.39 | 34.64 | 2,786,393 | 708,467,684 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,500 | 20,369,686 | 0.21 | 33.28 | 1,414,515 | 677,958,148 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,528 | 20,327,186 | 0.92 | 33.31 | 6,180,420 | 677,151,416 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216,284 | 20,141,658 | 1.09 | 32.56 | 7,043,267 | 655,911,079 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,614 | 19,925,374 | 0.19 | 33.00 | 1,274,254 | 657,533,357 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,890 | 19,886,760 | 0.13 | 33.06 | 822,744 | 657,360,829 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28,086 | 473,764 | -5.60 | 4.55 | -127,671 | 2,153,589 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,122,584 | 17,743,703 | -5.95 | 4.55 | -5,102,930 | 80,657,551 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153,618 | 2,559,999 | -5.66 | 4.55 | -698,301 | 11,636,987 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11,965 | 501,850 | -2.33 | 4.84 | -57,913 | 2,429,054 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486,800 | 18,866,287 | -2.52 | 4.84 | -2,356,209 | 91,316,602 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69,153 | 2,713,617 | -2.49 | 4.84 | -334,714 | 13,134,449 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10,534 | 513,815 | -2.01 | 5.36 | -56,453 | 2,753,586 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428,583 | 19,353,087 | -2.17 | 5.36 | -2,296,819 | 103,715,129 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60,883 | 2,782,770 | -2.14 | 5.36 | -326,278 | 14,913,143 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,076 | 19,861,870 | 0.50 | 36.57 | 3,586,737 | 726,368,448 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,639 | 19,763,794 | 0.05 | 36.75 | 390,999 | 726,349,075 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69,397 | 19,753,155 | 0.35 | 35.88 | 2,490,291 | 708,836,041 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,137 | 19,683,758 | 0.32 | 36.74 | 2,319,502 | 723,134,028 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,505 | 19,620,621 | 0.13 | 35.91 | 915,851 | 704,550,993 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,839 | 19,595,116 | 0.12 | 35.55 | 811,963 | 696,637,726 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,116 | 19,572,277 | 0.07 | 35.56 | 466,413 | 696,001,913 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17,098 | 19,559,161 | 0.09 | 34.91 | 596,816 | 682,724,250 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104,140 | 19,542,063 | 0.54 | 35.98 | 3,746,947 | 703,121,473 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,006 | 19,437,923 | 0.15 | 35.28 | 1,023,471 | 685,863,225 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,500 | 19,408,917 | 0.07 | 34.26 | 462,530 | 664,978,610 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,769 | 19,395,417 | 0.13 | 34.58 | 890,989 | 670,615,938 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866,669 | 19,369,648 | 4.68 | 33.79 | 29,287,172 | 654,554,641 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,394 | 18,502,979 | 0.02 | 33.71 | 148,139 | 623,807,584 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,166 | 18,498,585 | 0.21 | 34.83 | 1,329,390 | 644,339,013 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252,474 | 18,460,419 | 1.39 | 34.41 | 8,686,949 | 635,173,175 | |
2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 1,421,519 | 0.63 | 2.16 | 19,254 | 3,070,481 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1,348,711 | 0.05 | 28.54 | 19,978 | 38,492,212 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11,419,665 | 0.01 | 28.54 | 19,978 | 325,917,239 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192,618 | 0.36 | 28.54 | 19,978 | 5,497,318 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353,277 | 0.20 | 28.54 | 19,978 | 10,082,526 | |
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7,000 | 7,000 | |||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 1,412,605 | 0.44 | 2.83 | 17,495 | 3,997,672 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304,629 | 0.24 | 27.86 | 19,948 | 8,486,964 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,348,011 | 0.05 | 27.86 | 19,948 | 37,555,586 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11,418,965 | 0.01 | 27.86 | 19,948 | 318,132,365 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,908,088 | 0.04 | 27.86 | 19,948 | 53,159,332 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191,918 | 0.37 | 27.86 | 19,948 | 5,346,835 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352,577 | 0.20 | 27.86 | 19,948 | 9,822,795 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 257,722 | 1.68 | 60.45 | 256,912 | 15,579,295 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 1,893,297 | 0.22 | 60.45 | 256,912 | 114,449,804 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 212,711 | 2.04 | 60.45 | 256,912 | 12,858,380 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 322,445 | 1.34 | 60.45 | 256,912 | 19,491,800 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416,208 | 0.16 | 39.80 | 26,668 | 16,566,494 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27,046 | 18,207,945 | 0.15 | 39.80 | 1,076,523 | 724,738,118 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,471 | 415,538 | 0.36 | 39.93 | 58,731 | 16,590,770 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,400 | 18,180,899 | 0.33 | 39.93 | 2,371,604 | 725,890,573 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,938 | 414,067 | 0.47 | 39.99 | 77,503 | 16,559,036 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,262 | 18,121,499 | 0.43 | 39.99 | 3,129,791 | 724,700,491 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,155 | 412,129 | 0.28 | 39.84 | 46,021 | 16,421,239 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,653 | 18,043,237 | 0.26 | 39.84 | 1,858,884 | 718,930,974 | |
2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,534 | 410,974 | 1.36 | 38.96 | 215,578 | 16,009,574 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223,466 | 17,996,584 | 1.26 | 38.96 | 8,705,163 | 701,060,529 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405,440 | 0.13 | 38.56 | 20,591 | 15,633,847 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,559 | 17,773,118 | 0.12 | 38.56 | 831,319 | 685,334,985 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404,906 | 0.12 | 37.52 | 17,895 | 15,190,413 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,223 | 17,751,559 | 0.11 | 37.52 | 721,168 | 665,965,712 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,757 | 404,429 | 0.94 | 37.40 | 140,504 | 15,124,795 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,530 | 17,732,336 | 0.86 | 37.40 | 5,666,904 | 663,152,128 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,411 | 400,672 | 0.61 | 37.67 | 90,826 | 15,093,995 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,254 | 17,580,806 | 0.56 | 37.67 | 3,663,724 | 662,298,849 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398,261 | 0.12 | 37.63 | 18,667 | 14,988,274 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,011 | 17,483,552 | 0.11 | 37.63 | 753,100 | 657,981,241 | |
2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 397,765 | 0.39 | 36.04 | 55,281 | 14,334,377 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,878 | 17,463,541 | 0.36 | 36.04 | 2,229,916 | 629,338,866 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396,231 | 0.14 | 36.39 | 20,817 | 14,419,995 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,058 | 17,401,663 | 0.13 | 36.39 | 839,147 | 633,296,981 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395,659 | 0.00 | 35.27 | 670 | 13,956,001 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17,378,605 | 0.00 | 35.27 | 27,548 | 612,992,058 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,137 | 395,640 | 0.54 | 34.38 | 73,479 | 13,603,725 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86,201 | 17,377,824 | 0.50 | 34.38 | 2,963,944 | 597,520,838 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393,503 | 0.07 | 35.11 | 9,481 | 13,817,386 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,896 | 17,291,623 | 0.06 | 35.11 | 382,600 | 607,174,592 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,809 | 393,233 | 0.46 | 34.05 | 61,604 | 13,391,196 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,980 | 17,280,727 | 0.42 | 34.05 | 2,485,268 | 588,479,605 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391,424 | 0.12 | 34.21 | 16,421 | 13,391,046 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,348 | 17,207,747 | 0.11 | 34.21 | 661,916 | 588,695,953 | |
2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,151 | 390,944 | 0.30 | 34.08 | 39,232 | 13,325,287 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,460 | 17,188,399 | 0.27 | 34.08 | 1,583,584 | 585,864,861 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,921 | 389,793 | 0.76 | 34.03 | 99,415 | 13,266,449 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117,879 | 17,141,939 | 0.69 | 34.03 | 4,011,965 | 583,419,037 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 17,178,061 | 0.02 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383,372 | 0.13 | 34.26 | 17,304 | 13,136,012 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,395 | 17,020,560 | 0.12 | 34.26 | 698,822 | 583,199,276 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382,867 | 0.00 | 34.10 | 239 | 13,055,765 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17,000,165 | 0.00 | 34.10 | 9,991 | 579,705,626 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 253,472 | 3.26 | 65.10 | 520,800 | 16,501,027 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 1,889,047 | 0.43 | 65.10 | 520,800 | 122,976,960 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 208,461 | 3.99 | 65.10 | 520,800 | 13,570,811 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 318,195 | 2.58 | 65.10 | 520,800 | 20,714,494 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,347,295 | 0.06 | 26.57 | 19,981 | 35,797,628 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11,418,249 | 0.01 | 26.57 | 19,981 | 303,382,876 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,907,372 | 0.04 | 26.57 | 19,981 | 50,678,874 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191,202 | 0.39 | 26.57 | 19,981 | 5,080,237 | |
2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80,000 | 80,000 | |||||
2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60,000 | 60,000 | |||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9,031 | 211,614 | 4.46 | 105.75 | 955,028 | 22,378,180 | |
2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365,969 | 8,172,521 | 4.69 | 105.75 | 38,701,222 | 864,244,096 | |
2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,738 | 452,540 | 2.66 | 28.50 | 334,533 | 12,897,390 | |
2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475,644 | 18,476,847 | 2.64 | 28.50 | 13,555,854 | 526,590,140 | |
2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,934 | 1,552,055 | 2.57 | 28.50 | 1,109,619 | 44,233,568 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11,243,600 | 0.01 | 29.27 | 19,962 | 329,100,172 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1,732,723 | 0.04 | 29.27 | 19,962 | 50,716,802 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16,553 | 4.30 | 29.27 | 19,962 | 484,506 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177,212 | 0.39 | 29.27 | 19,962 | 5,186,995 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361,052 | 0.18 | 39.91 | 25,504 | 14,410,344 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,596 | 16,513,298 | 0.16 | 39.91 | 1,021,590 | 659,080,401 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,280 | 360,413 | 0.36 | 39.92 | 51,100 | 14,388,372 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51,244 | 16,487,702 | 0.31 | 39.92 | 2,045,758 | 658,220,390 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,063 | 359,133 | 0.30 | 39.65 | 42,153 | 14,241,383 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,646 | 16,436,458 | 0.26 | 39.65 | 1,691,123 | 651,786,098 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,486 | 358,070 | 0.70 | 39.70 | 98,694 | 14,215,379 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99,775 | 16,393,812 | 0.61 | 39.70 | 3,961,068 | 650,834,336 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,377 | 355,584 | 0.39 | 39.54 | 54,442 | 14,058,725 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55,256 | 16,294,037 | 0.34 | 39.54 | 2,184,656 | 644,217,341 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,056 | 354,207 | 0.87 | 39.53 | 120,798 | 14,001,201 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122,660 | 16,238,781 | 0.76 | 39.53 | 4,848,541 | 641,891,407 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,492 | 351,151 | 1.59 | 43.98 | 241,512 | 15,441,935 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219,958 | 16,116,121 | 1.38 | 43.98 | 9,672,697 | 708,709,644 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345,659 | 0.16 | 44.00 | 24,332 | 15,208,823 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,147 | 15,896,163 | 0.14 | 44.00 | 974,457 | 699,423,224 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,863 | 345,106 | 0.84 | 44.05 | 126,102 | 15,200,366 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114,663 | 15,874,016 | 0.73 | 44.05 | 5,050,389 | 699,178,972 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342,243 | 0.05 | 43.42 | 7,382 | 14,861,800 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,814 | 15,759,353 | 0.04 | 43.42 | 295,896 | 684,345,176 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,512 | 342,073 | 0.74 | 42.95 | 107,883 | 14,691,043 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,626 | 15,752,539 | 0.64 | 42.95 | 4,321,595 | 676,525,868 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339,561 | 0.10 | 43.72 | 14,864 | 14,845,233 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,632 | 15,651,913 | 0.09 | 43.72 | 595,976 | 684,284,419 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,011 | 339,221 | 0.30 | 43.01 | 43,479 | 14,588,403 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,471 | 15,638,281 | 0.26 | 43.01 | 1,740,480 | 672,533,657 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,818 | 338,210 | 0.54 | 43.20 | 78,547 | 14,612,329 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,807 | 15,597,810 | 0.47 | 43.20 | 3,145,619 | 673,901,821 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336,392 | 0.14 | 43.64 | 19,858 | 14,681,829 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,232 | 15,525,003 | 0.12 | 43.64 | 795,736 | 677,588,756 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335,937 | 0.09 | 42.65 | 12,369 | 14,328,721 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,617 | 15,506,771 | 0.07 | 42.65 | 495,500 | 661,410,303 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,551 | 335,647 | 1.07 | 42.56 | 151,129 | 14,284,968 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142,220 | 15,495,154 | 0.93 | 42.56 | 6,052,812 | 659,466,007 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,632 | 332,096 | 0.80 | 42.41 | 111,631 | 14,085,188 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105,414 | 15,352,934 | 0.69 | 42.41 | 4,470,924 | 651,163,990 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,816 | 329,464 | 0.86 | 42.31 | 119,144 | 13,939,556 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112,797 | 15,247,520 | 0.75 | 42.31 | 4,772,419 | 645,119,522 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127,000 | 892,000 | -12.46 | 432.60 | -54,940,390 | 385,880,538 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4,567,000 | 31,967,000 | -12.50 | 432.60 | -1,975,691,050 | 13,828,972,150 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1,084,000 | 7,587,000 | -12.50 | 432.60 | -468,940,026 | 3,282,147,580 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2,459,000 | 1,019,000 | -70.70 | 425.88 | -1,047,233,756 | 433,969,580 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88,153,000 | 36,534,000 | -70.70 | 425.88 | -37,542,414,519 | 15,559,023,199 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20,922,000 | 8,671,000 | -70.70 | 425.88 | -8,910,217,424 | 3,692,787,271 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170,000 | 6,050,000 | 2.89 | 104.52 | 17,768,043 | 632,333,295 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6,830,000 | 243,450,000 | 2.89 | 104.52 | 713,857,257 | 25,444,882,755 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242,000 | 5,880,000 | 4.29 | 104.25 | 25,228,500 | 612,990,000 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9,758,000 | 236,620,000 | 4.30 | 104.25 | 1,017,271,500 | 24,667,635,000 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61,000 | 5,638,000 | 1.09 | 103.75 | 6,328,750 | 584,942,500 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2,439,000 | 226,862,000 | 1.09 | 103.75 | 253,046,250 | 23,536,932,500 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121,000 | 5,577,000 | 2.22 | 104.75 | 12,674,750 | 584,190,750 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4,879,000 | 224,423,000 | 2.22 | 104.75 | 511,075,250 | 23,508,309,250 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133,000 | 5,674,000 | 2.40 | 104.09 | 13,844,090 | 590,611,767 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,367,000 | 228,326,000 | 2.41 | 104.09 | 558,655,860 | 23,766,658,833 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85,000 | 5,541,000 | 1.56 | 104.12 | 8,850,625 | 576,956,625 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3,415,000 | 222,959,000 | 1.56 | 104.12 | 355,586,875 | 23,215,605,875 | |
2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8,721 | 40,308 | 27.61 | 17.50 | 152,618 | 705,390 | |
2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346,965 | 2,213,897 | 18.58 | 17.50 | 6,071,888 | 38,743,198 | |
2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44,314 | 125,869 | 54.34 | 17.50 | 775,495 | 2,202,708 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302,479 | 0.22 | 30.33 | 19,957 | 9,174,188 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11,242,918 | 0.01 | 30.33 | 19,957 | 340,997,703 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1,732,041 | 0.04 | 30.33 | 19,957 | 52,532,804 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15,871 | 4.33 | 30.33 | 19,957 | 481,367 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176,530 | 0.37 | 30.33 | 19,957 | 5,354,155 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196,794 | 0.34 | 30.33 | 19,957 | 5,968,762 | |
2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25,663 | 202,583 | 14.51 | 56.63 | 1,453,296 | 11,472,275 | |
2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,024,337 | 7,806,552 | 15.10 | 56.63 | 58,008,204 | 442,085,040 | |
2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,705 | 145,533 | 20.45 | 4.40 | 108,702 | 640,345 | |
2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991,161 | 4,832,285 | 25.80 | 4.40 | 4,361,108 | 21,262,054 | |
2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120,498 | 1,642,513 | 7.92 | 4.40 | 530,191 | 7,227,057 | |
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81,555 | ||||||||
2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1,866,932 | ||||||||
2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31,587 | ||||||||
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1,731,383 | 0.04 | 32.85 | 19,907 | 56,875,932 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15,213 | 4.15 | 32.85 | 19,907 | 499,747 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175,872 | 0.35 | 32.85 | 19,907 | 5,777,395 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 380,839 | 2.70 | 4.44 | 44,400 | 1,690,925 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 380,839 | 2.70 | 4.44 | 44,400 | 1,690,925 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 12,455,783 | 0.08 | 4.44 | 44,400 | 55,303,677 | |
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5,437 | 440,802 | 1.25 | 14.46 | 78,641 | 6,375,804 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217,986 | 18,001,203 | 1.23 | 14.46 | 3,152,971 | 260,371,200 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26,577 | 1,513,121 | 1.79 | 14.46 | 384,412 | 21,885,933 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3,790 | 435,365 | 0.88 | 14.55 | 55,145 | 6,334,648 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151,980 | 17,783,217 | 0.86 | 14.55 | 2,211,339 | 258,749,364 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18,530 | 1,486,544 | 1.26 | 14.55 | 269,615 | 21,629,513 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4,312 | 431,575 | 1.01 | 14.58 | 62,885 | 6,294,003 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172,893 | 17,631,237 | 0.99 | 14.58 | 2,521,437 | 257,130,434 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21,080 | 1,468,014 | 1.46 | 14.58 | 307,427 | 21,409,223 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5,437 | 427,263 | 1.29 | 14.46 | 78,600 | 6,176,728 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217,986 | 17,458,344 | 1.26 | 14.46 | 3,151,315 | 252,386,550 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26,577 | 1,446,934 | 1.87 | 14.46 | 384,210 | 20,917,601 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,775 | 421,826 | 0.66 | 14.42 | 40,004 | 6,081,001 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111,266 | 17,240,358 | 0.65 | 14.42 | 1,604,000 | 248,535,277 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,566 | 1,420,357 | 0.96 | 14.42 | 195,566 | 20,475,724 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,552 | 419,051 | 2.83 | 14.45 | 166,955 | 6,056,335 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463,197 | 17,129,092 | 2.78 | 14.45 | 6,694,355 | 247,558,202 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56,475 | 1,406,791 | 4.18 | 14.45 | 816,205 | 20,331,647 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407,499 | 0.22 | 14.50 | 12,903 | 5,907,798 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35,702 | 16,665,895 | 0.21 | 14.50 | 517,597 | 241,617,146 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,353 | 1,350,316 | 0.32 | 14.50 | 63,108 | 19,576,476 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,189 | 406,609 | 1.29 | 14.00 | 72,641 | 5,692,119 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208,063 | 16,630,193 | 1.27 | 14.00 | 2,912,674 | 232,806,072 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,368 | 1,345,963 | 1.92 | 14.00 | 355,127 | 18,842,136 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,511 | 401,420 | 2.95 | 14.08 | 162,100 | 5,652,877 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461,548 | 16,422,130 | 2.89 | 14.08 | 6,499,611 | 231,259,719 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56,274 | 1,320,595 | 4.45 | 14.08 | 792,462 | 18,596,883 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,735 | 301,215 | 1.60 | 35.82 | 169,584 | 10,788,015 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189,886 | 11,241,654 | 1.72 | 35.82 | 6,800,767 | 402,619,838 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,152 | 1,730,777 | 1.36 | 35.82 | 829,189 | 61,987,778 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,558 | 296,480 | 1.21 | 36.62 | 130,294 | 10,857,098 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142,702 | 11,051,768 | 1.31 | 36.62 | 5,225,747 | 404,715,744 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,399 | 1,707,625 | 1.03 | 36.62 | 637,151 | 62,533,228 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,790 | 292,922 | 0.96 | 36.69 | 102,356 | 10,746,400 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111,907 | 10,909,066 | 1.04 | 36.69 | 4,105,521 | 400,219,813 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,644 | 1,690,226 | 0.81 | 36.69 | 500,556 | 62,009,152 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,114 | 290,132 | 0.39 | 36.75 | 40,942 | 10,662,989 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44,627 | 10,797,159 | 0.42 | 36.75 | 1,640,140 | 396,819,347 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,501 | 1,676,582 | 0.33 | 36.75 | 202,174 | 61,618,077 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,021 | 289,018 | 0.35 | 36.82 | 37,595 | 10,642,105 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,933 | 10,752,532 | 0.38 | 36.82 | 1,507,219 | 395,925,432 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,046 | 1,671,081 | 0.30 | 36.82 | 185,802 | 61,531,876 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,613 | 287,997 | 0.56 | 36.93 | 59,574 | 10,636,852 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64,679 | 10,711,599 | 0.61 | 36.93 | 2,388,848 | 395,621,126 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,974 | 1,666,035 | 0.48 | 36.93 | 294,511 | 61,533,170 | |
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 489,039 | 1.75 | ||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 489,039 | 1.75 | ||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 1,947,430 | 0.43 | ||||
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,358 | 286,384 | 0.48 | 36.93 | 50,154 | 10,576,877 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54,399 | 10,646,920 | 0.51 | 36.93 | 2,009,091 | 393,217,373 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6,760 | 1,658,061 | 0.41 | 36.93 | 249,664 | 61,236,338 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285,026 | 0.12 | 36.99 | 12,280 | 10,542,371 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,313 | 10,592,521 | 0.13 | 36.99 | 492,413 | 391,789,811 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,655 | 1,651,301 | 0.10 | 36.99 | 61,214 | 61,077,331 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284,694 | 0.01 | 36.18 | 1,266 | 10,300,969 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,392 | 10,579,208 | 0.01 | 36.18 | 50,366 | 382,783,251 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1,649,646 | 0.01 | 36.18 | 6,260 | 59,688,481 | |
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,184 | 389,909 | 12.45 | 12.50 | 539,800 | 4,873,862 | |
2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,730,970 | 15,960,582 | 12.16 | 12.50 | 21,637,125 | 199,507,275 | |
2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,846 | 1,264,321 | 20.93 | 12.50 | 2,735,575 | 15,804,012 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284,659 | 0.15 | 36.54 | 15,273 | 10,401,212 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,768 | 10,577,816 | 0.16 | 36.54 | 612,689 | 386,504,934 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,120 | 1,649,473 | 0.13 | 36.54 | 77,463 | 60,270,424 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,129 | 284,241 | 0.40 | 36.41 | 41,111 | 10,350,295 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45,279 | 10,561,048 | 0.43 | 36.41 | 1,648,780 | 384,567,890 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,725 | 1,647,353 | 0.35 | 36.41 | 208,469 | 59,986,383 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283,112 | 0.21 | 35.53 | 20,928 | 10,059,507 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,610 | 10,515,769 | 0.23 | 35.53 | 838,908 | 373,645,253 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,985 | 1,641,628 | 0.18 | 35.53 | 106,063 | 58,330,162 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,516 | 282,523 | 1.26 | 34.02 | 119,609 | 9,610,980 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140,962 | 10,492,159 | 1.36 | 34.02 | 4,795,302 | 356,926,462 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,822 | 1,638,643 | 1.10 | 34.02 | 606,276 | 55,744,013 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,104 | 279,007 | 0.40 | 34.74 | 38,358 | 9,694,098 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44,244 | 10,351,197 | 0.43 | 34.74 | 1,537,258 | 359,652,340 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,594 | 1,620,821 | 0.35 | 34.74 | 194,364 | 56,315,426 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277,903 | 0.26 | 27.99 | 19,985 | 7,778,505 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277,903 | 0.26 | 27.99 | 19,985 | 7,778,505 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10,306,953 | 0.01 | 27.99 | 19,985 | 288,491,614 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1,615,227 | 0.04 | 27.99 | 19,985 | 45,210,204 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14,607 | 5.14 | 27.99 | 19,985 | 408,850 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175,266 | 0.41 | 27.99 | 19,985 | 4,905,695 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277,189 | 0.22 | 27.63 | 16,912 | 7,659,813 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,508 | 10,306,239 | 0.24 | 27.64 | 677,325 | 284,832,497 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,080 | 1,614,513 | 0.19 | 27.64 | 85,122 | 44,620,134 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276,577 | 0.16 | 27.97 | 12,672 | 7,736,744 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18,151 | 10,281,731 | 0.18 | 27.97 | 507,742 | 287,612,918 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,281 | 1,611,433 | 0.14 | 27.97 | 63,807 | 45,076,938 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276,124 | 0.28 | 28.43 | 21,551 | 7,850,509 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30,102 | 10,263,580 | 0.29 | 28.43 | 855,833 | 291,804,869 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,940 | 1,609,152 | 0.25 | 28.43 | 112,019 | 45,749,961 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275,366 | 0.14 | 28.58 | 10,718 | 7,870,098 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14,878 | 10,233,478 | 0.15 | 28.58 | 425,221 | 292,477,918 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,947 | 1,605,212 | 0.12 | 28.58 | 55,646 | 45,877,762 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,742 | 274,991 | 0.64 | 28.23 | 49,180 | 7,763,463 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69,187 | 10,218,600 | 0.68 | 28.23 | 1,953,267 | 288,488,450 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,055 | 1,603,265 | 0.57 | 28.23 | 255,638 | 45,262,897 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273,249 | 0.29 | 27.96 | 22,033 | 7,640,288 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31,584 | 10,149,413 | 0.31 | 27.96 | 883,117 | 283,786,722 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,004 | 1,594,210 | 0.25 | 27.96 | 111,955 | 44,575,546 | |
2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20,099 | 176,920 | 12.82 | 47.53 | 955,305 | 8,409,008 | |
2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839,621 | 6,782,215 | 14.13 | 47.53 | 39,907,186 | 322,358,679 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272,461 | 0.13 | 27.24 | 9,997 | 7,421,838 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272,461 | 0.13 | 27.24 | 9,997 | 7,421,838 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 10,117,829 | 0.00 | 27.24 | 9,997 | 275,609,662 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 1,590,206 | 0.02 | 27.24 | 9,997 | 43,317,211 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 13,893 | 2.71 | 27.24 | 9,997 | 378,445 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 174,552 | 0.21 | 27.24 | 9,997 | 4,754,796 | |
2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
1,045,475 | ||||||||
2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
14,229,612 | ||||||||
2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
346,725 | ||||||||
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271,806 | 0.00 | 27.54 | 165 | 7,485,537 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10,117,174 | 0.00 | 27.54 | 7,381 | 278,626,972 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1,589,551 | 0.00 | 27.54 | 716 | 43,776,235 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,859 | 271,800 | 1.82 | 26.83 | 130,352 | 7,291,551 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202,311 | 10,116,906 | 2.04 | 26.83 | 5,427,377 | 271,405,226 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21,830 | 1,589,525 | 1.39 | 26.83 | 585,631 | 42,642,028 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,223 | 266,941 | 0.84 | 27.32 | 60,725 | 7,291,894 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92,592 | 9,914,595 | 0.94 | 27.32 | 2,529,289 | 270,832,034 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,352 | 1,567,695 | 0.54 | 27.32 | 228,147 | 42,823,940 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,231 | 264,718 | 0.85 | 27.99 | 62,450 | 7,409,960 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92,917 | 9,822,003 | 0.96 | 27.99 | 2,600,923 | 274,936,526 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,691 | 1,559,343 | 0.56 | 27.99 | 243,278 | 43,648,973 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,298 | 262,487 | 1.66 | 27.94 | 120,075 | 7,333,204 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178,978 | 9,729,086 | 1.87 | 27.94 | 5,000,180 | 271,805,367 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,724 | 1,550,652 | 1.09 | 27.94 | 467,225 | 43,321,185 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258,189 | 0.06 | 27.86 | 3,983 | 7,192,010 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258,046 | 0.01 | 26.68 | 640 | 6,884,693 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258,022 | 0.03 | 27.16 | 2,146 | 7,008,187 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,905 | 257,943 | 3.99 | 27.84 | 275,793 | 7,182,113 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248,038 | 0.26 | 26.91 | 17,516 | 6,673,735 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247,387 | 0.13 | 25.83 | 8,367 | 6,388,868 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,972 | 9,550,108 | 0.06 | 27.86 | 166,354 | 266,023,988 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9,544,136 | 0.01 | 26.68 | 26,146 | 254,638,503 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,298 | 9,543,156 | 0.03 | 27.16 | 89,578 | 259,203,569 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412,596 | 9,539,858 | 4.52 | 27.84 | 11,488,241 | 265,625,898 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27,125 | 9,127,262 | 0.30 | 26.91 | 729,828 | 245,579,024 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,447 | 9,100,137 | 0.15 | 25.83 | 347,274 | 235,014,678 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1,533,928 | 0.04 | 27.86 | 16,296 | 42,728,485 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1,533,343 | 0.01 | 26.68 | 2,561 | 40,909,745 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1,533,247 | 0.02 | 27.16 | 8,773 | 41,644,828 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,412 | 1,532,924 | 2.71 | 27.84 | 1,125,224 | 42,682,429 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,657 | 1,492,512 | 0.18 | 26.91 | 71,490 | 40,157,677 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,316 | 1,489,855 | 0.09 | 25.83 | 33,986 | 38,476,101 | |
2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103,608 | 463,839 | 28.76 | 3.00 | 310,824 | 1,391,517 | |
2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4,282,419 | 17,888,512 | 31.47 | 3.00 | 12,847,257 | 53,665,536 | |
2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336,639 | 1,922,230 | 21.23 | 3.00 | 1,009,917 | 5,766,690 | |
2012-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 288 | 288 | 35.89 | 10,336 | 10,336 | ||
2012-07-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Stock Options (right to buy) |
A - Award | 16,500 | 16,500 | |||||
2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21,082 | 156,821 | 15.53 | 41.20 | 868,578 | 6,461,025 | |
2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864,918 | 5,942,594 | 17.03 | 41.20 | 35,634,622 | 244,834,873 | |
2012-06-29 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy) |
A - Award | 7,500 | 7,500 | |||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12,500 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12,500 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -25,000 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -4,023 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -147,292 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -46,195 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -998 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -205 | 0 | -100.00 | ||||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -116,454 | 0 | -100.00 | 32.00 | -3,726,528 | ||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -4,922,226 | 0 | -100.00 | 32.00 | -157,511,232 | ||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -1,646,964 | 0 | -100.00 | 32.00 | -52,702,848 | ||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -99,636 | 0 | -100.00 | 32.00 | -3,188,352 | ||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -65,882 | 0 | -100.00 | 32.00 | -2,108,224 | ||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -60,827 | 0 | -100.00 | 32.00 | -1,946,464 | ||
2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -2,302 | 0 | -100.00 | 32.00 | -73,664 | ||
2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 380 | 247,063 | 0.15 | 32.94 | 12,518 | 8,138,922 | |
2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,026 | 9,086,690 | 0.19 | 32.94 | 560,882 | 299,340,103 | |
2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,732 | 246,683 | 1.12 | 32.21 | 87,992 | 7,945,166 | |
2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 546 | 243,951 | 0.22 | 32.04 | 17,493 | 7,815,922 | |
2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 122,268 | 9,069,664 | 1.37 | 32.21 | 3,938,008 | 292,115,738 | |
2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,454 | 8,947,396 | 0.27 | 32.04 | 783,479 | 286,664,726 | |
2012-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 17,500 | 17,500 | |||||
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 517 | 243,405 | 0.21 | 34.46 | 17,815 | 8,387,176 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,104 | 8,922,942 | 0.26 | 34.46 | 796,111 | 307,464,059 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,972 | 242,888 | 0.82 | 34.25 | 67,541 | 8,318,914 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 540 | 240,916 | 0.22 | 33.11 | 17,882 | 7,977,668 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 555 | 240,376 | 0.23 | 34.47 | 19,129 | 8,285,160 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 88,028 | 8,899,838 | 1.00 | 34.25 | 3,014,959 | 304,819,452 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,136 | 8,811,810 | 0.27 | 33.11 | 799,237 | 291,793,395 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,769 | 8,787,674 | 0.28 | 34.47 | 853,726 | 302,889,154 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,212 | 239,821 | 1.36 | 33.92 | 108,951 | 8,134,728 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 897 | 236,609 | 0.38 | 33.67 | 30,198 | 7,965,513 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 370 | 235,712 | 0.16 | 32.59 | 12,058 | 7,681,501 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 175 | 235,342 | 0.07 | 31.53 | 5,517 | 7,419,863 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143,388 | 8,762,905 | 1.66 | 33.92 | 4,863,721 | 297,237,738 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,073 | 8,619,517 | 0.47 | 33.67 | 1,349,070 | 290,178,626 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,526 | 8,579,444 | 0.19 | 32.59 | 538,558 | 279,591,211 | |
2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,797 | 8,562,918 | 0.09 | 31.53 | 245,824 | 269,971,679 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 627 | 235,167 | 0.27 | 30.22 | 18,946 | 7,105,877 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26,033 | 8,555,121 | 0.31 | 30.22 | 786,621 | 258,504,103 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 214 | 234,540 | 0.09 | 29.98 | 6,415 | 7,030,829 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,867 | 8,529,088 | 0.10 | 29.98 | 265,807 | 255,677,324 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,402 | 234,326 | 0.60 | 29.86 | 41,861 | 6,996,599 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 58,198 | 8,520,221 | 0.69 | 29.86 | 1,737,699 | 254,400,167 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 460 | 232,924 | 0.20 | 29.90 | 13,752 | 6,963,379 | |
2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,087 | 8,462,023 | 0.23 | 29.90 | 570,615 | 252,976,409 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 116 | 232,464 | 0.05 | 28.50 | 3,306 | 6,624,620 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,737 | 232,348 | 0.75 | 28.90 | 50,196 | 6,714,416 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 172 | 230,611 | 0.07 | 28.41 | 4,886 | 6,550,529 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,811 | 8,442,936 | 0.06 | 28.50 | 137,101 | 240,601,724 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 72,073 | 8,438,125 | 0.86 | 28.90 | 2,082,773 | 243,845,780 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,124 | 8,366,052 | 0.09 | 28.41 | 202,358 | 237,638,544 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 536 | 230,439 | 0.23 | 28.28 | 15,159 | 6,517,184 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 754 | 229,903 | 0.33 | 28.25 | 21,300 | 6,494,530 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,241 | 8,358,928 | 0.27 | 28.28 | 629,011 | 236,403,858 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31,273 | 8,336,687 | 0.38 | 28.25 | 883,431 | 235,503,071 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 722 | 1,488,539 | 0.05 | 28.28 | 20,419 | 42,098,265 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,014 | 1,487,817 | 0.07 | 28.25 | 28,644 | 42,029,342 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 | 229,149 | 0.00 | 28.00 | 140 | 6,416,172 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 369 | 229,144 | 0.16 | 27.99 | 10,330 | 6,414,863 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 935 | 228,775 | 0.41 | 28.03 | 26,208 | 6,412,540 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 188 | 8,305,414 | 0.00 | 28.00 | 5,264 | 232,551,592 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14,078 | 8,305,226 | 0.17 | 27.99 | 394,112 | 232,503,971 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35,727 | 8,291,148 | 0.43 | 28.03 | 1,001,424 | 232,400,049 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7 | 1,486,803 | 0.00 | 28.00 | 196 | 41,630,484 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 514 | 1,486,796 | 0.03 | 27.99 | 14,389 | 41,622,705 | |
2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,305 | 1,486,282 | 0.09 | 28.03 | 36,579 | 41,660,336 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 910 | 57,704 | 1.60 | 3.01 | 2,735 | 173,429 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1,482 | 56,794 | 2.68 | 2.99 | 4,430 | 169,763 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4,186 | 55,312 | 8.19 | 2.96 | 12,383 | 163,618 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15,076 | 51,126 | 41.82 | 2.55 | 38,444 | 130,371 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 8,628 | 36,050 | 31.46 | 2.34 | 20,186 | 84,343 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1,170 | 27,422 | 4.46 | 1.87 | 2,188 | 51,279 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 430 | 26,252 | 1.67 | 1.89 | 811 | 49,506 | |
2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
25,822 | ||||||||
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 34,544 | 3,540,015 | 0.99 | 3.01 | 103,822 | 10,639,515 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56,294 | 3,505,471 | 1.63 | 2.99 | 168,268 | 10,478,203 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 159,015 | 3,449,177 | 4.83 | 2.96 | 470,382 | 10,203,010 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 572,737 | 3,290,162 | 21.08 | 2.55 | 1,460,479 | 8,389,913 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 327,769 | 2,717,425 | 13.72 | 2.34 | 766,848 | 6,357,688 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 44,467 | 2,389,656 | 1.90 | 1.87 | 83,153 | 4,468,657 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 16,326 | 2,345,189 | 0.70 | 1.89 | 30,788 | 4,422,557 | |
2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
2,328,863 | ||||||||
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4,592 | 232,011 | 2.02 | 3.01 | 13,801 | 697,309 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 7,484 | 227,419 | 3.40 | 2.99 | 22,370 | 679,778 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15,599 | 219,935 | 7.63 | 2.96 | 46,143 | 650,590 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56,187 | 204,336 | 37.93 | 2.55 | 143,277 | 521,057 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 32,155 | 148,149 | 27.72 | 2.34 | 75,230 | 346,609 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4,363 | 115,994 | 3.91 | 1.87 | 8,159 | 216,909 | |
2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1,601 | 111,631 | 1.46 | 1.89 | 3,019 | 210,514 | |
2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
110,030 | ||||||||
2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 516 | 227,840 | 0.23 | 30.36 | 15,668 | 6,918,088 | |
2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 583 | 227,324 | 0.26 | 29.88 | 17,420 | 6,792,259 | |
2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,513 | 8,255,421 | 0.24 | 30.36 | 592,489 | 250,665,952 | |
2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,071 | 8,235,908 | 0.27 | 29.88 | 659,464 | 246,082,342 | |
2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,162 | 1,484,977 | 0.15 | 30.36 | 65,647 | 45,089,545 | |
2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,346 | 1,482,815 | 0.16 | 29.88 | 70,097 | 44,305,326 | |
2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
360,231 | ||||||||
2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
1,585,591 | ||||||||
2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
13,606,093 | ||||||||
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,845 | 226,741 | 0.82 | 30.07 | 55,477 | 6,817,830 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,254 | 224,896 | 1.01 | 29.96 | 67,521 | 6,737,007 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,419 | 222,642 | 1.10 | 29.52 | 71,410 | 6,572,503 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 405 | 220,223 | 0.18 | 29.47 | 11,936 | 6,490,060 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69,783 | 8,213,837 | 0.86 | 30.07 | 2,098,291 | 246,980,222 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 85,231 | 8,144,054 | 1.06 | 29.96 | 2,553,188 | 243,964,096 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91,459 | 8,058,823 | 1.15 | 29.52 | 2,699,915 | 237,900,484 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 15,288 | 7,967,364 | 0.19 | 29.47 | 450,543 | 234,801,404 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,372 | 1,480,469 | 0.57 | 30.07 | 251,736 | 44,515,926 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,225 | 1,472,097 | 0.70 | 29.96 | 306,301 | 44,098,285 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,972 | 1,461,872 | 0.76 | 29.52 | 323,899 | 43,155,192 | |
2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,763 | 1,450,900 | 0.12 | 29.47 | 51,956 | 42,758,603 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,149 | 219,818 | 1.92 | 29.06 | 120,562 | 6,387,493 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,353 | 215,669 | 0.63 | 29.11 | 39,384 | 6,277,801 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 974 | 214,316 | 0.46 | 29.03 | 28,276 | 6,221,722 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 156,902 | 7,952,076 | 2.01 | 29.06 | 4,559,274 | 231,072,220 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 51,248 | 7,795,174 | 0.66 | 29.11 | 1,491,752 | 226,905,822 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 36,881 | 7,743,926 | 0.48 | 29.03 | 1,070,678 | 224,810,818 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,552 | 1,449,137 | 1.37 | 29.06 | 568,144 | 42,109,168 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,934 | 1,429,585 | 0.42 | 29.11 | 172,730 | 41,613,075 | |
2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,270 | 1,423,651 | 0.30 | 29.03 | 123,961 | 41,329,443 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,639 | 213,342 | 0.77 | 28.12 | 46,095 | 5,999,988 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 145 | 211,703 | 0.07 | 27.98 | 4,057 | 5,923,683 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,238 | 211,558 | 0.59 | 27.98 | 34,635 | 5,918,737 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 62,098 | 7,707,045 | 0.81 | 28.12 | 1,746,432 | 216,751,392 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,511 | 7,644,947 | 0.07 | 27.98 | 154,204 | 213,914,027 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 46,909 | 7,639,436 | 0.62 | 27.98 | 1,312,368 | 213,727,737 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,477 | 1,419,381 | 0.53 | 28.12 | 210,282 | 39,918,387 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 638 | 1,411,904 | 0.05 | 27.98 | 17,852 | 39,506,627 | |
2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,217 | 1,411,266 | 0.37 | 27.98 | 145,955 | 39,482,848 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,419 | 210,320 | 1.16 | 29.85 | 72,219 | 6,279,062 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,460 | 207,901 | 1.20 | 29.61 | 72,842 | 6,156,073 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10 | 205,441 | 0.00 | 28.96 | 290 | 5,950,085 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 849 | 205,431 | 0.41 | 28.88 | 24,517 | 5,932,272 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,475 | 204,582 | 0.73 | 28.44 | 41,945 | 5,817,698 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91,543 | 7,592,527 | 1.22 | 29.85 | 2,732,998 | 226,673,375 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 93,088 | 7,500,984 | 1.26 | 29.61 | 2,756,392 | 222,108,637 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 349 | 7,407,896 | 0.00 | 28.96 | 10,108 | 214,551,188 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 32,125 | 7,407,547 | 0.44 | 28.88 | 927,680 | 213,909,216 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 55,804 | 7,375,422 | 0.76 | 28.44 | 1,586,898 | 209,734,875 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,838 | 1,406,049 | 0.78 | 29.85 | 323,566 | 41,977,312 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 11,021 | 1,395,211 | 0.80 | 29.61 | 326,338 | 41,313,035 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 41 | 1,384,190 | 0.00 | 28.96 | 1,187 | 40,089,603 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,944 | 1,384,149 | 0.29 | 28.88 | 113,892 | 39,970,348 | |
2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,341 | 1,380,205 | 0.53 | 28.44 | 208,756 | 39,248,890 | |
2012-02-14 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 150,000 | 557,211 | 36.84 | 20.85 | 3,128,040 | 11,619,855 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 753 | 203,107 | 0.37 | 26.52 | 19,967 | 5,385,666 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 492 | 202,354 | 0.24 | 26.62 | 13,098 | 5,387,048 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,980 | 201,862 | 1.50 | 26.60 | 79,278 | 5,370,195 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 102 | 198,882 | 0.05 | 26.24 | 2,676 | 5,217,868 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,312 | 198,780 | 0.66 | 26.33 | 34,540 | 5,233,162 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64 | 197,468 | 0.03 | 26.27 | 1,681 | 5,187,208 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,594 | 197,404 | 0.81 | 26.26 | 41,851 | 5,182,921 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,585 | 195,810 | 1.87 | 26.18 | 93,840 | 5,125,464 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 161 | 192,225 | 0.08 | 26.17 | 4,213 | 5,029,586 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 28,469 | 7,319,618 | 0.39 | 26.52 | 754,895 | 194,089,919 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18,628 | 7,291,149 | 0.26 | 26.62 | 495,913 | 194,104,240 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 112,735 | 7,272,521 | 1.57 | 26.60 | 2,999,123 | 193,473,058 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,883 | 7,159,786 | 0.05 | 26.24 | 101,874 | 187,844,145 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 49,670 | 7,155,903 | 0.70 | 26.33 | 1,307,632 | 188,389,165 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,441 | 7,106,233 | 0.03 | 26.27 | 64,122 | 186,670,792 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 60,315 | 7,103,792 | 0.86 | 26.26 | 1,583,594 | 186,512,900 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 135,681 | 7,043,477 | 1.96 | 26.18 | 3,551,545 | 184,367,941 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6,093 | 6,907,796 | 0.09 | 26.17 | 159,424 | 180,743,173 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,378 | 1,372,864 | 0.32 | 26.52 | 116,089 | 36,403,411 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,865 | 1,368,486 | 0.21 | 26.62 | 76,272 | 36,431,697 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,339 | 1,365,621 | 1.29 | 26.60 | 461,275 | 36,330,025 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 615 | 1,348,282 | 0.05 | 26.24 | 16,135 | 35,373,527 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,858 | 1,347,667 | 0.59 | 26.33 | 206,873 | 35,479,221 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 387 | 1,339,809 | 0.03 | 26.27 | 10,166 | 35,194,907 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,891 | 1,339,422 | 0.74 | 26.26 | 259,692 | 35,167,060 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,251 | 1,329,531 | 1.70 | 26.18 | 582,436 | 34,801,405 | |
2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 999 | 1,307,280 | 0.08 | 26.17 | 26,139 | 34,205,112 | |
2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 23,172 | 116,454 | 24.84 | 17.00 | 393,924 | 1,979,718 | |
2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 876,828 | 4,922,226 | 21.67 | 17.00 | 14,906,076 | 83,677,842 | |
2012-01-31 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -59,340 | 0 | -100.00 | 0.22 | -13,156 | ||
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12,907 | 407,211 | 3.27 | 17.89 | 230,942 | 7,286,145 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 28,966 | 394,304 | 7.93 | 17.95 | 519,960 | 7,078,033 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3,018 | 365,338 | 0.83 | 18.43 | 55,629 | 6,734,093 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 18,547 | 362,320 | 5.40 | 18.55 | 343,997 | 6,720,058 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 14,629 | 343,773 | 4.44 | 18.01 | 263,424 | 6,190,320 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7,926 | 329,144 | 2.47 | 17.86 | 141,534 | 5,877,491 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,944 | 195,858 | 1.00 | 17.89 | 34,784 | 3,504,448 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4,360 | 193,914 | 2.30 | 17.95 | 78,265 | 3,480,892 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 454 | 189,554 | 0.24 | 18.43 | 8,368 | 3,493,954 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2,792 | 189,100 | 1.50 | 18.55 | 51,784 | 3,507,294 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2,202 | 186,308 | 1.20 | 18.01 | 39,651 | 3,354,848 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,193 | 184,106 | 0.65 | 17.86 | 21,303 | 3,287,562 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 75,149 | 8,574,445 | 0.88 | 17.89 | 1,344,626 | 153,420,829 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 168,641 | 8,499,296 | 2.02 | 17.95 | 3,027,224 | 152,568,313 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 17,571 | 8,330,655 | 0.21 | 18.43 | 323,877 | 153,554,798 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 107,980 | 8,313,084 | 1.32 | 18.55 | 2,002,737 | 154,185,263 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 85,169 | 8,205,104 | 1.05 | 18.01 | 1,533,638 | 147,749,308 | |
2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 46,142 | 8,119,935 | 0.57 | 17.86 | 823,953 | 144,996,867 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7,925 | 321,218 | 2.53 | 16.84 | 133,456 | 5,409,279 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12,694 | 313,293 | 4.22 | 16.88 | 214,254 | 5,287,885 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7,590 | 300,599 | 2.59 | 16.90 | 128,252 | 5,079,372 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -16 | 0 | -100.00 | 1.50 | -24 | ||
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -28 | 16 | -63.64 | 1.25 | -35 | 20 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 16 | 44 | 57.14 | 1.50 | 24 | 66 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 1,600 | 293,009 | 0.55 | 15.00 | 24,000 | 4,395,135 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 2,800 | 291,409 | 0.97 | 15.00 | 42,000 | 4,371,135 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12,041 | 288,609 | 4.35 | 16.44 | 197,940 | 4,744,386 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 31,115 | 276,568 | 12.68 | 16.41 | 510,585 | 4,538,370 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 28 | 28 | 1.25 | 35 | 35 | ||
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 426 | 245,453 | 0.17 | 15.81 | 6,735 | 3,880,391 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,795 | 245,027 | 0.74 | 16.07 | 28,843 | 3,937,241 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3,839 | 243,232 | 1.60 | 16.07 | 61,686 | 3,908,300 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,201 | 182,913 | 0.66 | 16.84 | 20,225 | 3,080,237 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,923 | 181,712 | 1.07 | 16.88 | 32,457 | 3,067,008 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,149 | 179,789 | 0.64 | 16.90 | 19,415 | 3,037,985 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -2 | 0 | -100.00 | 1.50 | -3 | ||
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -5 | 2 | -71.43 | 1.25 | -6 | 2 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 2 | 7 | 40.00 | 1.50 | 3 | 10 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 200 | 178,640 | 0.11 | 15.00 | 3,000 | 2,679,600 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 500 | 178,440 | 0.28 | 15.00 | 7,500 | 2,676,600 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,824 | 177,940 | 1.04 | 16.44 | 29,984 | 2,925,120 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4,712 | 176,116 | 2.75 | 16.41 | 77,322 | 2,889,993 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 5 | 5 | 1.25 | 6 | 6 | ||
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 66 | 171,404 | 0.04 | 15.81 | 1,043 | 2,709,743 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 278 | 171,338 | 0.16 | 16.07 | 4,467 | 2,753,162 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 594 | 171,060 | 0.35 | 16.07 | 9,545 | 2,748,626 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 45,574 | 8,073,793 | 0.57 | 16.84 | 767,462 | 135,961,867 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 72,997 | 8,028,219 | 0.92 | 16.88 | 1,232,073 | 135,503,492 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 43,644 | 7,955,222 | 0.55 | 16.90 | 737,474 | 134,423,364 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -87 | 0 | -100.00 | 1.50 | -130 | ||
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -162 | 87 | -65.06 | 1.25 | -202 | 109 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 87 | 249 | 53.70 | 1.50 | 130 | 373 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 8,700 | 7,911,578 | 0.11 | 15.00 | 130,500 | 118,673,670 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 16,200 | 7,902,878 | 0.21 | 15.00 | 243,000 | 118,543,170 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 69,245 | 7,886,678 | 0.89 | 16.43 | 1,137,958 | 129,608,089 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 178,921 | 7,817,433 | 2.34 | 16.41 | 2,936,022 | 128,280,949 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 162 | 162 | 1.25 | 202 | 202 | ||
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2,449 | 7,638,512 | 0.03 | 15.81 | 38,716 | 120,758,000 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 10,327 | 7,636,063 | 0.14 | 16.07 | 165,940 | 122,700,842 | |
2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 22,081 | 7,625,736 | 0.29 | 16.07 | 354,802 | 122,531,851 | |
2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -20,000 | 59,340 | -25.21 | 0.20 | -4,000 | 11,868 | |
2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -118,800 | 79,340 | -59.96 | 0.21 | -25,233 | 16,852 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,122 | 355,839 | 0.32 | 16.62 | 18,648 | 5,914,115 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,965 | 354,717 | 0.56 | 16.58 | 32,576 | 5,880,463 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,769 | 352,752 | 0.79 | 16.46 | 45,570 | 5,805,345 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,919 | 349,983 | 1.72 | 16.21 | 95,924 | 5,671,859 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,850 | 344,064 | 0.84 | 16.38 | 46,691 | 5,636,697 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 41,677 | 12,430,783 | 0.34 | 16.62 | 692,680 | 206,602,100 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72,978 | 12,389,106 | 0.59 | 16.58 | 1,209,822 | 205,385,360 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 102,856 | 12,316,128 | 0.84 | 16.46 | 1,692,732 | 202,690,213 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 219,881 | 12,213,272 | 1.83 | 16.21 | 3,563,413 | 197,929,507 | |
2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 105,847 | 11,993,391 | 0.89 | 16.38 | 1,734,060 | 196,484,127 | |
2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 29,089 | 135,739 | 27.28 | 25.18 | 732,461 | 3,417,908 | |
2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 1,077,225 | 5,077,676 | 26.93 | 25.18 | 27,124,526 | 127,855,882 | |
2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 187,576 | 1,736,065 | 12.11 | 25.18 | 4,723,164 | 43,714,117 | |
2012-01-05 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Options (Right to Buy) |
A - Award | 12,500 | 12,500 | |||||
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -355,143 | 0 | -100.00 | ||||
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 355,143 | 15,131,223 | 2.40 | 6.25 | 2,219,644 | 94,570,144 | |
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -49,563 | 0 | -100.00 | ||||
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 49,563 | 450,461 | 12.36 | 6.25 | 309,769 | 2,815,381 | |
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -68,006 | 0 | -100.00 | ||||
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 68,006 | 539,130 | 14.43 | 6.25 | 425,038 | 3,369,562 | |
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -339,788 | 0 | -100.00 | ||||
2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 339,788 | 4,966,001 | 7.34 | 6.25 | 2,123,675 | 31,037,506 | |
2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -186,272 | 0 | -100.00 | 4.25 | -791,656 | ||
2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -6,669,338 | 0 | -100.00 | 4.25 | -28,344,686 | ||
2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -12,679 | 0 | -100.00 | 4.25 | -53,886 | ||
2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -79,054 | 0 | -100.00 | 4.25 | -335,980 | ||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | 284,115 | 284,115 | |||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -34,385 | 0 | -100.00 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -249,730 | 0 | -100.00 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | 355,143 | 355,143 | |||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -42,981 | 0 | -100.00 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -312,162 | 0 | -100.00 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 448,047 | 682,908 | 190.77 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -45,090 | 0 | -100.00 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -49,807 | 0 | -100.00 | ||||
2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -353,150 | 0 | -100.00 |